SEC Filing | IMAX Corporation

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting Company

View:

Download DOC

Download PDF

Download XLS

Download XBRL

10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Form 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2013

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file Number 001-35066

IMAX Corporation

(Exact name of registrant as specified in its charter)


Canada		98-0140269
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

2525 Speakman Drive, Mississauga, Ontario, Canada L5K 1B1 (905) 403-6500		110 E. 59^th Street, Suite 2100 New York, New York, USA 10022 (212) 821-0100

(Address of principal executive offices, zip code, telephone numbers)

Securities registered pursuant to Section 12(b) of the Act:


Title of Each Class		Name of Exchange on Which Registered
Common Shares, no par value		The New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act:

None

(Title of class)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

Indicate the number of shares of each of the issuer’s classes of common stock, as of the latest practicable date:


Class		Outstanding as of September 30, 2013
Common stock, no par value		67,518,740

IMAX CORPORATION

Table of Contents


		Page
PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements		4
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		43
Item 3.	Quantitative and Qualitative Factors about Market Risk		76
Item 4.	Controls and Procedures		78

PART II. OTHER INFORMATION
Item 1.	Legal Proceedings		78
Item 1A.	Risk Factors		78
Item 6.	Exhibits		79
Signatures			80

IMAX CORPORATION

SPECIAL NOTE REGARDING FORWARD-LOOKING INFORMATION

Certain statements included in this quarterly report may constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its wholly-owned subsidiaries (the “Company”) and expectations regarding the Company’s future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, general economic, market or business conditions; the opportunities (or lack thereof) that may be presented to and pursued by the Company; the performance of IMAX DMR films; competitive actions by other companies; conditions in the in-home and out-of-home entertainment industries; the signing of theater system agreements; changes in laws or regulations; conditions, changes and developments in the commercial exhibition industry; the failure to convert theater system backlog into revenue; risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the failure to respond to change and advancements in digital technology; risks related to the acquisition of AMC Entertainment Holdings, Inc. by Dalian Wanda Group Co., Ltd.; risks related to new business initiatives; the potential impact of increased competition in the markets within which the Company operates; risks related to the Company’s inability to protect the Company’s intellectual property; risks related to Eastman Kodak bankruptcy and the possibility of constrained analog film supply; risks related to the Company’s implementation of a new enterprise resource planning system; risks related to the Company’s prior restatements and the related litigation; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this quarterly report are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking information, whether as a result of new information, future events or otherwise.

IMAX^®, IMAX^® Dome, IMAX^® 3D, IMAX^® 3D Dome, Experience It In IMAX^®, The IMAX Experience^®, An IMAX Experience^®, An IMAX 3D Experience^®, IMAX DMR^®, DMR^®, IMAX nXos^®, IMAX think big^®, think big^® and IMAX Is Believing are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions.

IMAX CORPORATION

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements


	Page
The following unaudited Condensed Consolidated Financial Statements are filed as part of this Report:

Condensed Consolidated Balance Sheets as at September 30, 2013 (unaudited) and December 31, 2012		5
Condensed Consolidated Statements of Operations for the three and nine month periods ended September 30, 2013 and 2012 (unaudited)		6
Condensed Consolidated Statements of Comprehensive Income for the three and nine month periods ended September 30, 2013 and 2012 (unaudited)		7
Condensed Consolidated Statements of Cash Flows for the nine month periods ended September 30, 2013 and 2012 (unaudited)		8
Notes to Condensed Consolidated Financial Statements (unaudited)		9

IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)


	September 30,			December 31,
	2013			2012
Assets
Cash and cash equivalents	$	25,955		$	21,336
Accounts receivable, net of allowance for doubtful accounts of $1,513 (December 31, 2012 — $1,564)		44,321			42,007
Financing receivables (notes 4 and 18(c))		99,591			94,193
Inventories (note 5)		14,306			15,794
Prepaid expenses		4,576			3,833
Film assets		6,305			3,737
Property, plant and equipment (note 6)		126,930			113,610
Other assets (notes 10(c), 18(d) and 18(e))		27,739			23,963
Deferred income taxes (note 14(a))		31,052			36,461
Goodwill		39,027			39,027
Other intangible assets (note 7)		27,688			27,911

Total assets	$	447,490		$	421,872


Liabilities
Bank indebtedness (note 8)	$	5,000		$	11,000
Accounts payable		17,051			15,144
Accrued and other liabilities (notes 9(a), 9(c), 10, 15(b), 17(a), 17(c) and 18(d))		67,181			68,695
Deferred revenue		73,789			73,954

Total liabilities		163,021			168,793


Commitments, contingencies and guarantees (notes 9 and 10)

Shareholders’ equity
Capital stock (note 15) common shares — no par value. Authorized — unlimited number.
Issued and outstanding — 67,518,740 (December 31, 2012 — 66,482,425)		323,744			313,744
Other equity		33,642			28,892
Deficit		(70,880	)		(87,166	)
Accumulated other comprehensive loss (notes 17(a) and 18(d))		(2,037	)		(2,391	)

Total shareholders’ equity		284,469			253,079

Total liabilities and shareholders’ equity	$	447,490		$	421,872

(the accompanying notes are an integral part of these condensed consolidated financial statements)

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)


	Three Months						Nine Months
	Ended September 30,						Ended September 30,
	2013			2012			2013			2012
				As Revised						As Revised
				(note 3)						(note 3)
Revenues
Equipment and product sales	$	9,623		$	24,327		$	40,649		$	55,756
Services (note 11(c))		29,061			40,316			98,019			102,312
Rentals (note 11(c))		10,987			14,013			38,782			42,912
Finance income		2,071			2,055			6,079			5,537
Other		—			—			375			—

		51,742			80,711			183,904			206,517

Costs and expenses applicable to revenues
Equipment and product sales (note 11(a))		4,086			10,652			20,561			27,727
Services (notes 11(a) and 11(c))		16,339			21,107			54,783			55,378
Rentals (note 11(a))		4,059			4,202			11,687			12,968
Other		—			—			—			—

		24,484			35,961			87,031			96,073

Gross margin		27,258			44,750			96,873			110,444
Selling, general and administrative expenses (note 11(b) and 17(d)) (including share-based compensation expense of $2.8 million and $8.8 million for the three and nine months ended September 30, 2013, respectively (2012 - expense of $2.8 million and $10.3 million, respectively))		19,778			19,432			59,364			59,032
Research and development		3,974			2,528			11,267			7,623
Amortization of intangibles		409			166			1,146			532
Receivable provisions, net of recoveries		224			241			279			829
Impairment of available-for-sale investment (note 18(b))		—			—			—			150

Income from operations		2,873			22,383			24,817			42,278
Interest income		14			22			39			73
Interest expense		(315	)		(373	)		(1,008	)		(1,375	)

Income from operations before income taxes		2,572			22,032			23,848			40,976
Provision for income taxes		(619	)		(6,787	)		(6,564	)		(11,484	)
Loss from equity-accounted investments		(344	)		(334	)		(998	)		(1,038	)

Net income	$	1,609		$	14,911		$	16,286		$	28,454


Net income per share - basic and diluted: (note 15(c))
Net income per share - basic	$	0.02		$	0.23		$	0.24		$	0.43

Net income per share - diluted	$	0.02		$	0.22		$	0.24		$	0.42

(the accompanying notes are an integral part of these condensed consolidated financial statements)

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)


	Three Months						Nine Months
	Ended September 30,						Ended September 30,
	2013			2012			2013			2012
				As Revised						As Revised
				(note 3)						(note 3)

Net income	$	1,609		$	14,911		$	16,286		$	28,454
Amortization of defined benefit plan actuarial loss (note 17(a))		111			91			333			273
Unrealized postretirement benefit plan actuarial loss (note 17(d))		—			(32	)		—			(96	)
Loss on curtailment of postretirement benefit plan (note 17(d))		—			—			398			—
Unrealized net gain (loss) from cash flow hedging instruments (note 18(d))		535			589			(265	)		826
Realization of cash flow hedging net loss (gain) upon settlement (note 18(d))		179			(158	)		131			(22	)
Foreign currency translation adjustments (note 1)		(2	)		—			(115	)		—
Change in market value of available-for-sale investment (note 18(b))		—			—			—			338
Other-than-temporary impairment of available-for-sale investment (note 18(b))		—			—			—			150

Other comprehensive income, before tax		823			490			482			1,469
Income tax expense related to other comprehensive income (note 14(b))		(213	)		(126	)		(128	)		(311	)

Comprehensive income	$	2,219		$	15,275		$	16,640		$	29,612

(the accompanying notes are an integral part of these condensed consolidated financial statements)

IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

In accordance with United States Generally Accepted Accounting Principles

(In thousands of U.S. dollars)

(Unaudited)


	Nine Months
	Ended September 30,
	2013			2012
				As Revised
				(note 3)
Cash provided by (used in):
Operating Activities
Net income	$	16,286		$	28,454
Adjustments to reconcile net income to cash from operations:
Depreciation and amortization (note 12(c))		29,027			24,704
Write-downs, net of recoveries (note 12(d))		279			1,516
Change in deferred income taxes		5,579			9,431
Stock and other non-cash compensation		9,348			11,099
Gain on curtailment of postretirement benefits (note 17(d))		(2,185	)		—
Unrealized foreign currency exchange loss (gain)		275			(152	)
Loss from equity-accounted investments		998			1,038
Investment in film assets		(16,772	)		(13,508	)
Changes in other non-cash operating assets and liabilities (note 12(a))		(9,860	)		(8,672	)

Net cash provided by operating activities		32,975			53,910


Investing Activities
Purchase of property, plant and equipment		(6,167	)		(2,599	)
Investment in joint revenue sharing equipment		(16,363	)		(15,174	)
Investment in new business ventures		(2,500	)		(381	)
Acquisition of other intangible assets		(1,812	)		(5,046	)

Net cash used in investing activities		(26,842	)		(23,200	)


Financing Activities
Increase in bank indebtedness		12,000			9,917
Repayment of bank indebtedness		(18,000	)		(35,000	)
Common shares issued - stock options exercised (note 15(d))		6,745			5,831
Credit facility amendment fees paid		(2,089	)		—
Share issuance expenses		(202	)		—

Net cash used in financing activities		(1,546	)		(19,252	)


Effects of exchange rate changes on cash		32			(146	)


Increase in cash and cash equivalents during the period		4,619			11,312

Cash and cash equivalents, beginning of period		21,336			18,138

Cash and cash equivalents, end of period	$	25,955		$	29,450

(the accompanying notes are an integral part of these condensed consolidated financial statements)

IMAX CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

In accordance with U.S. Generally Accepted Accounting Principles

(Tabular amounts in thousands of U.S. dollars unless otherwise stated)

(Unaudited)

1. Basis of Presentation

IMAX Corporation, together with its wholly-owned subsidiaries (the “Company”), reports its results under United States Generally Accepted Accounting Principles (“U.S. GAAP”).

The condensed consolidated financial statements include the accounts of the Company together with its wholly-owned subsidiaries, and any entities which the Company has identified as variable interest entities (“VIEs”) where the Company is not the primary beneficiary. The nature of the Company’s business is such that the results of operations for the interim periods presented are not necessarily indicative of results to be expected for the fiscal year. In the opinion of management, the information contained herein reflects all adjustments necessary to make the results of operations for the interim periods a fair statement of such operations.

The Company has evaluated its various variable interests to determine whether they are VIEs as required by the Consolidation Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC” or “Codification”). The Company has 9 film production companies that are VIEs. For two of the Company’s film production companies, the Company has determined that it is the primary beneficiary of these entities as the Company has the power to direct the activities of the respective VIE that most significantly impact the respective VIE’s economic performance and has the obligation to absorb losses of the VIE that could potentially be significant to the respective VIE or the right to receive benefits from the respective VIE that could potentially be significant to the respective VIE. The Company continues to consolidate these entities, with no material impact on the operating results or financial condition of the Company, as these production companies have total assets and total liabilities of $nil as at September 30, 2013 (December 31, 2012 — $nil). For the other 7 film production companies which are VIEs, the Company did not consolidate these film entities since it does not have the power to direct activities and does not absorb the majority of the expected losses or expected residual returns. The Company equity accounts for these entities. As at September 30, 2013, these 7 VIEs have total assets and total liabilities of $0.6 million (December 31, 2012 — $15.9 million). Earnings of the investees included in the Company’s condensed consolidated statement of operations amounted to $nil and $nil for the three and nine months ended September 30, 2013, respectively (2012 — $nil and $nil, respectively). The carrying value of these investments in VIEs that are not consolidated is $nil at September 30, 2013 (December 31, 2012 — $nil). A loss in value of an investment other than a temporary decline is recognized as a charge to the condensed consolidated statement of operations. The Company’s exposure, which is determined based on the level of funding contributed by the Company and the development stage of the respective film, is $1.4 million at September 30, 2013 (December 31, 2012 — $0.9 million).

The Company accounts for investments in new business ventures using the guidance of ASC 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”) and ASC 320 – “Investments in Debt and Equity Securities” (“ASC 320”), as appropriate. At September 30, 2013, the equity method of accounting is being utilized for an investment with a carrying value of $2.0 million (December 31, 2012 – $3.0 million). The Company has determined it is not the primary beneficiary of this VIE, and therefore it has not been consolidated. In addition, the Company has an investment in preferred stock of another business venture with a total cost of $1.5 million which meets the criteria for classification as a debt security under ASC 320 and is recorded at a total fair value of $1.4 million at September 30, 2013 (December 31, 2012 – $1.4 million). This investment is classified as an available-for-sale investment. In 2013, the Company invested $2.5 million in the preferred shares of an enterprise which meet the criteria for classification as an equity security under ASC 325 – “Investments – Others” (“ASC 325”). The total carrying value of investments in new business ventures at September 30, 2013 and December 31, 2012, is $5.9 million and $4.4 million, respectively, and is recorded in Other Assets.

All significant intercompany accounts and transactions, including all unrealized intercompany profits on transactions with equity-accounted investees, have been eliminated.

In the first quarter of 2013, the Company determined that the functional currency of one of its wholly-owned subsidiaries had changed from the Company’s reporting currency to the currency of the nation in which it is domiciled. As a result, in accordance with the FASB ASC 830 “Foreign Currency Matters”, the adjustment attributable to current-rate translation of non-monetary assets as of the date of the change was reported in other comprehensive income.

The year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.

These interim financial statements should be read in conjunction with the consolidated financial statements included in the Company’s 2012 Annual Report on Form 10-K for the year ended December 31, 2012 (“the 2012 Form 10-K”) which should be consulted for a summary of the significant accounting policies utilized by the Company. These interim financial statements are prepared following accounting policies consistent with the Company’s financial statements for the year ended December 31, 2012, except as noted below.

2. New Accounting Standards and Accounting Changes

Adoption of New Accounting Policies

In January 2013, the FASB issued ASU No. 2013-01, “Balance Sheet (Topic 210): Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities” (“ASU 2013-01”). The purpose of the amendment is to address implementation issues about the scope of FASB issued ASU No. 2011-11 “Balance Sheet (Topic 210) - Disclosures about Offsetting Assets and Liabilities” “(ASU 2011-11”). ASU 2011-11 and ASU 2013-01 were issued in an effort to provide greater comparability within disclosures between entities reporting in U.S. GAAP and International Financial Reporting Standards (“IFRS”) that have offsetting (netting) assets and liabilities. Entities will be required to disclose both gross and net information about both instruments and transactions eligible for offset in the statement of financial position and instruments and transactions subject to an agreement similar to a master netting arrangement. An entity is required to apply the amendments in ASU 2013-01 for annual reporting periods beginning on or after January 1, 2013 and interim periods within those annual periods. It is to be applied retrospectively for all comparative periods presented. The Company adopted the amended standard on January 1, 2013. The adoption of the amended standard did not have a material impact on the Company’s condensed consolidated financial statements.

In February 2013, the FASB issued ASU No. 2013-02, “Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income” (“ASU 2013-02”). The amendments in ASU 2013-02 require an entity to report the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income if the amount being reclassified is required under U.S. GAAP to be reclassified in its entirety to net income. For other amounts that are not required under U.S. GAAP to be reclassified in their entirety to net income in the same reporting period, an entity is required to cross-reference other disclosures required under U.S. GAAP that provide additional detail about those amounts. For public entities, the amendments are effective prospectively for reporting periods beginning after December 15, 2012. The Company adopted the amended standard on January 1, 2013. The adoption of the amended standard did not have a material impact on the Company’s condensed consolidated financial statements.

In July 2013, the FASB issued ASU No. 2013-10, “Derivative and Hedging (Topic 815): Inclusion of the Fed Funds Effective Swap Rate (or Overnight Index Swap Rate) as a Benchmark Interest Rate for Hedge Accounting Purposes (a consensus of the FASB Emerging Issues Task Force)” (“ASU 2013-10”). The amendments in ASU 2013-10 are to permit the use of the Fed Funds Effective Swap Rate (OIS) as a U.S. benchmark interest rate for hedge accounting purposes, in addition to U.S. government (UST) and London Interbank Offered Rate (LIBOR). The amendment also removes the restriction of using different benchmark rates for similar hedges. For public entities, the amendments are effective prospectively for qualifying new or redesignated hedging relationships entered into on or after July 17, 2013. The Company adopted the amended standard on July 17, 2013. The adoption of the amended standard did not have a material impact on the Company’s condensed consolidated financial statements.

Recently Issued FASB Accounting Standard Codification Updates

In February 2013, the FASB issued ASU No. 2013-04, “Liabilities (Topic 405): Obligations Resulting from Joint and Several Liability Arrangements for Which the Total Amount of the Obligation Is Fixed at the Reporting Date” (“ASU 2013-04”). The purpose of ASU 2013-04 is to provide guidance for the recognition, measurement, and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this guidance is fixed at the reporting date, except for obligations addressed within existing guidance in U.S. GAAP. ASU 2013-04 requires an entity to measure obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of this guidance is fixed at the reporting date, as the sum of the amount the reporting entity agreed to pay on the basis of its arrangement among its co-obligors and any additional amount the reporting entity expects to pay on behalf of its co-obligors, as well as the nature and amount of the obligation as well as other information about those obligations. For public entities, the amendments are effective for fiscal years and interim reporting periods beginning after December 15, 2013. Early adoption by public entities is permitted. The Company is currently evaluating the impact of this standard on its condensed consolidated financial statements.

In March 2013, the FASB issued ASU No. 2013-05, “Foreign Currency Matters (Topic 830): Parent’s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity” (“ASU 2013-05”). The purpose of ASU 2013-05 is to resolve the diversity in practice in relation to the treatment of the release of cumulative translation adjustments (“CTA”) upon sale (in full or part) of a foreign investment. It applies to the release of the CTA into net income when a parent either sells a part of all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets that is a nonprofit activity or a business within a foreign entity. For public entities, the amendments are effective for fiscal years and interim reporting periods beginning after December 15, 2013. Early adoption by public entities is permitted. The Company is currently evaluating the impact of this standard on its condensed consolidated financial statements.

In April 2013, the FASB issued ASU No. 2013-07, “Presentation of Financial Statements (Topic 205): Liquidation Basis of Accounting” (“ASU 2013-07”). The amendments of ASU 2013-07 require an entity to prepare its financial statements using the liquidation basis of accounting when liquidation is imminent and to present relevant information about an entity’s expected resources in liquidation by measuring and presenting assets at the amount of the expected cash proceeds from liquidation. The amendments are effective for entities that determine liquidation is imminent during annual reporting periods beginning after December 15, 2013 and interim periods therein. Standards should be applied prospectively from the day liquidation becomes imminent. Early adoption is permitted. The Company does not believe that this standard will have a material impact on its condensed consolidated financial statements.

In July 2013, the FASB issued ASU No. 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the FASB Emerging Issues Task Force)” (“ASU 2013-11”). The amendments of ASU 2013-11 provide entities with guidance of how to present a provision for uncertain tax positions in the financial statements when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. For public entities, the amendments are effective for fiscal years and interim reporting periods beginning after December 15, 2013. The Company does not believe that the adoption of this standard will have a material impact on its condensed consolidated financial statements.

3. Revision of Previously Issued Financial Statements

During the fourth quarter of 2012, after a review of the Company’s existing benefit packages, the Company determined that Canadian employees, upon meeting certain eligibility requirements, are entitled to postretirement health and welfare benefits for which the obligation had not been included in the prior financial statements as required under ASC Topic 715 “Compensation – Retirement Benefits”. See note 4 to the audited consolidated financial statements in Item 8 of the Company’s 2012 Form 10-K for additional details.

The following table presents the impact of the revisions on the Company’s previously issued condensed consolidated statements of operations and comprehensive income:


	Three Months Ended						Nine Months Ended
(in thousands of U.S dollars, except per share amounts)	September 30, 2012						September 30, 2012
	As Reported			As Revised			As Reported			As Revised
Selling, general and administrative expenses	$	19,326		$	19,432		$	58,713		$	59,032
Income from operations	$	22,489		$	22,383		$	42,597		$	42,278
Income from operations before income taxes	$	22,138		$	22,032		$	41,295		$	40,976
Provision for income taxes	$	(6,814	)	$	(6,787	)	$	(11,599	)	$	(11,484	)
Net income	$	14,990		$	14,911		$	28,658		$	28,454
Net income per share - basic	$	0.23		$	0.23		$	0.44		$	0.43
Net income per share - diluted	$	0.22		$	0.22		$	0.42		$	0.42

Other comprehensive income, before tax	$	522		$	490		$	1,565		$	1,469
Income tax expense related to other comprehensive income	$	(134	)	$	(126	)	$	(336	)	$	(311	)
Comprehensive income	$	15,378		$	15,275		$	29,887			$29,612

4. Financing Receivables

Financing receivables, consisting of net investment in sales-type leases and receivables from financed sales of theater systems are as follows:


	September 30,			December 31,
	2013			2012
Gross minimum lease payments receivable	$	17,893		$	18,880
Unearned finance income		(3,613	)		(4,705	)

Minimum lease payments receivable		14,280			14,175
Accumulated allowance for uncollectible amounts		(1,430	)		(1,130	)

Net investment in leases		12,850			13,045

Gross financed sales receivables		119,691			114,492
Unearned finance income		(32,884	)		(33,278	)

Financed sales receivables		86,807			81,214
Accumulated allowance for uncollectible amounts		(66	)		(66	)

Net financed sales receivables		86,741			81,148

Total financing receivables	$	99,591		$	94,193


Net financed sales receivables due within one year	$	15,682		$	10,482
Net financed sales receivables due after one year	$	71,059		$	70,666

As at September 30, 2013, the financed sale receivables had a weighted average effective interest rate of 9.7% (December 31, 2012 — 8.7%).

5. Inventories


	September 30,		December 31,
	2013		2012
Raw materials	$	4,701	$	5,424
Work-in-process		917		338
Finished goods		8,688		10,032

	$	14,306	$	15,794

At September 30, 2013, finished goods inventory for which title had passed to the customer and revenue was deferred amounted to $2.3 million (December 31, 2012 — $6.8 million). In 2013, the Company recognized revenue for 13 theater systems (10 sales and 3 operating leases) under xenon-based digital upgrade arrangements, which were previously installed, but revenue recognition was deferred. Upon recognition of these 13 theater systems, the Company’s finished goods inventory decreased by $4.7 million from December 31, 2012.

Inventories at September 30, 2013 includes provisions for excess and obsolete inventory based upon current estimates of net realizable value considering future events and conditions of $3.9 million (December 31, 2012 — $4.4 million).

6. Property, Plant and Equipment


	As at September 30, 2013
			Accumulated		Net Book
	Cost		Depreciation		Value
Equipment leased or held for use
Theater system components^(1)(2)(3)	$	148,252	$	48,593	$	99,659
Camera equipment⁽⁶⁾		4,669		4,410		259

		152,921		53,003		99,918

Assets under construction⁽⁴⁾		12,749		—		12,749

Other property, plant and equipment
Land		1,593		—		1,593
Buildings		15,309		10,267		5,042
Office and production equipment⁽⁵⁾		28,049		21,314		6,735
Leasehold improvements		9,822		8,929		893

		54,773		40,510		14,263

	$	220,443	$	93,513	$	126,930


	As at December 31, 2012
			Accumulated		Net Book
	Cost		Depreciation		Value
Equipment leased or held for use
Theater system components⁽¹⁾⁽²⁾	$	131,240	$	39,140	$	92,100
Camera equipment⁽⁶⁾		4,668		4,306		362

		135,908		43,446		92,462

Assets under construction⁽⁴⁾		6,910		—		6,910

Other property, plant and equipment
Land		1,593		—		1,593
Buildings		15,242		9,864		5,378
Office and production equipment⁽⁵⁾		25,777		19,779		5,998
Leasehold improvements		9,734		8,465		1,269

		52,346		38,108		14,238

	$	195,164	$	81,554	$	113,610

(1)	Included in theater system components are assets with costs of $13.9 million (December 31, 2012 — $8.1 million) and accumulated depreciation of $8.6 million (December 31, 2012 — $7.3 million) that are leased to customers under operating leases.

(2)	Included in theater system components are assets with costs of $128.7 million (December 31, 2012 — $118.5 million) and accumulated depreciation of $35.4 million (December 31, 2012 — $29.2 million) that are used in joint revenue sharing arrangements.

(3)

During 2013, the Company signed an amending agreement governing one of its joint revenue sharing arrangements which increased the length of the term for all IMAX theater systems under that arrangement from 10 to 13 years. As a result, the Company adjusted the estimated useful life of its IMAX digital projection systems in use for those joint revenue sharing theaters, on a prospective basis, to reflect the change in term from 10 years to 13 years. This will result in decreased depreciation expense of $0.7 million in 2013 and $1.4 million in each of the next 5 years as the theater systems will now be depreciated over a longer estimated useful life.

(4)	Included in assets under construction are components with costs of $8.4 million (December 31, 2012 — $4.1 million) that will be utilized to construct assets to be used in joint revenue sharing arrangements.

(5)	Fully amortized office and production equipment is still in use by the Company.

(6)	Fully amortized camera equipment is still in use by the Company.

7. Other Intangible Assets


	As at September 30, 2013
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	9,126	$	6,010	$	3,116
Licenses and intellectual property		19,910		2,869		17,041
Other		8,136		605		7,531

	$	37,172	$	9,484	$	27,688


	As at December 31, 2012
			Accumulated		Net Book
	Cost		Amortization		Value
Patents and trademarks	$	8,499	$	5,670	$	2,829
Licenses and intellectual property		19,790		1,730		18,060
Other		7,022		—		7,022

	$	35,311	$	7,400	$	27,911

Other intangible assets of $8.1 million are comprised mainly of the Company’s investment in a new enterprise resource planning system, which the Company started amortizing on January 1, 2013. Fully amortized other intangible assets are still in use by the Company.

During the nine months ended September 30, 2013, the Company acquired $1.9 million in other intangible assets. The net book value of these other intangible assets was $1.8 million as at September 30, 2013. The weighted average amortization period for these additions was 10 years.

During the three and nine months ended September 30, 2013, the Company incurred costs of less than $0.1 million and $0.1 million, respectively, to renew or extend the term of acquired other intangible assets which were recorded in selling, general and administrative expenses (2012 – less than $0.1 million and $0.1 million).

As at September 30, 2013, estimated amortization expense for each of the years ended December 31, are as follows:


2013 (three months remaining)	$	707
2014		2,827
2015		2,781
2016		2,608
2017		2,608
2018		2,608

8. Credit Facility

On February 7, 2013, the Company amended and restated the terms of its existing senior secured credit facility (the “Prior Credit Facility”). The amended and restated facility (the “Credit Facility”), with a scheduled maturity of February 7, 2018, has a maximum borrowing capacity of $200.0 million. The Prior Credit Facility had a maximum borrowing capacity of $110.0 million. Certain of the Company’s subsidiaries serve as guarantors (the “Guarantors”) of the Company’s obligations under the Credit Facility. The Credit Facility is collateralized by a first priority security interest in substantially all of the present and future assets of the Company and the Guarantors.

The terms of the Credit Facility are set forth in the Third Amended and Restated Credit Agreement (the “Credit Agreement”), dated February 7, 2013, among the Company, the Guarantors, the lenders named therein, Wells Fargo Bank, National Association (“Wells Fargo”), as agent and issuing lender (Wells Fargo, together with the lenders named therein, the “Lenders”) and Wells Fargo Securities, LLC, as Sole Lead Arranger and Sole Bookrunner and in various collateral and security documents entered into by the Company and the Guarantors. Each of the Guarantors has also entered into a guarantee in respect of the Company’s obligations under the Credit Facility.

The Credit Facility permits the Company to undertake up to $150.0 million in stock buybacks and dividends, provided certain covenants in the Credit Agreement are maintained. In the event that the Company undertakes stock buybacks or makes dividend payments, any amounts outstanding under the revolving portion of the Credit Facility up to the first $75.0 million of any such stock buybacks and dividend payments will be converted to a term loan.

The amounts outstanding under the Credit Facility bear interest, at the Company’s option, at (i) LIBOR plus a margin of (a) 1.50%, 1.75% or 2.00% depending on the Company’s Total Leverage Ratio (as defined in the Credit Agreement) per annum, or (ii) Wells Fargo’s prime rate plus a margin of 0.50% per annum. In addition, the Company is obligated to pay a Commitment Fee (as defined in the Credit Agreement) per annum of between 0.25% and 0.50% of the unused portion of the Credit Facility, depending on the Company’s Total Leverage Ratio. Term loans, if any, under the Credit Facility must be repaid under a 5-year straight line amortization, with a balloon payment due at maturity. The Company is required to provide an interest rate hedge for 50% of any term loans outstanding after January 1, 2015. Under the Credit Facility, the effective interest rate for the three and nine months ended September 30, 2013 for the revolving loan portion was 1.95% and 2.26%, respectively. Under the Prior Credit Facility, the effective interest rate for the three and nine months ended September 30, 2012 was 2.39% and 2.41%, respectively.

The Credit Facility provides that the Company will be required to maintain a Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.1:1. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $70.0 million between closing and September 30, 2013, which requirement increases to $80.0 million on December 31, 2013, $90.0 million on December 31, 2014, and $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.5:1 between closing and September 30, 2013, which requirement decreases to (i) 2.25:1 on December 31, 2013; (ii) 2.0:1 on December 31, 2014; and (iii) 1.75:1 on December 31, 2015. The Company was in compliance with all of these requirements at September 30, 2013.

The Credit Facility contains typical affirmative and negative covenants, including covenants that limit or restrict the ability of the Company and the guarantors to: incur certain additional indebtedness; make certain loans, investments or guarantees; pay dividends; make certain asset sales; incur certain liens or other encumbrances; conduct certain transactions with affiliates and enter into certain corporate transactions.

The Credit Facility also contains customary events of default, including upon an acquisition or change of control or upon a change in the business and assets of the Company or a Guarantor that in each case is reasonably expected to have a material adverse effect on the Company or a Guarantor. If an event of default occurs and is continuing under the Credit Facility, the Lenders may, among other things, terminate their commitments and require immediate repayment of all amounts owed by the Company.

Bank indebtedness includes the following:


	September 30,		December 31,
	2013		2012

Revolving Loan	$	5,000	$	11,000

Total amounts drawn and available under the Credit Facility at September 30, 2013 were $5.0 million and $195.0 million, respectively (December 31, 2012 — $11.0 million and $99.0 million, respectively).

As at September 30, 2013, the Company does not have any letters of credit and advance payment guarantees outstanding (December 31, 2012 — $nil), under the Credit Facility.

In accordance with the loan agreement, the Company is obligated to make payments on the principal of the loan as follows:


2013 (three months remaining)	$	—
2014		—
2015		—
2016		—
2017		—
Thereafter		5,000

	$	5,000

Wells Fargo Foreign Exchange Facility

Within the Credit Facility, the Company is able to purchase foreign currency forward contracts and/or other swap arrangements. There is no settlement risk on its foreign currency forward contracts at September 30, 2013 as the fair value exceeded the notional value of the forward contracts. As at September 30, 2013, the Company has $24.6 million of such arrangements outstanding.

Bank of Montreal Facility

As at September 30, 2013, the Company has available a $10.0 million facility (December 31, 2012 — $10.0 million) with the Bank of Montreal for use solely in conjunction with the issuance of performance guarantees and letters of credit fully insured by EDC (the “Bank of Montreal Facility”). As at September 30, 2013, the Company has letters of credit and advance payment guarantees outstanding of $0.3 million (December 31, 2012 — $0.9 million) under the Bank of Montreal Facility.

9. Commitments

(a) The Company’s lease commitments consist of rent and equipment under operating leases. The Company accounts for any incentives provided over the term of the lease. Total minimum annual rental payments to be made by the Company as at September 30, 2013 for each of the years ended December 31, are as follows:


	Operating Leases		Capital Leases
2013 (three months remaining)	$	1,718	$	4
2014		5,699		—
2015		1,242		—
2016		533		—
2017		533		—
Thereafter		847		—

	$	10,572	$	4

Rent expense was $1.5 million and $4.9 million for three and nine months ended September 30, 2013, respectively (2012 — $1.5 million and $4.6 million, respectively).

Recorded in the accrued liabilities balance as at September 30, 2013 is $2.5 million (December 31, 2012 — $2.6 million) related to accrued rent and lease inducements being recognized as an offset to rent expense over the term of the respective leases.

Purchase obligations under long-term supplier contracts as at September 30, 2013 were $9.8 million (December 31, 2012 — $12.1 million).

(b) As at September 30, 2013, the Company did not have any letters of credit and advance payment guarantees outstanding (December 31, 2012 — $nil), under the Credit Facility. As at September 30, 2013, the Company had letters of credit and advance payment guarantees outstanding of $0.3 million as compared to $0.9 million as at December 31, 2012, under the Bank of Montreal Facility.

(c) The Company compensates its sales force with both fixed and variable compensation. Commissions on the sale or lease of the Company’s theater systems are payable in graduated amounts from the time of collection of the customer’s first payment to the Company up to the collection of the customer’s last initial payment. At September 30, 2013, $1.6 million (December 31, 2012 —$1.8 million) of commissions have been accrued and will be payable in future periods.

10. Contingencies and Guarantees

The Company is involved in lawsuits, claims, and proceedings, including those identified below, which arise in the ordinary course of business. In accordance with the Contingencies Topic of the FASB ASC, the Company will make a provision for a liability when it is both probable that a loss has been incurred and the amount of the loss can be reasonably estimated. The Company believes it has adequate provisions for any such matters. The Company reviews these provisions in conjunction with any related provisions on assets related to the claims at least quarterly and adjusts these provisions to reflect the impacts of negotiations, settlements, rulings, advice of legal counsel and other pertinent information related to the case. Should developments in any of these matters outlined below cause a change in the Company’s determination as to an unfavorable outcome and result in the need to recognize a material provision, or, should any of these matters result in a final adverse judgment or be settled for significant amounts, they could have a material adverse effect on the Company’s results of operations, cash flows, and financial position in the period or periods in which such a change in determination, settlement or judgment occurs.

The Company expenses legal costs relating to its lawsuits, claims and proceedings as incurred.

(a) In March 2005, the Company, together with Three-Dimensional Media Group, Ltd. (“3DMG”), filed a complaint in the U.S. District Court for the Central District of California, Western Division, against In-Three, Inc. (“In-Three”) alleging patent infringement. On March 10, 2006, the Company and In-Three entered into a settlement agreement settling the dispute between the Company and In-Three. Despite the settlement reached between the Company and In-Three, co-plaintiff 3DMG refused to dismiss its claims against In-Three. Accordingly, the Company and In-Three moved jointly for a motion to dismiss the Company’s and In-Three’s claims. On August 24, 2010, the Court dismissed all of the claims pending between the Company and In-Three, thus dismissing the Company from the litigation.

On May 15, 2006, the Company initiated arbitration against 3DMG before the International Centre for Dispute Resolution in New York (the “ICDR”), alleging breaches of the license and consulting agreements between the Company and 3DMG. On June 15, 2006, 3DMG filed an answer denying any breaches and asserting counterclaims that the Company breached the parties’ license agreement. On June 21, 2007, the ICDR unanimously denied 3DMG’s Motion for Summary Judgment filed on April 11, 2007 concerning the Company’s claims and 3DMG’s counterclaims. The proceeding was suspended on May 4, 2009 due to failure of 3DMG to pay fees associated with the proceeding. The proceeding was further suspended on October 11, 2010 pending resolution of reexamination proceedings currently pending involving one of 3DMG’s patents. The Company will continue to pursue its claims vigorously and believes that all allegations made by 3DMG are without merit. The Company further believes that the amount of loss, if any, suffered in connection with the counterclaims would not have a material impact on the financial position or results of operations of the Company, although no assurance can be given with respect to the ultimate outcome of the arbitration.

(b) In January 2004, the Company and IMAX Theatre Services Ltd., a subsidiary of the Company, commenced an arbitration seeking damages before the International Court of Arbitration of the International Chambers of Commerce (the “ICC”) with respect to the breach by Electronic Media Limited (“EML”) of its December 2000 agreement with the Company. In June 2004, the Company commenced a related arbitration before the ICC against EML’s affiliate, E-City Entertainment (I) PVT Limited (“E-City”), seeking damages as a result of E-City’s breach of a September 2000 lease agreement. An arbitration hearing took place in November 2005 against E-City which considered all claims by the Company. On February 1, 2006, the ICC issued an award on liability finding unanimously in the Company’s favor on all claims. Further hearings took place in July 2006 and December 2006. On August 24, 2007, the ICC issued an award unanimously in favor of the Company in the amount of $9.4 million, consisting of past and future rents owed to the Company under its lease agreements, plus interest and costs. In the award, the ICC upheld the validity and enforceability of the Company’s theater system contract. The Company thereafter submitted its application to the arbitration panel for interest and costs. On March 27, 2008, the arbitration panel issued a final award in favor of the Company in the amount of $11.3 million, plus an additional $2,512 each day in interest from October 1, 2007 until the date the award is paid, which the Company is seeking to enforce

and collect in full. In July 2008, E-City commenced a proceeding in Mumbai, India seeking an order that the ICC award may not be recognized in India. The Company has opposed that application on a number of grounds and seeks to have the ICC award recognized in India. That Mumbai proceeding is still pending, and on June 13, 2013, the Bombay High Court ruled that it has jurisdiction over the proceeding. On June 24, 2011, the Company commenced an application to the Ontario Superior Court of Justice for recognition of the final award. On December 2, 2011, the Ontario court issued an order recognizing the final award and requiring E-City to pay the Company $30,000 to cover the costs of the application. On January 18, 2012, the Company filed an application in New York State Supreme Court seeking recognition of the Ontario order in New York. On April 11, 2012, the New York court issued an order granting the Company’s application leading to an entry of $15.5 million judgment in favor of the Company on May 4, 2012. On January 30, 2013, the Company filed an action in the New York Supreme Court seeking to collect the amount due under the New York judgment from certain entities and individuals affiliated with E-City. The defendants in the New York action have answered and objected to the Company’s petition, and they have moved to dismiss for improper service of process. The New York Court heard oral arguments on August 20, 2013 and has taken the matter under advisement.

(c) The Company and certain of its officers and directors were named as defendants in eight purported class action lawsuits filed between August 11, 2006 and September 18, 2006, alleging violations of U.S. federal securities laws. These eight actions were filed in the U.S. District Court for the Southern District of New York (the “Court”). On January 18, 2007, the Court consolidated all eight class action lawsuits and appointed Westchester Capital Management, Inc. as the lead plaintiff and Abbey Spanier Rodd & Abrams, LLP as lead plaintiff’s counsel. On October 2, 2007, plaintiffs filed a consolidated amended class action complaint. The amended complaint, brought on behalf of shareholders who purchased the Company’s common stock on the NASDAQ between February 27, 2003 and July 20, 2007 (the “U.S. Class”), alleges primarily that the defendants engaged in securities fraud by disseminating materially false and misleading statements during the class period regarding the Company’s revenue recognition of theater system installations, and failing to disclose material information concerning the Company’s revenue recognition practices. The amended complaint also added PricewaterhouseCoopers LLP, the Company’s auditors, as a defendant. On April 14, 2011, the Court issued an order appointing The Merger Fund as the lead plaintiff and Abbey Spanier Rodd & Abrams, LLP as lead plaintiff’s counsel. On November 2, 2011, the parties entered into a memorandum of understanding containing the terms and conditions of a settlement of this action. On January 26, 2012, the parties executed and filed with the Court a formal stipulation of settlement and proposed form of notice to the class, which the Court preliminarily approved on February 1, 2012. Under the terms of the settlement, members of the U.S. Class who did not opt out of the settlement will release defendants from liability for all claims that were alleged in this action or could have been alleged in this action or any other proceeding (including the action in Canada as described in (d) of this note (the “Canadian Action”) relating to the purchase of IMAX securities on the NASDAQ from February 27, 2003 and July 20, 2007 or the subject matter and facts relating to this action. As part of the settlement and in exchange for the release, defendants will pay $12.0 million to a settlement fund which amount will be funded by the carriers of the Company’s directors and officers insurance policy and by PricewaterhouseCoopers LLP. On March 26, 2012, the parties executed and filed with the Court an amended formal stipulation of settlement and proposed form of notice to the class, which the court preliminarily approved on March 28, 2012. On June 20, 2012, the Court issued an order granting final approval of the settlement. The settlement is conditioned on the Company’s receipt of an order from the court in the Canadian Action, the Ontario Superior Court of Justice, (the “Canadian Court”) excluding from the class in the Canadian Action every member of the class in both actions who has not opted out of the U.S. settlement. A hearing on the motion for the order occurred on July 30, 2012 before the Canadian Court and on March 19, 2013, the Canadian Court issued a decision granting the Company’s motion to exclude from the class in the Canadian Action every member of the classes in both actions who has not opted out of the U.S. settlement. However, no final order will be granted by the Court until the plaintiffs in the Canadian Action have exhausted their appeals.

(d) A class action lawsuit was filed on September 20, 2006 in the Canadian Court against the Company and certain of its officers and directors, alleging violations of Canadian securities laws. This lawsuit was brought on behalf of shareholders who acquired the Company’s securities between February 17, 2006 and August 9, 2006. The lawsuit seeks $210.0 million in compensatory and punitive damages, as well as costs. For reasons released December 14, 2009, the Canadian Court granted leave to the plaintiffs to amend their statement of claim to plead certain claims pursuant to the Securities Act (Ontario) against the Company and certain individuals and granted certification of the action as a class proceeding. These are procedural decisions, and do not contain any conclusions binding on a judge at trial as to the factual or legal merits of the claim. Leave to appeal those decisions was denied. The Company believes the allegations made against it in the statement of claim are meritless and will vigorously defend the matter, although no assurance can be given with respect to the ultimate outcome of such proceedings. The Company’s directors’ and officers’ insurance policy provides for reimbursement of costs and expenses incurred in connection with this lawsuit as well as potential damages awarded, if any, subject to certain policy limits, exclusions and deductibles.

(e) On June 26, 2013, the Company filed suit against GDC Technology (USA) LLC and certain of its affiliates (collectively, “GDC”) in the U.S. District Court for the Central District of California alleging trade secret misappropriation, unjust enrichment and unfair competition and seeking injunctive relief, compensatory damages, and punitive damages. On August 12, 2013, in light of the complicating effects of the interwoven corporate relationships among the GDC defendants on federal diversity jurisdiction, the Company voluntarily dismissed the federal court action and filed a complaint in the Los Angeles County Superior Court alleging the same set of operative facts and same causes of action that had been contained in the District Court action. This action is based on GDC’s commercial exploitation of large format digital theater projection system and film conversion technologies, which the lawsuit alleges were stolen from the Company by its former employee, Gary Tsui, and then provided by Tsui to various technology companies in China. The Company’s action against GDC alleges that GDC is now knowingly and actively using these trade secrets and marketing large format film projection systems and conversion technology that the Company is informed and believes were derived from and incorporate the trade secrets stolen by Tsui. GDC has been served with the lawsuit, but has not yet filed its response. The lawsuit is at a very early stage, and the Company cannot predict the timing or outcome of this matter at this time.

(f) The Company is also involved in litigation against Tsui and related parties in both Canada and China based on Tsui’s theft and use of the Company’s trade secrets. The Company filed a lawsuit against Tsui and other related individuals and entities in the Ontario Superior Court of Justice on December 8, 2009, through which the Company sought injunctive relief to prohibit Tsui from disclosing or using the Company’s confidential and proprietary information and from competing with the Company. The Company is also seeking compensatory and punitive damages. The Ontario Court awarded the injunctive relief sought by the Company on December 22, 2009. On April 30, 2013, a warrant was issued for Tsui’s arrest based on his refusal to comply with the orders of the Ontario court, including with respect to the continued use of the Company’s trade secrets. The Ontario action is to proceed to trial in 2013, though all of Tsui’s defenses were stricken by the Ontario court in a January 2012 contempt order. The Company also initiated suit against Tsui and related parties in Beijing No. 1 Intermediate People’s Court in Beijing, China on February 16, 2013, seeking relief similar to that sought in the Ontario action. The actions in Canada and China remain ongoing.

(g) In March 2013, IMAX (Shanghai) Multimedia Technology Co., Ltd. (“IMAX China”), the Company’s wholly-owned subsidiary in China, received notice from the Shanghai office of the General Administration of Customs that it had been selected for a customs audit. The Company is unable to assess the potential impact, if any, of the audit at this time.

(h) In addition to the matters described above, the Company is currently involved in other legal proceedings or governmental inquiries which, in the opinion of the Company’s management, will not materially affect the Company’s financial position or future operating results, although no assurance can be given with respect to the ultimate outcome of any such proceedings.

(i) In the normal course of business, the Company enters into agreements that may contain features that meet the definition of a guarantee. The Guarantees Topic of the FASB ASC defines a guarantee to be a contract (including an indemnity) that contingently requires the Company to make payments (either in cash, financial instruments, other assets, shares of its stock or provision of services) to a third party based on (a) changes in an underlying interest rate, foreign exchange rate, equity or commodity instrument, index or other variable, that is related to an asset, a liability or an equity security of the counterparty, (b) failure of another party to perform under an obligating agreement or (c) failure of another third party to pay its indebtedness when due.

Financial Guarantees

The Company has provided no significant financial guarantees to third parties.

Product Warranties

The following summarizes the accrual for product warranties that was recorded as part of accrued liabilities in the condensed consolidated balance sheets:


	September 30,			December 31,
	2013			2012
Balance at the beginning of period	$	32		$	94
Warranty redemptions		(77	)		(66	)
Warranties issued		60			53
Revisions		(8	)		(49	)

Balance at the end of period	$	7		$	32

Director/Officer Indemnifications

The Company’s General By-law contains an indemnification of its directors/officers, former directors/officers and persons who have acted at its request to be a director/officer of an entity in which the Company is a shareholder or creditor, to indemnify them, to the extent permitted by the Canada Business Corporations Act, against expenses (including legal fees), judgments, fines and any amount actually and reasonably incurred by them in connection with any action, suit or proceeding in which the directors and/or officers are sued as a result of their service, if they acted honestly and in good faith with a view to the best interests of the Company. The nature of the indemnification prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. The Company has purchased directors’ and officers’ liability insurance. No amount has been accrued in the condensed consolidated balance sheets as at September 30, 2013 and December 31, 2012 with respect to this indemnity.

Other Indemnification Agreements

In the normal course of the Company’s operations, the Company provides indemnifications to counterparties in transactions such as: theater system lease and sale agreements and the supervision of installation or servicing of the theater systems; film production, exhibition and distribution agreements; real property lease agreements; and employment agreements. These indemnification agreements require the Company to compensate the counterparties for costs incurred as a result of litigation claims that may be suffered by the counterparty as a consequence of the transaction or the Company’s breach or non-performance under these agreements. While the terms of these indemnification agreements vary based upon the contract, they normally extend for the life of the agreements. A small number of agreements do not provide for any limit on the maximum potential amount of indemnification; however, virtually all of the Company’s system lease and sale agreements limit such maximum potential liability to the purchase price of the system. The fact that the maximum potential amount of indemnification required by the Company is not specified in some cases prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay to counterparties. Historically, the Company has not made any significant payments under such indemnifications and no amounts have been accrued in the condensed consolidated financial statements with respect to the contingent aspect of these indemnities.

11. Condensed Consolidated Statements of Operations Supplemental Information

(a) Selling Expenses

The Company defers direct selling costs such as sales commissions and other amounts related to its sale and sales-type lease arrangements until the related revenue is recognized. These costs, included in costs and expenses applicable to revenues-equipment and product sales, totaled $0.2 million and $0.9 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.9 million and $2.1 million, respectively).

Film exploitation costs, including advertising and marketing, totaled $0.9 million and $3.3 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.5 million and $3.4 million, respectively) and are recorded in costs and expenses applicable to revenues-services as incurred.

Commissions are recognized as costs and expenses applicable to revenues-rentals in the month they are earned. These costs totaled $0.4 million and $0.9 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.5 million and $1.0 million, respectively). Direct advertising and marketing costs for each theater are charged to costs and expenses applicable to revenues-rentals as incurred. These costs totaled $0.5 million and $1.1 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.6 million and $1.1 million, respectively).

(b) Foreign Exchange

Included in selling, general and administrative expenses for the three and nine months ended September 30, 2013 is a gain of $0.8 million and a loss of less than $0.1 million, respectively, for net foreign exchange gains/losses related to the translation of foreign currency denominated monetary assets and liabilities and unhedged foreign exchange contracts compared with a gain of $0.3 million and gain of $1.2 million for the three and nine months ended September 30, 2012, respectively. See note 18(d) for additional information.

(c) Collaborative Arrangements

Joint Revenue Sharing Arrangements

In a joint revenue sharing arrangement, the Company receives a portion of a theater’s box-office and concession revenues and in some cases a small upfront or initial payment, in exchange for placing a theater system at the theater operator’s venue. Under joint revenue sharing arrangements, the customer has the right and the ability to operate the hardware components or direct others to operate them in a manner determined by the customer. The Company’s joint revenue sharing arrangements are typically non-cancellable for 10 to 13 years with renewal provisions. Title to equipment under joint revenue sharing arrangements does not transfer to the customer. The Company’s joint revenue sharing arrangements do not contain a guarantee of residual value at the end of the term. The customer is required to pay for executory costs such as insurance and taxes and is required to pay the Company for maintenance and extended warranty throughout the term. The customer is responsible for obtaining insurance coverage for the theater systems commencing on the date specified in the arrangement’s shipping terms and ending on the date the theater systems are delivered back to the Company.

The Company has signed joint revenue sharing agreements with 36 exhibitors for a total of 545 theater systems, of which 351 theaters were operating as of September 30, 2013, the terms of which are similar in nature, rights and obligations. The accounting policy for the Company’s joint revenue sharing arrangements is disclosed in note 2(m) of the Company’s 2012 Form 10-K.

Amounts attributable to transactions arising between the Company and its customers under joint revenue sharing arrangements are included in Equipment and Product Sales revenue and Rentals revenue and for the three and nine months ended September 30, 2013 amounted to $12.0 million and $39.7 million, respectively (2012 — $13.2 million and $40.5 million, respectively).

IMAX DMR

In an IMAX DMR arrangement, the Company transforms conventional motion pictures into the Company’s large screen format, allowing the release of Hollywood content to the IMAX theater network. In a typical IMAX DMR film arrangement, the Company will absorb its costs for the digital re-mastering of the film and then recoup this cost from a percentage of the gross box-office receipts of the film, which range from 10-15%. The Company does not typically hold distribution rights or the copyright to these films.

For the nine months ended September 30, 2013, the majority of IMAX DMR revenue was earned from the exhibition of 33 IMAX DMR films throughout the IMAX theater network. The Company has entered into arrangements with film producers to convert 9 additional films which are expected to be released during the remainder of 2013, the terms of which are similar in nature, rights and obligations. The accounting policy for the Company’s IMAX DMR arrangements is disclosed in note 2(m) of the Company’s 2012 Form 10-K.

Amounts attributable to transactions arising between the Company and its customers under IMAX DMR arrangements are included in Services revenue and for the three and nine months ended September 30, 2013 amounted to $14.5 million and $54.9 million, respectively (2012 — $25.3 million and $58.8 million, respectively).

Co-Produced Film Arrangements

In certain film arrangements, the Company co-produces a film with a third party whereby the third party retains the copyright and rights to the film, except that the Company obtains exclusive theatrical distribution rights to the film. Under these arrangements, both parties contribute funding to the Company’s wholly-owned production company for the production of the film and for associated exploitation costs. Clauses in the film arrangements provide for the third party to take over the production of the film if the cost of the production exceeds its approved budget or if it appears as though the film will not be delivered on a timely basis.

The accounting policies relating to co-produced film arrangements are disclosed in notes 2(a) and 2(m) of the Company’s 2012 Form 10-K.

At September 30, 2013, the Company has 4 significant co-produced film arrangements which makes up greater than 50% of the VIE total assets and liabilities balance of $0.6 million and 3 other co-produced film arrangements, the terms of which are similar.

For the three and nine months ended September 30, 2013, amounts totaling $0.7 million and $2.8 million, respectively (2012 — $1.5 million and $4.7 million, respectively) attributable to transactions between the Company and other parties involved in the production of the films have been included in cost and expenses applicable to revenues-services.

12. Condensed Consolidated Statements of Cash Flows Supplemental Information

(a) Changes in other non-cash operating assets and liabilities are comprised of the following:


	Nine Months
	Ended September 30,
	2013			2012
Decrease (increase) in:
Accounts receivable	$	(2,284	)	$	9,915
Financing receivables		(5,707	)		(4,900	)
Inventories		(5,522	)		(4,169	)
Prepaid expenses		(744	)		(955	)
Commissions and other deferred selling expenses		(506	)		113
Insurance recoveries		78			138
Other assets		926			(1,313	)
Increase (decrease) in:
Accounts payable		2,824			(11,174	)
Accrued and other liabilities⁽¹⁾		1,240			(1,528	)
Deferred revenue		(165	)		5,201

	$	(9,860	)	$	(8,672	)

(1)	Change in accrued and other liabilities for the nine months ended September 30, 2013 includes payments of $2.0 million for variable stock-based compensation (2012 - $0.3 million).

(b) Cash payments made on account of:


	Nine Months Ended September 30,
	2013		2012
Income taxes	$	831	$	977

Interest	$	347	$	1,181


	Nine Months
	Ended September 30,
	2013		2012
Film assets	$	13,901	$	12,131
Property, plant and equipment
Joint revenue sharing arrangements		8,588		7,384
Other property, plant and equipment		3,617		3,186
Other intangible assets		2,131		1,507
Other assets		437		368
Deferred financing costs		353		128

	$	29,027	$	24,704

(d) Write-downs, net of recoveries, are comprised of the following:


	Nine Months
	Ended September 30,
	2013			2012

Accounts receivable (recovery) charge	$	(31	)	$	674
Financing receivables		310			155
Inventories⁽¹⁾		—			503
Impairment of available-for-sale investment		—			150
Property, plant and equipment		—			18
Other intangible assets		—			11
Other assets		—			5

	$	279		$	1,516

(1)

In the nine months ended September 30, 2013, the Company recorded a charge of $nil (2012 — $0.2 million) in costs and expenses applicable to revenues – services for certain service parts inventories and a charge of $nil (2012 — $0.3 million) in costs and expenses applicable to revenues – equipment and product sales for the write-down of certain film based inventories.

13. Receivable Provisions, Net of Recoveries

The following table reflects the Company’s receivable provisions net of recoveries recorded in the condensed consolidated statements of operations:


	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2013		2012		2013			2012
Accounts receivable provisions, net of recoveries	$	14	$	241	$	(31	)	$	674
Financing receivables, net of recoveries		210		—		310			155

Receivable provisions, net of recoveries	$	224	$	241	$	279		$	829

14. Income Taxes

(a) Income Taxes

The Company’s effective tax rate differs from the statutory tax rate and varies from year to year primarily as a result of numerous permanent differences, investment and other tax credits, the provision for income taxes at different rates in foreign and other provincial jurisdictions, enacted statutory tax rate increases or reductions in the year, changes due to foreign exchange, changes in the Company’s valuation allowance based on the Company’s recoverability assessments of deferred tax assets, and favorable or unfavorable resolution of various tax examinations. During the nine months ended September 30, 2013, there was no change in the Company’s estimates of the recoverability of its deferred tax assets based on an analysis of both positive and negative evidence including projected future earnings.

As at September 30, 2013, the Company had net deferred income tax assets after valuation allowance of $31.1 million (December 31, 2012 — $36.5 million). As at September 30, 2013, the Company had a gross deferred income tax asset before valuation allowance of $37.2 million (December 31, 2012 — $42.6 million), against which the Company is carrying a $6.1 million valuation allowance (December 31, 2012 — $6.1 million).

Due to a change in enacted tax rates, the Company recorded an increase to deferred tax assets and a decrease to the deferred tax provision of $0.7 million in the second quarter of 2012.

As at September 30, 2013 and December 31, 2012, the Company had a provision for uncertain tax positions (including interest and penalties) of $3.1 million and $2.8 million, respectively, for international withholding taxes. All of the provisions for uncertain tax positions could impact the Company’s effective tax rate if recognized. While the Company believes it has adequately provided for all tax positions, amounts asserted by taxing authorities could differ from the Company’s accrued position. Accordingly, additional provisions on federal, state, provincial and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved.

Consistent with its historical financial reporting, the Company has elected to classify interest and penalties related to income tax liabilities, when applicable, as part of the interest expense in its condensed consolidated statement of operations rather than income tax expense. The Company recognized approximately $nil and $nil in potential interest and penalties associated with its provisions for uncertain tax positions for the three and nine months ended September 30, 2013, respectively (2012 — $0.1 million and $0.2 million, respectively).

(b) Income Tax Effect on Comprehensive Income

The income tax (expense) benefit related to the following items included in other comprehensive income are as follows:


	Three Months						Nine Months
	Ended September 30,						Ended September 30,
	2013			2012			2013			2012
				As Revised						As Revised
				(note 3)						(note 3)

Amortization of actuarial loss on defined benefit plan	$	(29	)	$	(23	)	$	(87	)	$	(69	)
Unrecognized actuarial loss on postretirement benefit plan		—			8			—			25
Loss on curtailment of postretirement benefit plan		—			—			(100	)		—
Unrealized change in cash flow hedging instruments		(138	)		(153	)		68			(213	)
Realization of net cash flow hedging settlements		(46	)		42			(35	)		7
Foreign currency translation adjustments		—			—			26			—
Change in market value of available-for-sale investment		—			—			—			(42	)
Other-than-temporary impairment of available-for-sale investment		—			—			—			(19	)

	$	(213	)	$	(126	)	$	(128	)	$	(311	)

15. Capital Stock

(a) Authorized

Common Shares

The authorized capital of the Company consists of an unlimited number of common shares. The following is a summary of the rights, privileges, restrictions and conditions of the common shares.

The holders of common shares are entitled to receive dividends if, as and when declared by the directors of the Company, subject to the rights of the holders of any other class of shares of the Company entitled to receive dividends in priority to the common shares.

The holders of the common shares are entitled to one vote for each common share held at all meetings of the shareholders.

(b) Stock-Based Compensation

The Company issues stock-based compensation to eligible employees, directors and consultants under the Company’s 2013 Long-Term Incentive Plan and the China Long Term Incentive Plan, as described below. No further awards may be granted under the Company’s Stock Option Plan.

On June 11, 2013, the Company’s shareholders approved the IMAX 2013 Long-Term Incentive Plan (“IMAX LTIP”) at the Company’s Annual and Special Meeting. Awards to employees, directors and consultants under the IMAX LTIP may consist of stock options, restricted share units (“RSUs”) and other awards.

The Company’s Stock Option Plan (“SOP”) which shareholders approved in June 2008, permitted the grant of stock options to employees, directors and consultants. As a result of the implementation of the IMAX LTIP on June 11, 2013, stock options will no longer be granted under the SOP.

A separate stock option plan, the China Long Term Incentive Plan (the “China LTIP”) was adopted by a subsidiary of the Company in October 2012.

The compensation costs recorded in the condensed consolidated statement of operations for all the plans were $2.8 million and $8.8 million for the three and nine months ended September 30, 2013, respectively (2012 — expense of $2.8 million and $10.3 million, respectively).

As at September 30, 2013, the Company has reserved a total of 10,951,073 (December 31, 2012 — 13,296,485) common shares for future issuance under the SOP and IMAX LTIP. Of the common shares reserved for issuance, there are options in respect of 6,683,471 common shares and RSUs in respect of 272,981 common shares outstanding at September 30, 2013. At September 30, 2013, options in respect of 3,521,758 common shares were vested and exercisable.

Stock Options

The Company’s policy is to issue new common shares from treasury to satisfy stock options which are exercised.

The Company utilizes a lattice-binomial option-pricing model (“Binomial Model”) to determine the fair value of stock-based payment awards. The fair value determined by the Binomial Model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the Company’s expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The Binomial Model also considers the expected exercise multiple which is the multiple of exercise price to grant price at which exercises are expected to occur on average. Option-pricing models were developed for use in estimating the value of traded options that have no vesting or hedging restrictions and are fully transferable. Because the Company’s employee stock options have certain characteristics that are significantly different from traded options, and because changes in the subjective assumptions can materially affect the estimated value, in management’s opinion, the Binomial Model best provides a fair measure of the fair value of the Company’s employee stock options.

All awards of stock options are made at fair market value of the Company’s common shares on the date of grant. The fair market value of a common share on a given date means the higher of the closing price of a common share on the grant date (or the most recent trading date if the grant date is not a trading date) on the New York Stock Exchange (“NYSE”), the Toronto Stock Exchange (the “TSX”) and such national exchange, as may be designated by the Company’s Board of Directors (the “Fair Market Value”). The stock options vest within 5 years and expire 10 years or less from the date granted. The SOP and IMAX LTIP provide that vesting will be accelerated if there is a change of control, as defined in each plan and upon certain conditions.

The Company recorded an expense of $1.9 million and $6.3 million for the three and nine months ended September 30, 2013, respectively (2012 — $3.2 million and $9.8 million, respectively), related to stock option grants issued to employees and directors in the IMAX LTIP and SOP plans. No income tax benefit is recorded in the condensed consolidated statements of operations for these costs.

The weighted average fair value of all stock options, granted to employees and directors for the three and nine months ended September 30, 2013 at the measurement date was $7.67 per share and $7.10 per share, respectively (2012 — $6.93 per share and $7.49 per share, respectively). The following assumptions were used to estimate the average fair value of the stock options:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2013	2012	2013	2012

Average risk-free interest rate	1.94%	1.07%	1.63%	1.38%
Expected option life (in years)	4.51 - 4.55	5.29 - 5.30	4.51 - 4.63	2.89 - 5.36
Expected volatility	40%	50%	40%	50%
Annual termination probability	0% - 8.52%	8.52% - 8.76%	0% - 8.52%	0% - 8.76%
Dividend yield	0%	0%	0%	0%

Stock options to Non-Employees

During the three and nine months ended September 30, 2013, an aggregate of nil and 2,500, respectively (2012 — nil and 12,500, respectively), stock options to purchase the Company’s common stock with an average exercise price of n/a and $26.28, respectively (2012 — n/a and $22.82, respectively) were granted to certain advisors and strategic partners of the Company. These stock options granted have a maximum contractual life of 7 years and vest between one and 5 years. The stock options granted in 2013 were granted under the IMAX LTIP.

As at September 30, 2013, non-employee stock options outstanding amounted to 75,501 stock options (2012 — 120,001) with a weighted average exercise price of $15.06 (2012 — $14.14). 29,009 stock options (2012 — 34,717) were exercisable with an average weighted exercise price of $10.72 (2012 — $11.59) and the vested stock options have an aggregate intrinsic value of $0.6 million (2012 — $0.3 million). The weighted average fair value of stock options granted to non-employees during the three and nine months ended September 30, 2013 at the measurement date was n/a and $11.50 per share, respectively (2012 — n/a and $11.73 per share, respectively), utilizing a Binomial Model with the following underlying assumptions:

Three Months
Ended September 30,

Nine Months
Ended September 30,

2013

2012

2013

2012

Average risk-free interest rate

n/a

1.64

1.28

Contractual option life

n/a

7 Years

Average expected volatility

n/a

Dividend yield

n/a

For the three and nine months ended September 30, 2013, the Company recorded a charge of less than $0.1 million and $0.2 million, respectively (2012 — less than $0.1 million and $0.1 million, respectively) to cost and expenses related to revenues – services and selling, general and administrative expenses related to the non-employee stock options. Included in accrued liabilities is an accrual of $0.1 million for non-employee stock options recorded (December 31, 2012 – $0.1 million).

China Long Term Incentive Plan (“China LTIP”)

The China LTIP was adopted by a subsidiary of the Company in October 2012. Each stock option issued under the China LTIP represents an opportunity to participate economically in the future growth and value creation of the subsidiary. The China LTIP options issued by the subsidiary (“China Options”) operate in tandem with options granted to certain employees of the subsidiary under the Company’s Stock Option Plan (“SOP Options”).

The China Options vest and become exercisable only upon specified events, including upon the occurrence of a qualified initial public offering or upon a change in control on or prior to the fifth anniversary of the grant date. If such a specified event occurs, the China Options vest over a 5 year period beginning on the date of grant. Upon vesting of the China options, the SOP Options are forfeited. The term of the China Options is 7 years. The total stock option expense associated with the China Options if a specified event and vesting were to occur is $2.7 million.

The SOP Options vest in full if a specified event does not occur on or prior to the fifth anniversary of the grant date. Upon vesting of the SOP Options, the China Options are forfeited.

In the fourth quarter of 2012, an aggregate of 146,623 SOP Options were granted to certain employees in conjunction with China Options with an average price of $22.39 in accordance with the China LTIP. The SOP Options have a contractual life of 7 years. As at September 30, 2013, there were 146,623 (December 31, 2012 — 146,623) outstanding and unvested SOP Options issued under the China LTIP with a weighted average exercise price of $22.39 (December 31, 2012 — $22.39). The weighted average fair value of the SOP Options granted in the fourth quarter of 2012 was $6.96 per share. The total fair value of the SOP Options granted with respect to the China LTIP was $1.6 million. The Company is recognizing this expense over a 5 year period. If a performance event occurs, the 146,623 SOP Options issued forfeit immediately and the related charge would be reversed. There were no common share option awards issued under the China LTIP during the nine months ended September 30, 2013, and 2012.

The Company has included a charge of $0.1 million and $0.2 million for the three and nine months ended September 30, 2013 (September 30, 2012 — $nil and $nil) within its SOP related to the stock options issued thereunder.

Stock Option Summary

The following table summarizes certain information in respect of option activity under the SOP and IMAX LTIP for the nine month periods ended September 30:


							Weighted Average Exercise
	Number of Shares						Price Per Share
	2013			2012			2013		2012

Options outstanding, beginning of year		7,441,068			7,200,721		$	18.48	$	14.60
Granted		375,650			1,686,862			25.29		24.78
Exercised		(993,854	)		(924,579	)		6.79		6.31
Forfeited		(135,733	)		(154,958	)		23.62		23.03
Expired		—			—			—		—
Cancelled		(3,660	)		(4,120	)		29.67		33.73

Options outstanding, end of period		6,683,471			7,803,926			20.50		17.61

Options exercisable, end of period		3,521,758			3,706,631			18.21		13.80

The Company cancelled 2,110 and 3,660 stock options from its SOP (2012 — 3,820 and 4,120, respectively) surrendered by Company employees during the three and nine months ended September 30, 2013, respectively.

As at September 30, 2013, 6,212,580 options were fully vested or are expected to vest with a weighted average exercise price of $20.20, aggregate intrinsic value of $64.0 million and weighted average remaining contractual life of 4.8 years. As at September 30, 2013, options that are exercisable have an intrinsic value of $43.3 million and a weighted average remaining contractual life of 4.7 years. The intrinsic value of options exercised in the three and nine months ended September 30, 2013 was $8.4 million and $19.4 million, respectively (2012 — $1.0 million and $15.3 million, respectively).

Restricted Share Units

RSUs have been granted to employees, consultants and directors under the IMAX LTIP. Each RSU represents a contingent right to receive one common share and is the economic equivalent of one common share. The grant date fair value of each RSU is equal to the share price of the Company’s stock at the grant date. The Company recorded an expense of $0.6 million and $1.7 million for the three and nine month period ended September 30, 2013, respectively, related to RSU grants issued to employees and directors in the plan. The annual termination probability assumed for the three and nine months ended September 30, 2013, ranged from 0% to 8.52%, respectively. In addition, the Company recorded an expense of less than $0.1 million and less than $0.1 million for the three and nine months ended September 30, 2013, respectively, related to RSU grants issued to certain advisors and strategic partners of the Company.

As of September 30, 2013, there was $5.4 million of compensation expense that has yet to be recognized related to non-vested RSUs. This expense is expected to be recognized over the remaining weighted-average vesting period of 3.1 years. The Company’s actual tax benefits realized for the tax deductions related to the vesting of RSUs was less than $0.1 million for the nine months ended September 30, 2013.

RSUs granted under the IMAX LTIP vest between one and four years and expire 10 years or less from the date granted. Vesting of the RSUs is subject to continued employment or service with the Company.

The following table summarizes certain information in respect of RSU activity under the IMAX LTIP for the nine months ended September 30, 2013:


				Weighted Average Grant Date Fair Value
	Number of Awards			Per Share

RSUs outstanding, beginning of year		—		$	—
Granted		322,561			26.16
Vested		(46,360	)		26.23
Forfeited		(3,220	)		26.28

RSUs outstanding, end of period		272,981			26.15

Stock Appreciation Rights

There have been no stock appreciation rights (“SARs”) granted since 2007. For the three and nine months ended September 30, 2013, 50,000 and 100,000 SARs were cash settled for $1.0 million and $2.0 million, respectively (2012 – nil and 15,000 SARs were cash settled for $nil and $0.3 million, respectively). The average exercise price for the settled SARs for the three and nine months ended September 30, 2013 was $6.86 and $6.86, respectively (2012 – n/a and $6.86, respectively) per SAR. As at September 30, 2013, 18,000 SARs were outstanding and exercisable with a weighted average fair value of $23.46 per right (December 31, 2012 — $16.23). The SARs have a remaining contractual life of 4.25 years as at September 30, 2013. None of the SARs were forfeited, cancelled, or expired for the three and nine months ended September 30, 2013 and 2012. The Company accounts for the obligation of these SARs as a liability (September 30, 2013 — $0.4 million; December 31, 2012 — $1.9 million), which is classified within accrued liabilities. The Company has recorded an expense of $0.2 million and $0.5 million for the three and nine months ended September 30, 2013, respectively (2012 — recovery of $0.4 million and an expense of $0.3 million, respectively) to selling, general and administrative expenses related to these SARs. The following assumptions were used for measuring the fair value of the SARs:


	As at September 30, 2013			As at December 31, 2012

Average risk-free interest rate		1.39	%		0.72	%
Expected option life (in years)		0.52			2.17
Expected volatility		40	%		50	%
Annual termination probability		8.52	%		8.52	%
Dividend yield		0	%		0	%

(c) Income Per Share

Reconciliations of the numerator and denominator of the basic and diluted per-share computations are comprised of the following:


	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2013		2012		2013		2012
			As Revised (note 3)				As Revised (note 3)

Net income from operations applicable to common shareholders	$	1,609	$	14,911	$	16,286	$	28,454

Weighted average number of common shares (000’s):
Issued and outstanding, beginning of period		67,099		65,893		66,482		65,053
Weighted average number of shares issued during the period		210		37		487		665

Weighted average number of shares used in computing basic income per share		67,309		65,930		66,969		65,718
Assumed exercise of stock options and RSUs, net of shares assumed		1,807		2,371		1,884		2,469

Weighted average number of shares used in computing diluted income per share		69,116		68,301		68,853		68,187

(d) Shareholders’ Equity

The following summarizes the movement of Shareholders’ Equity for the nine months ended September 30, 2013:


Balance as at December 31, 2012	$	253,079
Net income		16,286
Adjustments to capital stock:
Issuance of common shares for stock options exercised		6,745
Issuance of common shares for vested RSUs		1,114
Stock options exercised		2,343
Share issuance expenses		(202	)
Adjustments to other equity:
Employee stock options granted		6,420
Non-employee stock options granted		175
RSUs granted		1,714
Stock options exercised		(2,343	)
RSUs vested		(1,216	)
Adjustments to accumulated other comprehensive income:
Unrealized net gain from cash flow hedging instruments		(265	)
Realization of cash flow hedging net loss upon settlement		131
Amortization of actuarial loss on defined benefit plan		333
Loss on curtailment of postretirement benefit plan		398
Foreign currency translation adjustment		(115	)
Tax effect of movement in other comprehensive income		(128	)

Balance as at September 30, 2013	$	284,469

16. Segmented Information

The Company has seven reportable segments identified by category of product sold or service provided: IMAX systems; theater system maintenance; joint revenue sharing arrangements; film production and IMAX DMR; film distribution; film post-production; and other. The IMAX systems segment designs, manufactures, sells or leases IMAX theater projection system equipment. The theater system maintenance segment maintains IMAX theater projection system equipment in the IMAX theater network. The joint revenue sharing arrangements segment provides IMAX theater projection system equipment to an exhibitor in exchange for a share of the box-office and concession revenues. The film production and IMAX DMR segment produces films and performs film re-mastering services. The film distribution segment distributes films for which the Company has distribution rights. The film post-production segment provides film post-production and film print services. The Company refers to all theaters using the IMAX theater system as “IMAX theaters”. The other segment includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items. The accounting policies of the segments are the same as those described in note 2 to the audited consolidated financial statements included in the Company’s 2012 Form 10-K.

Management, including the Company’s Chief Operating Decision Maker (as defined in the Segment Reporting Topic of the FASB ASC), who is the Company’s Chief Executive Officer (“CEO”), assesses segment performance based on segment revenues, gross margins and film performance. Selling, general and administrative expenses, research and development costs, amortization of intangibles, receivables provisions (recoveries), write-downs net of recoveries, interest income, interest expense and tax (provision) recovery are not allocated to the segments.

Transactions between the film production and IMAX DMR segment and the film post-production segment are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

Transactions between the other segments are not significant.


	Three Months					Nine Months
	Ended September 30,					Ended September 30,
	2013			2012		2013			2012
Revenue⁽¹⁾
IMAX theater systems
IMAX systems	$	9,902		$	25,358	$	43,432		$	59,063
Theater system maintenance		8,103			7,042		23,844			20,878
Joint revenue sharing arrangements		11,960			13,186		39,672			40,477

		29,965			45,586		106,948			120,418


Films
Production and IMAX DMR		14,547			25,223		54,854			58,805
Distribution		1,878			3,259		6,550			11,122
Post-production		3,122			1,646		7,190			5,778

		19,547			30,128		68,594			75,705


Other		2,230			4,997		8,362			10,394

Total	$	51,742		$	80,711	$	183,904		$	206,517


Gross margins
IMAX theater systems
IMAX systems⁽²⁾	$	7,205		$	15,956	$	26,148		$	34,475
Theater system maintenance		3,218			2,828		9,432			8,122
Joint revenue sharing arrangements⁽²⁾		7,153			9,286		26,796			28,340

		17,576			28,070		62,376			70,937


Films
Production and IMAX DMR⁽²⁾		8,596			15,426		30,372			35,714
Distribution⁽²⁾		476			587		988			2,133
Post-production		912			103		3,166			1,373

		9,984			16,116		34,526			39,220


Other		(302	)		564		(29	)		287

Total	$	27,258		$	44,750	$	96,873		$	110,444

(1)	For the three and nine months ended September 30, 2013, the Company’s two largest customers collectively represent 20.1% and 20.8%, respectively, of total revenues (2012 — 15.0% and 16.5%, respectively).

(2)

IMAX systems include commission costs of $0.2 million and $0.9 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.9 million and $2.1 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $0.9 million and $2.0 million for the three and nine months ended September 30, 2013, respectively (2012 — $1.1 million and $2.1 million, respectively). Production and IMAX DMR segment margins include marketing costs of $0.8 million and $3.1 million for the three and nine months ended September 30, 2013, respectively (2012 — $0.5 million and $2.2 million, respectively). Distribution segment margins include a marketing cost of $0.1 million and $0.2 million for the three and nine months ended September 30, 2013, respectively (2012 — recovery of less than $0.1 million and expense of $1.2 million, respectively).


	September 30,		December 31,
	2013		2012
Assets
IMAX systems	$	145,205	$	153,201
Theater system maintenance		17,246		14,632
Joint revenue sharing arrangements		142,520		125,602
Films
Production and IMAX DMR		14,596		17,653
Distribution		7,294		6,790
Post-production		4,538		3,694
Other		4,654		3,142
Corporate and other non-segment specific assets		111,437		97,158

Total	$	447,490	$	421,872

Geographic Information

Revenue by geographic area is based on the location of the customer. Revenue related to IMAX DMR is presented based upon the geographic location of the theaters that exhibit the re-mastered films. IMAX DMR revenue is generated through contractual relationships with studios and other third parties and these may not be in the same geographical location as the theater. Prior years’ figures have been reclassified to conform to the current year geographical classification.


	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2013		2012		2013		2012
Revenue
United States	$	24,621	$	38,897	$	90,821	$	98,007
Canada		2,112		6,357		7,564		14,289
Greater China		8,258		7,567		28,155		29,002
Russia and the CIS		3,067		7,994		14,919		14,615
Asia (excluding Greater China)		5,766		9,840		17,915		21,030
Western Europe		4,969		4,426		14,048		15,201
Latin America		1,162		2,893		5,796		8,157
Rest of the World		1,787		2,737		4,686		6,216

Total	$	51,742	$	80,711	$	183,904	$	206,517

No single country in the Rest of the World, Western Europe, Latin America and Asia (excluding Greater China) classifications comprise more than 5% of the total revenue.

17. Employee’s Pension and Postretirement Benefits

(a) Defined Benefit Plan

The Company has an unfunded U.S. defined benefit pension plan (the “SERP”) covering Richard L. Gelfond, CEO of the Company and Bradley J. Wechsler, Chairman of the Company’s Board of Directors. The SERP provides for a lifetime retirement benefit from age 55 determined as 75% of the member’s best average 60 consecutive months of earnings over the member’s employment history. The benefits were 50% vested as at July 2000, the SERP initiation date. The vesting percentage increases on a straight-line basis from inception until age 55. As at September 30, 2013, the benefits of Mr. Gelfond were 100% vested. Upon a termination for cause, prior to a change of control, the executive shall forfeit any and all benefits to which such executive may have been entitled, whether or not vested.

Under the terms of the SERP, if Mr. Gelfond’s employment terminated other than for cause (as defined in his employment agreement), he is entitled to receive SERP benefits in the form of a lump sum payment. SERP benefit payments to Mr. Gelfond are subject to a deferral for six months after the termination of his employment, at which time Mr. Gelfond will be entitled to receive interest on the deferred amount credited at the applicable federal rate for short-term obligations. The term of Mr. Gelfond’s current employment agreement has been extended through December 31, 2013, although Mr. Gelfond has not informed the Company that he intends to retire at that time. Under the terms of the extension, Mr. Gelfond also agreed that any compensation earned during 2011, 2012 and 2013 would not be included in calculating his entitlement under the SERP

The amounts accrued for the SERP are determined as follows:


	September 30,		December 31,
	2013		2012
Obligation, beginning of period	$	20,366	$	18,990
Interest cost		147		272
Actuarial loss		—		1,104

Obligation, end of period and unfunded status	$	20,513	$	20,366

The following table provides disclosure of pension expense for the SERP:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013		2012
Interest cost	$	49	$	68	$	147	$	204
Amortization of actuarial loss		111		91		333		273

Pension expense	$	160	$	159	$	480	$	477

The accumulated benefit obligation for the SERP was $20.5 million at September 30, 2013 (December 31, 2012 - $20.4 million).

The following amounts were included in accumulated other comprehensive income (“AOCI”) and will be recognized as components of net periodic benefit cost in future periods:


	As at		As at
	September 30,		December 31,
	2013		2012
Unrecognized actuarial loss	$	3,034	$	3,367

No contributions are expected to be made for the SERP during 2013. The Company expects interest costs of less than $0.1 million and amortization of actuarial losses of $0.1 million to be recognized as a component of net periodic benefit cost during the remainder of 2013.

The following benefit payments are expected to be made as per the current SERP assumptions and the terms of the SERP in each of the next 5 years, and in the aggregate:


2013 (three months remaining)	$	—
2014		21,058
2015		—
2016		—
2017		—
Thereafter		—

	$	21,058

(b) Defined Contribution Plan

The Company also maintains defined contribution pension plans for its employees, including its executive officers. The Company makes contributions to these plans on behalf of employees in an amount up to 5% of their base salary subject to certain prescribed maximums. During the three and nine months ended September 30, 2013, the Company contributed and expensed an aggregate of $0.3 million and $1.0 million, respectively (2012 — $0.3 million and $0.8 million, respectively), to its Canadian plan and an aggregate of less than $0.1 million and $0.2 million, respectively (2012 — less than $0.1 million and $0.2 million, respectively), to its defined contribution employee pension plan under Section 401(k) of the U.S. Internal Revenue Code.

(c) Postretirement Benefits - Executives

The Company has an unfunded postretirement plan for Messrs. Gelfond and Wechsler. The plan provides that the Company will maintain health benefits for Messrs. Gelfond and Wechsler until they become eligible for Medicare and, thereafter, the Company will provide Medicare supplement coverage as selected by Messrs. Gelfond and Wechsler. The postretirement benefits obligation as at September 30, 2013 is $0.5 million (December 31, 2012 — $0.5 million). The Company has expensed less than $0.1 million and less than $0.1 million for the three and nine months ended September 30, 2013, respectively (2012 — less than $0.1 million and less than $0.1 million, respectively).

The following benefit payments are expected to be made as per the current plan assumptions in each of the next 5 years:


2013 (three months remaining)	$	15
2014		16
2015		35
2016		38
2017		42
Thereafter		401

	$	547

(d) Postretirement Benefits – Canadian Employees

The Company has an unfunded postretirement plan for its Canadian employees who meet specific eligibility requirements. The Company will provide eligible participants, upon retirement, with health and welfare benefits. The postretirement benefits obligation as at September 30, 2013 is $2.0 million (December 31, 2012 — $4.6 million). The Company has expensed less than $0.1 million and $0.1 million for the three and nine months ended September 30, 2013, respectively (2012 —$0.1 million and $0.3 million, respectively).

In February 2013, the Company amended the Canadian postretirement plan to reduce future benefits provided under the plan. As a result of this change, the Company recognized a pre-tax curtailment gain in the first quarter of 2013 of $2.2 million (included in selling, general and administrative expenses) and a reduction in the postretirement liability of $2.6 million.

The following benefit payments are expected to be made as per the current plan assumptions in each of the next 5 years:


2013 (three months remaining)	$	44
2014		60
2015		67
2016		84
2017		98
Thereafter		1,640

	$	1,993

18. Financial Instruments

(a) Financial Instruments

The Company maintains cash with various major financial institutions. The Company’s cash is invested with highly rated financial institutions.

The Company’s accounts receivables and financing receivables are subject to credit risk. The Company’s accounts receivable and financing receivables are concentrated with the theater exhibition industry and film entertainment industry. To minimize the Company’s credit risk, the Company retains title to underlying theater systems leased, performs initial and ongoing credit evaluations of its customers and makes ongoing provisions for its estimate of potentially uncollectible amounts. The Company believes it has adequately provided for related exposures surrounding receivables and contractual commitments.

(b) Fair Value Measurements

The carrying values of the Company’s cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities due within one year approximate fair values due to the short-term maturity of these instruments. The Company’s other financial instruments are comprised of the following:


	As at September 30, 2013						As at December 31, 2012
	Carrying			Estimated			Carrying			Estimated
	Amount			Fair Value			Amount			Fair Value
Borrowings under Credit Facility	$	(5,000	)	$	(5,000	)	$	(11,000	)	$	(11,000	)
Net financed sales receivable	$	86,741		$	84,767		$	81,148		$	78,933
Net investment in sales-type leases	$	12,850		$	12,914		$	13,045		$	13,513
Available-for-sale investment	$	1,350		$	1,350		$	1,350		$	1,350
Foreign exchange contracts — designated forwards	$	164		$	164		$	297		$	297
Foreign exchange contracts — non-designated forwards	$	—		$	—		$	—		$	—

The carrying value of borrowings under the Credit Facility approximates fair value as the interest rates offered under the Credit Facility are close to September 30, 2013 and December 31, 2012 market rates for the Company for debt of the same remaining maturities (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at September 30, 2013 and December 31, 2012, respectively.

The estimated fair values of the net financed sales receivable and net investment in sales-type leases are estimated based on discounting future cash flows at currently available interest rates with comparable terms (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at September 30, 2013 and December 31, 2012, respectively.

The fair value of the Company’s available-for-sale investment is determined using the present value of expected cash flows based on projected earnings and other information readily available from the business venture (Level 3 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at September 30, 2013 and December 31, 2012, respectively. The discounted cash flow valuation technique is based on significant unobservable inputs of revenue and expense projections, appropriately risk weighted, as the investment is in a start-up entity. The significant unobservable inputs used in the fair value measurement of the Company’s available-for-sale investment are long-term revenue growth and pretax operating margin. A significant increase (decrease) in any of those inputs in isolation would result in a lower or higher fair value measurement.

The fair value of foreign currency derivatives are determined using quoted prices in active markets (Level 2 input in accordance with the Fair Value Measurements Topic of the FASB ASC hierarchy) as at September 30, 2013 and December 31, 2012, respectively. These identical instruments are traded on a closed exchange.

There were no significant transfers between Level 1 and Level 2 during the nine months ended September 30, 2013 or 2012. When a determination is made to classify an asset or liability within Level 3, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. The table below sets forth a summary of changes in the fair value of the Company’s available-for-sale investment measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the period:


	Available For Sale Investments
	2013		2012

Beginning balance, January 1,	$	1,350	$	1,012
Transfers into/out of Level 3		—		—
Total gains or losses (realized/unrealized)
Included in earnings		—		—
Change in other comprehensive income		—		338
Purchases, issuances, sales and settlements		—		—

Ending balance, September 30,	$	1,350	$	1,350


The amount of total gains or losses for the period included in earnings attributable to the change in unrealized gains or losses relating to assets still held at the reporting date	$	—	$	(150	)

There were no transfers in or out of the Company’s level 3 assets during the nine months ended September 30, 2013.

In the nine months ended September 30, 2012, the Company recognized a $0.2 million other-than-temporary impairment of its available-for-sale investment, in “Impairment of available-for-sale investment” in the condensed consolidated statement of operations, as the value is not expected to recover based on the length of time and extent to which the market value has been less than cost.

(c) Financing Receivables

The Company’s net investment in leases and its net financed sale receivables are subject to the disclosure requirements of ASC 310 “Receivables”. Due to differing risk profiles of its net investment in leases and its net financed sales receivables, the Company views its net investment in leases and its net financed sale receivables as separate classes of financing receivables. The Company does not aggregate financing receivables to assess impairment.

The Company monitors the credit quality of each customer on a frequent basis through collections and aging analyses. The Company also holds meetings monthly in order to identify credit concerns and whether a change in credit quality classification is required for the customer. A customer may improve in their credit quality classification once a substantial payment is made on overdue balances or the customer has agreed to a payment plan with the Company and payments have commenced in accordance to the payment plan. The change in credit quality indicator is dependent upon management approval.

The Company classifies its customers into four categories to indicate the credit quality worthiness of its financing receivables for internal purposes only:

Good standing — Theater continues to be in good standing with the Company as the client’s payments and reporting are up-to-date.

Credit Watch — Theater operator has begun to demonstrate a delay in payments, has been placed on the Company’s credit watch list for continued monitoring, but active communication continues with the Company. Depending on the size of outstanding balance,

length of time in arrears and other factors, transactions may need to be approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the “Pre-approved transactions” category, but not in as good of condition as those receivables in “Good standing”.

Pre-approved transactions only — Theater operator is demonstrating a delay in payments with little or no communication with the Company. All service or shipments to the theater must be reviewed and approved by management. These financing receivables are considered to be in better condition than those receivables related to theaters in the “All transactions suspended” category, but not in as good of condition as those receivables in “Credit Watch.” Depending on the individual facts and circumstances of each customer, finance income recognition may be suspended if management believes the receivable to be impaired.

All transactions suspended — Theater is severely delinquent, non-responsive or not negotiating in good faith with the Company. Once a theater is classified as “All transactions suspended”, the theater is placed on nonaccrual status and all revenue recognitions related to the theater are stopped.

The following table discloses the recorded investment in financing receivables by credit quality indicator:


	As at September 30, 2013						As at December 31, 2012
	Minimum Lease Payments		Financed Sales Receivables		Total		Minimum Lease Payments		Financed Sales Receivables		Total

In good standing	$	10,996	$	76,350	$	87,346	$	11,508	$	69,310	$	80,818
Credit watch		414		10,044		10,458		—		10,930		10,930
Pre-approved transactions		659		—		659		467		293		760
Transactions suspended		2,211		413		2,624		2,200		681		2,881

	$	14,280	$	86,807	$	101,087	$	14,175	$	81,214	$	95,389

While recognition of finance income is suspended, payments received by a customer are applied against the outstanding balance owed. If payments are sufficient to cover any unreserved receivables, a recovery of provision taken on the billed amount, if applicable, is recorded to the extent of the residual cash received. Once the collectibility issues are resolved and the customer has returned to being in good standing, the Company will resume recognition of finance income. During the year ended December 31, 2012, a financing receivable was modified as a troubled debt restructuring. The customer has paid all overdue amounts in accordance with such restructuring which has resulted in a change in the credit quality classification from ‘pre-approved transactions’ to ‘in good standing’.

The Company’s investment in financing receivables on nonaccrual status is as follows:


	As at September 30, 2013					As at December 31, 2012
	Recorded		Related			Recorded		Related
	Investment		Allowance			Investment		Allowance

Net investment in leases	$	2,870	$	(1,230	)	$	2,666	$	(1,130	)
Net financed sales receivables		413		(66	)		1,322		(66	)

	$	3,283	$	(1,296	)	$	3,988	$	(1,196	)

The Company considers financing receivables with aging between 60-89 days as indications of theaters with potential collection concerns. The Company will begin to focus its review on these financing receivables and increase its discussions internally and with the theater regarding payment status. Once a theater’s aging exceeds 90 days, the Company’s policy is to review and assess collectibility on the theater’s past due accounts. Over 90 days past due is used by the Company as an indicator of potential impairment as invoices up to 90 days outstanding could be considered reasonable due to the time required for dispute resolution or for the provision of further information or supporting documentation to the customer.

The Company’s aged financing receivables are as follows:


	As at September 30, 2013
	Accrued and Current		30-89 Days		90+ Days		Billed Financing Receivables		Related Unbilled Recorded Investment		Total Recorded Investment		Related Allowances			Recorded Investment Net of Allowances

Net investment in leases	$	569	$	113	$	1,577	$	2,259	$	12,021	$	14,280	$	(1,430	)	$	12,850
Net financed sales receivables		2,044		755		1,960		4,759		82,048		86,807		(66	)		86,741

Total	$	2,613	$	868	$	3,537	$	7,018	$	94,069	$	101,087	$	(1,496	)	$	99,591


	As at December 31, 2012
	Accrued and Current		30-89 Days		90+ Days		Billed Financing Receivables		Related Unbilled Recorded Investment		Total Recorded Investment		Related Allowances			Recorded Investment Net of Allowances

Net investment in leases	$	144	$	202	$	1,240	$	1,586	$	12,589	$	14,175	$	(1,130	)	$	13,045
Net financed sales receivables		1,063		670		1,267		3,000		78,214		81,214		(66	)		81,148

Total	$	1,207	$	872	$	2,507	$	4,586	$	90,803	$	95,389	$	(1,196	)	$	94,193

The Company’s recorded investment in past due financing receivables for which the Company continues to accrue finance income is as follows:


	As at September 30, 2013
	Accrued and Current		30-89 Days		90+ Days		Billed Financing Receivables		Related Unbilled Recorded Investment		Related Allowance		Recorded Investment Past Due and Accruing

Net investment in leases	$	182	$	41	$	208	$	431	$	3,487	$	—	$	3,918
Net financed sales receivables		590		755		1,960		3,305		24,098		—		27,403

Total	$	772	$	796	$	2,168	$	3,736	$	27,585	$	—	$	31,321


	As at December 31, 2012
	Accrued and Current		30-89 Days		90+ Days		Billed Financing Receivables		Related Unbilled Recorded Investment		Related Allowance		Recorded Investment Past Due and Accruing

Net investment in leases	$	11	$	59	$	23	$	93	$	1,449	$	—	$	1,542
Net financed sales receivables		223		382		864		1,469		16,173		—		17,642

Total	$	234	$	441	$	887	$	1,562	$	17,622	$	—	$	19,184

The Company considers financing receivables to be impaired when it believes it to be probable that it will not recover the full amount of principal and interest owing under the arrangement. The Company uses its knowledge of the industry and economic trends, as well as its prior experiences to determine the amount recoverable for impaired financing receivables. The following table discloses information regarding the Company’s impaired financing receivables:


	For the Three Months Ended September 30, 2013
	Recorded Investment		Unpaid Principal		Related Allowance			Average Recorded Investment		Interest Income Recognized
Recorded investment for which there is a related allowance:
Net financed sales receivables		185		220		(66	)		161		—

Recorded investment for which there is no related allowance:
Net financed sales receivables		349		43		—			352		—

Total recorded investment in impaired loans:

Net financed sales receivables	$	534	$	263	$	(66	)	$	513	$	—


	For the Three Months Ended September 30, 2012
	Recorded Investment		Unpaid Principal		Related Allowance			Average Recorded Investment		Interest Income Recognized
Recorded investment for which there is a related allowance:
Net financed sales receivables		671		195		(66	)		671		—

Recorded investment for which there is no related allowance:
Net financed sales receivables		385		19		—			474		11

Total recorded investment in impaired loans:

Net financed sales receivables	$	1,056	$	214	$	(66	)	$	1,145	$	11


	For the Nine Months Ended September 30, 2013
	Recorded Investment		Unpaid Principal		Related Allowance			Average Recorded Investment		Interest Income Recognized
Recorded investment for which there is a related allowance:
Net financed sales receivables		185		220		(66	)		172		—

Recorded investment for which there is no related allowance:
Net financed sales receivables		349		43		—			363		22

Total recorded investment in impaired loans:

Net financed sales receivables	$	534	$	263	$	(66	)	$	535	$	22


	For the Nine Months Ended September 30, 2012
	Recorded Investment		Unpaid Principal		Related Allowance			Average Recorded Investment		Interest Income Recognized
Recorded investment for which there is a related allowance:
Net financed sales receivables		671		195		(66	)		204		—

Recorded investment for which there is no related allowance:
Net financed sales receivables		385		19		—			512		11

Total recorded investment in impaired loans:

Net financed sales receivables	$	1,056	$	214	$	(66	)	$	716	$	11

The Company’s activity in the allowance for credit losses for the period and the Company’s recorded investment in financing receivables is as follows:


	Three Months Ended September 30, 2013						Nine Months Ended September 30, 2013
	Net Investment in Leases			Net Financed Sales Receivables			Net Investment in Leases			Net Financed Sales Receivables
Allowance for credit losses:

Beginning balance	$	1,230		$	66		$	1,130		$	66
Provision		200			—			300			—

Ending balance	$	1,430		$	66		$	1,430		$	66


Ending balance: individually evaluated for impairment	$	1,430		$	66		$	1,430		$	66


Financing receivables:

Ending balance: individually evaluated for impairment	$	14,280		$	86,807		$	14,280		$	86,807


	Three Months Ended September 30, 2012						Nine Months Ended September 30, 2012
	Net Investment in Leases			Net Financed Sales Receivables			Net Investment in Leases			Net Financed Sales Receivables
Allowance for credit losses:

Beginning balance	$	1,892		$	173		$	1,833		$	316
Charge-offs		(762	)		(107	)⁽¹⁾		(1,019	)		(109	)⁽¹⁾
Provision		—			—			316			(141	)

Ending balance	$	1,130		$	66		$	1,130		$	66


Ending balance: individually evaluated for impairment	$	1,130		$	66		$	1,130		$	66


Financing receivables:

Ending balance: individually evaluated for impairment	$	14,452		$	78,277		$	14,452		$	78,277

(1)	As a result of a troubled debt restructuring in the period ended September 30, 2012, the Company recorded a $0.1 million write-down on a $0.5 million recorded investment.

(d) Foreign Exchange Risk Management

The Company is exposed to market risk from changes in foreign currency rates. A majority portion of the Company’s revenues is denominated in U.S. dollars while a substantial portion of its costs and expenses is denominated in Canadian dollars. A portion of the net U.S. dollar cash flows of the Company is periodically converted to Canadian dollars to fund Canadian dollar expenses through the spot market. In China and Japan the Company has ongoing operating expenses related to its operations in Chinese Renminbi and Japanese yen, respectively. Net cash flows are converted to and from U.S. dollars through the spot market. The Company also has cash receipts under leases denominated in Chinese Renminbi, Japanese yen, Canadian dollar and Euros which are converted to U.S. dollars through the spot market. The Company’s policy is to not use any financial instruments for trading or other speculative purposes.

The Company entered into a series of foreign currency forward contracts to manage the Company’s risks associated with the volatility of foreign currencies. Certain of these foreign currency forward contracts met the criteria required for hedge accounting under the Derivatives and Hedging Topic of the FASB ASC at inception, and continue to meet hedge effectiveness tests at September 30, 2013 (the “Foreign Currency Hedges”), with settlement dates throughout 2014. Foreign currency derivatives are recognized and measured in the balance sheet at fair value. Changes in the fair value (gains or losses) are recognized in the condensed consolidated statement of operations except for derivatives designated and qualifying as foreign currency hedging instruments. For foreign currency hedging instruments, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in other comprehensive income and reclassified to the condensed consolidated statement of operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the consolidated statement of operations. The Company currently does not hold any derivatives which are not designated as hedging instruments and therefore no gain or loss pertaining to an ineffective portion has been recognized.

The following tabular disclosures reflect the impact that derivative instruments and hedging activities have on the Company’s condensed consolidated financial statements:

Notional value foreign exchange contracts as at:


	September 30, 2013		December 31, 2012
Derivatives designated as hedging instruments:
Foreign exchange contracts - Forwards	$	24,617	$	8,069

Fair value of derivatives in foreign exchange contracts as at:


	Balance Sheet Location	September 30, 2013			December 31, 2012
Derivatives designated as hedging instruments:
Foreign exchange contracts — Forwards	Other Assets	$	231		$	297
Foreign exchange contracts — Forwards	Accrued and other liabilities		(67	)		—

		$	164		$	297

Derivatives in Foreign Currency Hedging relationships are as follows:


		Three Months Ended September 30,					Nine Months Ended September 30,
		2013			2012		2013			2012
Foreign exchange contracts - Forwards	Derivative Gain (Loss) Recognized in OCI (Effective Portion)	$	535		$	589	$	(265	)	$	826

		$	535		$	589	$	(265	)	$	826


	Location of Derivative (Loss) Gain Reclassified from AOCI into Income	Three Months Ended September 30,					Nine Months Ended September 30,
	(Effective Portion)	2013			2012		2013			2012
Foreign exchange contracts - Forwards	Selling, general and administrative expenses	$	(179	)	$	158	$	(131	)	$	22

		$	(179	)	$	158	$	(131	)	$	22

Non Designated Derivatives in Foreign Currency relationships are as follows:


		Three Months Ended September 30,				Nine Months Ended September 30,
	Location of Derivative Gain (Loss)	2013		2012		2013		2012
Foreign exchange contracts - Forwards	Selling, general and administrative expenses	$	—	$	400	$	—	$	1,229

		$	—	$	400	$	—	$	1,229

(e) Investments in New Business Ventures

The Company accounts for investments in new business ventures using the guidance of ASC 323 and ASC 320, as appropriate. As at September 30, 2013, the equity method of accounting is being utilized for an investment with a carrying value of $2.0 million (December 31, 2012 — $3.0 million). For the three months ended September 30, 2013, gross revenues, cost of revenue and net loss for the investment were $1.2 million, $3.1 million and $3.3 million, respectively (2012 — $2.7 million, $2.9 million and $3.0 million, respectively). For the nine months ended September 30, 2013, gross revenues, cost of revenue and net loss for the investment $5.4 million, $10.0 million and $9.8 million, respectively (2012 — $6.5 million, $8.9 million and $9.9 million, respectively). The Company has determined it is not the primary beneficiary of this VIE, and therefore it has not been consolidated. The difference between the Company’s investment balance and the amount of underlying equity in net assets owned by the Company amounts to $0.4 million and relates to goodwill. In addition, the Company has an investment in preferred stock of another business venture of $1.5 million which meets the criteria for classification as a debt security under ASC 320 and is recorded at a total fair value of $1.4 million at September 30, 2013 (December 31, 2012 — $1.4 million). In the nine months ended September 30, 2012, the Company recognized an other-than-temporary impairment for its investment of $0.2 million. This investment is classified as an available-for-sale investment. In 2013, the Company invested $2.5 million in the preferred shares of an enterprise which meets the criteria for classification as an equity security under ASC 325. The total carrying value of investments in new business ventures at September 30, 2013 is $5.9 million (December 31, 2012 — $4.4 million) and is recorded in Other Assets.

IMAX CORPORATION

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

OVERVIEW

IMAX Corporation, together with its wholly-owned subsidiaries (the “Company”), is one of the world’s leading entertainment technology companies, specializing in motion picture technologies and presentations. The Company refers to all theaters using the IMAX theater system as “IMAX theaters.” IMAX offers a unique end-to-end cinematic solution combining proprietary software, theater architecture and equipment to create the highest-quality, most immersive motion picture experience for which the IMAX^® brand has become known globally. Top filmmakers and studios utilize IMAX theaters to connect with audiences in innovative ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the world. As of September 30, 2013 there were 785 IMAX theater systems (653 commercial multiplexes, 19 commercial destinations, 113 institutional) operating in 55 countries. This compares to 689 theater systems (556 commercial multiplexes, 20 commercial destinations, 113 institutional) operating in 52 countries as of September 30, 2012.

IMAX theater systems combine:

•

IMAX DMR (Digital Re-Mastering) movie conversion technology, which results in higher image and sound fidelity than conventional cinema experiences;

•

advanced, high-resolution projectors with specialized equipment and automated theater control systems, which generate significantly more contrast and brightness than conventional theater systems;

•

large screens and proprietary theater geometry, which result in a substantially larger field of view so that the screen extends to the edge of a viewer’s peripheral vision and creates more realistic images;

•

sound system components, which deliver more expansive sound imagery and pinpointed origination of sound to any specific spot in an IMAX theater; and

•

specialized theater acoustics, which result in a four-fold reduction in background noise.

The components together cause audiences in IMAX theaters to feel as if they are a part of the on-screen action, creating a more intense, immersive and exciting experience than in a traditional theater.

As a result of the immersiveness and superior image and sound quality of The IMAX Experience, the Company’s exhibitor customers typically charge a premium for IMAX DMR films over films exhibited in their other auditoriums. The premium pricing, combined with the higher attendance levels associated with IMAX, generates incremental box-office for the Company’s exhibitor customers and for the movie studios releasing their films to the IMAX network. The incremental box office generated by IMAX DMR films has helped establish IMAX as a key premium distribution and marketing platform for Hollywood blockbuster films.

As one of the world’s leaders in entertainment technology, the Company strives to remain at the forefront of advancements in cinema technology. Accordingly, one of the Company’s key short-term initiatives is the development of a next-generation laser-based digital projection system, which it plans to begin rolling out by the end of 2014. The Company believes that a laser projection solution will be the first IMAX digital projection system capable of illuminating the largest screens in its network, which are currently film-based, and will enhance the access of these screens to the full array of IMAX digital content. In 2011, the Company announced the completion of a deal in which it secured certain license rights to a portfolio of intellectual property in the digital cinema field owned by the Eastman Kodak Company (“Kodak”). The transaction involves exclusive rights to technology related to laser projection as well as rights in the digital cinema field to a broader range of Kodak technology. On February 7, 2012, the Company announced an agreement with Barco N.V. (“Barco”) to co-develop a laser-based digital projection system that incorporates Kodak technology. The Company believes that these arrangements with Kodak and Barco will enable IMAX laser projectors to present greater brightness and clarity, a wider color gamut and deeper blacks, and consume less power and last longer than existing digital technology.

Important factors that the Company’s Chief Executive Officer (“CEO”) Richard L. Gelfond uses in assessing the Company’s business and prospects include:

•

the signing, installation and financial performance of theater system arrangements (particularly its joint revenue sharing arrangements);

•

film performance and the securing of new film projects (particularly IMAX DMR films);

•

revenue and gross margins from the Company’s operating segments;

•

operating leverage;

•

earnings from operations as adjusted for unusual items that the Company views as non-recurring;

•

short- and long-term cash flow projections;

•

the continuing ability to invest in and improve the Company’s technology to enhance its differentiation of presentation versus other cinematic experiences; and

•

the overall execution, reliability and consumer acceptance of The IMAX Experience, related technologies and new initiatives.

The primary revenue sources for the Company can be categorized into two main groups: theater systems and films. On the theater systems side, the Company derives revenues from theater exhibitors primarily through either a sale or sales-type lease arrangement or a joint revenue sharing arrangement. Theater exhibitors also pay for associated maintenance and extended warranty services. The Company also derives a small portion of other revenues from the operation of its own theaters, the provision of aftermarket parts for its system components, and camera rentals. Film revenue is derived primarily from film studios for the provision of film production and digital re-mastering services for exhibition on IMAX theater systems around the world. The Company derives other film revenues from the distribution of certain films and the provision of post-production services.

IMAX Theater Systems: IMAX Systems (Sales and Sales-type Leases), Joint Revenue Sharing Arrangements and Theater System Maintenance

One of the Company’s principal businesses is the design, manufacture and delivery of premium theater systems (“IMAX theater systems”). The theater system equipment components (including the projection system, sound system, screen system and, if applicable, 3D glasses cleaning machine), theater design support, supervision of installation, projectionist training and the use of the IMAX brand are all elements of what the Company considers the system deliverable (the “System Deliverable”). The IMAX theater systems are based on proprietary and patented technology developed over the course of the Company’s 46-year history. The Company’s customers who purchase, lease or otherwise acquire the IMAX theater systems through joint revenue sharing arrangements are theater exhibitors that operate commercial theaters (particularly multiplexes), museums, science centers, or destination entertainment sites. The Company generally does not own IMAX theaters, but licenses the use of its trademarks along with the sale, lease or contribution of the IMAX theater system.

IMAX Systems

The Company provides IMAX theater systems to customers on a sales or long-term lease basis, typically with an initial 10-year term. These agreements typically comprise of initial fees and ongoing fees (which can include a fixed minimum amount per annum and contingent fees in excess of the minimum payments), as well as maintenance and extended warranty fees. The initial fees vary depending on the system configuration and location of the theater and are paid to the Company in installments between the time of system signing and the time of system installation, which is when the total of these fees, in addition to the present value of future annual minimum payments, are recognized as revenue. Ongoing fees are paid over the term of the contract, commencing after the theater system has been installed and are equal to the greater of a fixed minimum amount per annum or a percentage of box-office receipts. Contingent payments in excess of fixed minimum ongoing payments are recognized as revenue when reported by theater operators, provided collectibility is reasonably assured. Typically, ongoing fees are indexed to a local consumer price index. Finance income is derived over the term of a financed sale or sales-type lease arrangement as the unearned income on that financed sale or sales-type lease is earned.

Under a sales agreement, title to the theater system equipment components passes to the customer. In certain instances, however, the Company retains title or a security interest in the equipment until the customer has made all payments required under the agreement. Under the terms of a sales-type lease agreement, title to the theater system equipment components remains with the Company. The Company has the right to remove the equipment for non-payment or other defaults by the customer.

The revenue earned from customers under the Company’s theater system sales or lease agreements varies from quarter to quarter and year to year based on a number of factors, including the number and mix of theater system configurations sold or leased, the timing of installation of the theater systems, the nature of the arrangement and other factors specific to individual contracts.

Joint Revenue Sharing Arrangements

The Company also provides IMAX theater systems to customers under joint revenue sharing arrangements. Under these arrangements the Company provides the IMAX theater system in return for a portion of the customer’s IMAX box-office receipts and, in some cases, concession revenues and/or a small upfront or initial payment. Pursuant to these revenue-sharing arrangements, the Company retains title to the theater system equipment components and the applicable rent payments are contingent, instead of fixed or determinable, on film performance. The initial term of IMAX theater systems under joint revenue sharing arrangements are typically non-cancellable for 10 to 13 years and are renewable by the customer for one or more additional terms of between 5 and 10 years. The Company has the right to remove the equipment for non-payment or other defaults by the customer. The contracts are non-cancellable by the customer unless the Company fails to perform its obligations.

The introduction of joint revenue sharing arrangements has been an important factor in the expansion of the Company’s commercial theater network, which has grown by approximately 275% since 2008. Joint revenue sharing arrangements allow commercial theater exhibitors to install IMAX theater systems without the significant initial capital investment required in a sale or sales-type lease arrangement. Joint revenue sharing arrangements drive recurring cash flows and earnings for the Company, as customers under joint revenue sharing arrangements pay the Company a portion of their ongoing box-office. The Company funds its joint revenue sharing arrangements through cash flows from operations and the Company’s credit facility. As at September 30, 2013, the Company had 351 theaters in operation under joint revenue sharing arrangements, a 22.3% increase as compared to the 287 joint revenue sharing arrangements open as at September 30, 2012. The Company also had contracts in backlog for an additional 194 theaters under joint revenue sharing arrangements as at September 30, 2013.

The revenue earned from customers under the Company’s joint revenue sharing arrangements can vary from quarter to quarter and year to year based on a number of factors including film performance, the mix of theater system configurations, the timing of installation of these theater systems, the nature of the arrangement, the location, size and management of the theater and other factors specific to individual arrangements. Ongoing revenue from theater systems under joint revenue sharing arrangements is derived from box-office results and concession revenues reported by the theater operator, provided collectibility is reasonably assured.

Theater System Maintenance

For all IMAX theaters, theater owners or operators are also responsible for paying the Company an annual maintenance and extended warranty fee. Under these arrangements, the Company provides proactive and reactive maintenance services to every theater in its network to ensure that each presentation is up to the highest IMAX quality standard. Annual maintenance fees are paid throughout the duration of the term of the theater agreements and are typically indexed to a local consumer price index.

Other Theater Revenues

The Company derives a small portion of its revenues from other sources. As at September 30, 2013 and December 31, 2012, the Company had four owned and operated theaters. In addition, the Company has a commercial arrangement with one theater resulting in the sharing of profits and losses and provides management services to two theaters. The Company also rents its proprietary 2D and 3D large-format film and digital cameras to third party production companies. The Company maintains cameras and other film equipment and also offers production advice and technical assistance to both documentary and Hollywood filmmakers. Additionally, the Company generates revenues from the sale of after-market parts and 3D glasses.

Revenue from theater system arrangements is recognized at a different time from when cash is collected. See “Critical Accounting Policies” below for further discussion on the Company’s revenue recognition policies.

IMAX Theater Network

The following table outlines the breakdown of the theater network by type and geographic location as at September 30:


	2013 Theater Network Base								2012 Theater Network Base
	Commercial Multiplex		Commercial Destination		Institutional		Total		Commercial Multiplex		Commercial Destination		Institutional		Total
United States		306		6		54		366		281		6		57		344
Canada		33		2		7		42		32		2		7		41
Greater China⁽¹⁾		131		—		21		152		92		—		19		111
Asia (excluding Greater China)		57		3		7		67		48		4		7		59
Western Europe		44		7		11		62		34		7		11		52
Russia & the CIS		39		—		—		39		29		—		—		29
Latin America⁽²⁾		20		—		11		31		19		—		10		29
Rest of the World		23		1		2		26		21		1		2		24

Total		653		19		113		785		556		20		113		689

(1)	Greater China includes China, Hong Kong, Taiwan and Macau.

(2)	Latin America includes South America, Central America and Mexico.

As of September 30, 2013, 52.0% of IMAX systems in operation were located in the United States and Canada compared to 55.9% as at September 30, 2012. The commercial exhibitor market in the United States and Canada represents an important customer base for the Company in terms of both collections under existing arrangements and potential future theater system contracts. The Company has targeted these operators for the sale or sales-type lease of its IMAX digital projection system, as well as for joint revenue sharing arrangements. While the Company is pleased with its progress in the U.S. and Canadian exhibitor markets, there is no assurance that the Company’s progress in these markets will continue, particularly as a higher percentage of these markets are penetrated. To minimize the Company’s credit risk in this area, the Company retains title to the underlying theater systems leased, performs initial and ongoing credit evaluations of its customers and makes ongoing provisions for its estimates of potentially uncollectible amounts.

The Company believes that over time its commercial multiplex theater network could grow to approximately 1,700 IMAX theaters worldwide from 653 commercial multiplex IMAX theaters operating as of September 30, 2013. While the Company continues to grow in the United States and Canada, it believes that the majority of its future growth will come from underpenetrated, international markets. As at September 30, 2013, 48.0% of IMAX systems in operation were located within international markets (defined as all countries other than the United States and Canada), up from 44.1% as at September 30, 2012. Risks associated with the Company’s international business are outlined in Risk Factors – “The Company conducts business internationally, which exposes it to uncertainties and risks that could negatively affect its operations, sales and future growth prospects” in Item 1A of the Company’s 2012 Form 10-K.

The following table outlines the breakdown of the Commercial Multiplex theater network by arrangement type and geographic location as at September 30:


	2013						2012
	IMAX Commercial Multiplex Theater Network						IMAX Commercial Multiplex Theater Network
	JRSA		Sale / Sales- type lease		Total		JRSA		Sale / Sales- type lease		Total

Domestic Total (United States & Canada)		223		116		339		204		109		313


International:
Greater China		73		58		131		43		49		92
Asia (excluding Greater China)		28		29		57		24		24		48
Western Europe		27		17		44		16		18		34
Russia & the CIS		—		39		39		—		29		29
Latin America		—		20		20		—		19		19
Rest of the World		—		23		23		—		21		21

International Total		128		186		314		83		160		243

Worldwide Total		351		302		653		287		269		556

As at September 30, 2013, 223 (2012 — 204) of the 351 (2012 — 287) theaters under joint revenue sharing arrangements in operation, or 63.5% (2012 — 71.1%) were located in the United States and Canada, with the remaining 128 (2012 — 83) or 36.5% of arrangements being located in international markets. The Company continues to seek to expand its network of theaters under joint revenue sharing arrangements, particularly in select international markets.

Sales Backlog

The Company’s current sales backlog is as follows:


	September 30, 2013					September 30, 2012
	Number of Systems			Dollar Value *(in thousands)*		Number of Systems			Dollar Value *(in thousands)*
Sales and sale-type lease arrangements		162		$	195,567		136		$	172,926
Joint revenue sharing arrangements		194			50,499		149			29,558

		356	⁽¹⁾	$	246,066		285	⁽²⁾	$	202,484

(1)	Includes 23 upgrades to a digital theater system, in an existing IMAX theater location (5 xenon and 18 laser, of which 3 are under joint revenue sharing arrangements).

(2)	Includes 3 upgrades to a digital theater system, in an existing IMAX theater location (2 xenon and 1 laser).

The number of theater systems in the backlog reflects the minimum number arising from signed contracts. The dollar value could fluctuate depending on the number of new theater system arrangements signed from quarter to quarter, which adds to backlog, and its installation and acceptance of theater systems and the settlement of contracts, both of which reduce backlog. Sales backlog typically represents the fixed contracted revenue under signed theater system sale and lease agreements that the Company believes will be recognized as revenue upon installation and acceptance of the associated theater. Sales backlog includes initial fees along with the estimated present value of contractual ongoing fees due over the lease term; however, it excludes amounts allocated to maintenance and extended warranty revenues as well as fees in excess of contractual ongoing fees that may be received in the future. The value of sales backlog does not include revenue from theaters in which the Company has an equity interest, operating leases, letters of intent or long-term conditional theater commitments. The value of theaters under joint revenue sharing arrangements is excluded from the dollar value of sales backlog, although certain theater systems under joint revenue sharing arrangements provide for contracted upfront payments and therefore carry a backlog value based on those payments. The Company believes that the contractual obligations for theater system installations that are listed in sales backlog are valid and binding commitments.

From time to time, in the normal course of its business, the Company will have customers who are unable to proceed with a theater system installation for a number of reasons, including the inability to obtain certain consents, approvals or financing. Once the determination is made that the customer will not proceed with installation, the agreement with the customer is terminated or amended. If the agreement is terminated, once the Company and the customer are released from all their future obligations under the agreement, all or a portion of the initial rents or fees that the customer previously made to the Company are recognized as revenue.

The following table outlines the breakdown of the total backlog by arrangement type and geographic location as at September 30:


	2013							2012
	JRSA		Sale / Lease		Total			JRSA		Sale / Lease		Total

Domestic Total (United States & Canada)		36		25		61			47		12		59


International:
Greater China		132		43		175			76		47		123
Asia (excluding Greater China)		13		24		37			14		20		34
Western Europe		9		5		14			12		—		12
Russia & the CIS		—		19		19			—		19		19
Latin America		—		39		39			—		35		35
Rest of the World		4		7		11			—		3		3

International Total		158		137		295			102		124		226

Worldwide Total		194		162		356	⁽¹⁾		149		136		285	⁽²⁾

(1)	Includes 23 upgrades to a digital theater system, in an existing IMAX theater location (5 xenon and 18 laser, of which 3 are under joint revenue sharing arrangements).

(2)	Includes 3 upgrades to a digital theater system, in an existing IMAX theater location (2 xenon and 1 laser).

Approximately 83% of IMAX theater system arrangements in backlog as at September 30, 2013 are scheduled to be installed in international markets.


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2013			2012			2013			2012
Theater System Signings:
Full new sales and sale-type lease arrangements		6			4			38			32
New joint revenue sharing arrangements		82			28			92			61

Total new theaters		88			32			130			93
Upgrades of IMAX theater systems		11	⁽¹⁾		9	⁽⁴⁾		28	⁽²⁾		11	⁽⁴⁾

Total theater signings		99			41			158			104


	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2013			2012			2013			2012
Theater System Installations:
Full new sales and sale-type lease arrangements		6	⁽³⁾		14			23			33
New joint revenue sharing arrangements		13			14			35			31

Total new theaters		19			28			58			64
Upgrades of IMAX theater systems		9	⁽¹⁾		5			17	⁽²⁾		15

Total theater installations		28			33			75			79

(1)	Includes upgrades to xenon-based digital systems under short-term operating lease arrangements (4 signings, 3 installations).

(2)	Includes upgrades to xenon-based digital systems under short-term operating lease arrangements (9 signings, 5 installations).

(3)	Includes one full xenon-based digital system under a short-term operating lease arrangement.

(4)	Includes 3 IMAX theaters acquired from another existing customer that had been operating under a joint revenue sharing arrangement. These theaters were purchased from the Company under a sales arrangement.

Earlier in the year, the Company disclosed that it expected to install approximately 110 - 125 new theater systems (excluding digital upgrades) for the full year of 2013. The Company currently anticipates that installs for 2013 will be at the low end of that range. Unlike in previous years in which the Company’s installation estimates were limited to scheduled installations from backlog, the Company now includes in its estimates not only scheduled systems from backlog, but also the Company’s estimate of installations from arrangements that will sign and install in the same calendar year. The Company cautions, however, that theater system installations may slip from period to period in the course of the Company’s business, usually for reasons beyond its control.

Films: Digital Re-Mastering (IMAX DMR) and other film revenue

Digital Re-Mastering (IMAX DMR)

In 2002, the Company developed a proprietary technology to digitally re-master Hollywood films into IMAX digital cinema package format or 15/70-format film for exhibition in IMAX theaters at a modest cost that is incurred by the Company. This system, known as IMAX DMR, digitally enhances the image resolution of motion picture films for projection on IMAX screens while maintaining or enhancing the visual clarity and sound quality to levels for which The IMAX Experience is known. This technology enabled the IMAX theater network to release Hollywood films simultaneously with their broader domestic release. The development of this technology was critical in helping the Company execute its strategy of expanding its commercial theater network by establishing IMAX theaters as a key, premium distribution platform for Hollywood films. In a typical IMAX DMR film arrangement, the Company will receive a percentage of net box-office receipts of any commercial films released in the IMAX network, which range from 10-15%, from a film studio for the conversion of the film to the IMAX DMR format and access to its premium distribution platform.

IMAX films benefit from enhancements made by individual filmmakers exclusively for the IMAX release, and filmmakers and studios have increasingly sought IMAX-specific enhancements to generate interest in and excitement for their films. Such enhancements include shooting selected scenes with IMAX cameras to increase the audience’s immersion in the film and taking advantage of the unique dimensions of the IMAX screen by shooting the film in a larger aspect ratio and early release windows exclusively in IMAX. Several recent films have featured select sequences shot with IMAX cameras including Star Trek Into Darkness: An IMAX 3D Experience, released in May 2013. In addition, several upcoming films will feature select sequences shot with IMAX cameras including The Hunger Games: Catching Fire: The IMAX Experience, to be released in November 2013. Several recent movies, including Skyfall: The IMAX Experience in 2012 and Oblivion: The IMAX Experience in 2013, have featured footage taking advantage of the larger projected IMAX aspect ratio.

The original soundtrack of a film to be released to the IMAX network is re-mastered for the IMAX five or six-channel digital sound systems for the IMAX DMR release. Unlike the soundtracks played in conventional theaters, IMAX re-mastered soundtracks are uncompressed and full fidelity. IMAX sound systems use proprietary loudspeaker systems and proprietary surround sound configurations that ensure every theater seat is in a good listening position.

The Company believes that its international expansion is an important driver of future growth for the Company. In fact, during the nine months ended September 30, 2013, 55.7% of the Company’s gross box-office from IMAX DMR films was generated in international markets, as compared to 48.9% in the nine months ended September 30, 2012. To support growth in international markets, the Company has sought to bolster its international film strategy, supplementing the Company’s film slate of Hollywood DMR titles with appealing local IMAX DMR releases in select markets. During 2012, five local-language IMAX DMR films were released, including four in China and one in France. For 2013, the Company has announced the release of eight local language IMAX DMR films, including four in China and one in each of Japan, Russia, France, and India. The Company expects to announce additional local language IMAX DMR films to be released to the IMAX network in 2014 and beyond.

In addition to the 28 IMAX DMR films released to the IMAX theater network during the first nine months of 2013, 9 additional IMAX DMR films are scheduled to be released to the IMAX theater network during the remaining three months of 2013:

•

Gravity: An IMAX 3D Experience (Warner Bros., October 2013);

•

Stalingrad: An IMAX 3D Experience (AR Films, October 2013, Russia and the CIS only);

•

Captain Phillips: The IMAX Experience (Sony, October 2013);

•

The Young and Prodigious T.S. Spivet: An IMAX 3D Experience (Epithète Films., October 2013, France only);

•

Thor: The Dark World: An IMAX 3D Experience (Walt Disney Pictures, October 2013, International only);

•

Ender’s Game: The IMAX Experience (Lionsgate, November 2013);

•

The Hunger Games: Catching Fire: The IMAX Experience (Lionsgate, November 2013);

•

The Hobbit: The Desolation of Smaug: An IMAX 3D Experience (Warner Bros., December 2013); and

•

Dhoom 3: The IMAX Experience (Yash Raj Films, December 2013, India only).

In addition, in conjunction with MacGillivray Freeman Films (“MFF”), the Company will release an IMAX original production, Journey to the South Pacific: An IMAX 3D Experience, on November 27, 2013.

To date, the Company has announced the following 9 titles to be released to the IMAX theater network in 2014:

•

I, Frankenstein: An IMAX 3D Experience (Lionsgate, January 2014);

•

Robocop: The IMAX Experience (MGM, February 2014);

•

300: Rise of an Empire: An IMAX 3D Experience (Warner Bros., March 2014);

•

Divergent: The IMAX Experience (Summit Entertainment, March 2014);

•

Godzilla: The IMAX Experience (Warner Bros., May 2014);

•

Edge of Tomorrow: The IMAX Experience (Warner Bros., June 2014);

•

Transformers: Age of Extinction: An IMAX 3D Experience (Paramount Pictures, June 2014);

•

Interstellar: The IMAX Experience (Paramount Pictures and Warner Bros., November 2014); and

•

The Hobbit: There and Back Again: An IMAX 3D Experience (Warner Bros., December 2014).

The Company remains in active negotiations with all of the major Hollywood studios for additional films to fill out its short and long-term film slate, and anticipates that a similar number of IMAX DMR films will be released to the IMAX network in 2014 to the 37 slated for release in 2013 and the 35 films that were released to the IMAX network in 2012.

In addition, in conjunction with Warner Bros. Pictures (“WB”), the Company will release an IMAX original production, Island of Lemurs: Madagascar: An IMAX 3D Experience, on April 4, 2014.

Other Film Revenues: Film Distribution and Post-Production

The Company is also a distributor of large-format films, primarily for its institutional theater partners. The Company generally distributes films which it produces or for which it has acquired distribution rights from independent producers. The Company receives either a percentage of the theater box-office receipts or a fixed amount as a distribution fee.

Films produced by the Company are typically financed through third parties, whereby the Company will generally receive a film production fee in exchange for producing the film and a distribution fee for distributing the film. The ownership rights to such films may be held by the film sponsors, the film investors and/or the Company. The Company utilizes third-party funding for the majority of original films it produces and distributes. In 2012, the Company, along with WB and MFF released an original title, To the Artic 3D: An IMAX 3D Experience. In 2011, the Company, along with WB, released Born to be Wild 3D: An IMAX 3D Experience. In January 2013, the Company announced an agreement with MFF to jointly finance, market and distribute up to four films (with an option for four additional films) produced by MFF to be released exclusively to IMAX theaters. The agreement will ensure IMAX’s institutional theater partners access to a steady flow of the highest-quality, large-format documentaries over the years to come. One of the four films produced with MFF will be released in November 2013, Journey to the South Pacific: An IMAX 3D Experience.

David Keighley Productions 70MM Inc., a wholly-owned subsidiary of the Company, provides film post-production and quality control services for large-format films (whether produced internally or externally), and digital post-production services.

CRITICAL ACCOUNTING POLICIES

The Company prepares its consolidated financial statements in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP”).

The preparation of these consolidated financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, management evaluates its estimates, including those related to selling prices associated with the individual elements in multiple element arrangements; residual values of leased theater systems; economic lives of leased assets; allowances for potential uncollectibility of accounts receivable, financing receivables and net investment in leases; provisions for inventory obsolescence; ultimate revenues for film assets; impairment provisions for film assets, long-lived assets and goodwill; depreciable lives of property, plant and equipment; useful lives of intangible assets; pension plan and post retirement assumptions; accruals for contingencies including tax contingencies; valuation allowances for deferred income tax assets; and, estimates of the fair value and expected exercise dates of stock-based payment awards. Management bases its estimates on historical experience, future expectations and other assumptions that are believed to be reasonable at the date of the consolidated financial statements. Actual results may differ from these estimates due to uncertainty involved in measuring, at a specific point in time, events which are continuous in nature, and differences may be material. The Company’s significant accounting policies are discussed in note 2 to its audited consolidated financial statements in Item 8 of the Company’s 2012 Form 10-K for the year ended December 31, 2012 (the “2012 Form 10-K”).

The Company considers the following significant estimates, assumptions and judgments to have the most significant effect on its results:

Revenue Recognition

The Company generates revenue from various sources as follows:

•

design, manufacture, sale and lease of proprietary theater systems for IMAX theaters principally owned and operated by commercial and institutional customers located in 55 countries as at September 30, 2013;

•

production, digital re-mastering, post-production and/or distribution of certain films shown throughout the IMAX theater network;

•

operation of certain IMAX theaters primarily in the United States;

•

provision of other services to the IMAX theater network, including ongoing maintenance and extended warranty services for IMAX theater systems; and

•

other activities, which includes short-term rental of cameras and aftermarket sales of projector system components.

Multiple Element Arrangements

The Company’s revenue arrangements with certain customers may involve multiple elements consisting of a theater system (projector, sound system, screen system and, if applicable, 3D glasses cleaning machine); services associated with the theater system including theater design support, supervision of installation, and projectionist training; a license to use of the IMAX brand; 3D glasses; maintenance and extended warranty services; and licensing of films. The Company evaluates all elements in an arrangement to determine what are considered typical deliverables for accounting purposes and which of the deliverables represent separate units of accounting based on the applicable accounting guidance in the Leases Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC” or “Codification”); the Guarantees Topic of the FASB ASC; the Entertainment – Films Topic of the FASB ASC; and the Revenue Recognition Topic of the FASB ASC. If separate units of accounting are either required under the relevant accounting standards or determined to be applicable under the Revenue Recognition Topic, the total consideration received or receivable in the arrangement is allocated based on the applicable guidance in the above noted standards.

Theater Systems

The Company has identified the projection system, sound system, screen system and, if applicable, 3D glasses cleaning machine, theater design support, supervision of installation, projectionist training and the use of the IMAX brand to be a single deliverable and a

single unit of accounting, (“the System Deliverable”). When an arrangement does not include all the elements of a System Deliverable, the elements of the System Deliverable included in the arrangement are considered by the Company to be a single deliverable and a single unit of accounting. The Company is not responsible for the physical installation of the equipment in the customer’s facility; however, the Company supervises the installation by the customer. The customer has the right to use the IMAX brand from the date the Company and the customer enter into an arrangement.

The Company’s System Deliverable arrangements involve either a lease or a sale of the theater system. Consideration in the Company’s arrangements that are not joint revenue sharing arrangements, consists of upfront or initial payments made before and after the final installation of the theater system equipment and ongoing payments throughout the term of the lease or over a period of time, as specified in the arrangement. The ongoing payments are the greater of an annual fixed minimum amount or a certain percentage of the theater box-office. Amounts received in excess of the annual fixed minimum amounts are considered contingent payments. The Company’s arrangements are non-cancellable, unless the Company fails to perform its obligations. In the absence of a material default by the Company, there is no right to any remedy for the customer under the Company’s arrangements. If a material default by the Company exists, the customer has the right to terminate the arrangement and seek a refund only if the customer provides notice to the Company of a material default and only if the Company does not cure the default within a specified period.

Sales Arrangements

For arrangements qualifying as sales, the revenue allocated to the System Deliverable is recognized in accordance with the Revenue Recognition Topic of the FASB ASC, when all of the following conditions have been met: (i) the projector, sound system and screen system have been installed and are in full working condition, (ii) the 3D glasses cleaning machine, if applicable, has been delivered, (iii) projectionist training has been completed, and (iv) the earlier of (a) receipt of written customer acceptance certifying the completion of installation and run-in testing of the equipment and the completion of projectionist training or (b) public opening of the theater, provided there is persuasive evidence of an arrangement, the price is fixed or determinable and collectibility is reasonably assured.

The initial revenue recognized consists of the initial payments received and the present value of any future initial payments and fixed minimum ongoing payments that have been attributed to this unit of accounting. Contingent payments in excess of the fixed minimum ongoing payments are recognized when reported by theater operators, provided collectibility is reasonably assured.

The Company has also agreed, on occasion, to sell equipment under lease or at the end of a lease term. Consideration agreed to for these lease buyouts is included in revenues from equipment and product sales, when persuasive evidence of an arrangement exists, the fees are fixed or determinable, collectibility is reasonably assured and title to the theater system passes from the Company to the customer.

In a certain sales arrangement not subject to the provisions of the amended FASB ASC 605-25, “Revenue Recognition: Multiple-Element Arrangements” (“ASC 605-25”), the Company provided a customer with digital upgrades on several systems, including several specified upgrades to an as-of-yet undeveloped product. At the current period-end, the upgrade right in the agreement expired such that contract consideration became fixed. Accordingly, in the first nine months of 2013, the Company allocated total arrangement consideration on a relative selling price allocation basis, and recognized revenue on all delivered elements based on this allocation.

Lease Arrangements

The Company uses the Leases Topic of the FASB ASC to evaluate whether an arrangement is a lease and the classification of the lease. Arrangements not within the scope of the accounting standard are accounted for either as a sales or services arrangement, as applicable.

For lease arrangements, the Company determines the classification of the lease in accordance with the Leases Topic of the FASB ASC. A lease arrangement that transfers substantially all of the benefits and risks incident to ownership of the equipment is classified as a sales-type lease based on the criteria established in the accounting standard; otherwise the lease is classified as an operating lease. Prior to commencement of the lease term for the equipment, the Company may modify certain payment terms or make concessions. If these circumstances occur, the Company reassesses the classification of the lease based on the modified terms and conditions.

For sales-type leases, the revenue allocated to the System Deliverable is recognized when the lease term commences, which the Company deems to be when all of the following conditions have been met: (i) the projector, sound system and screen system have

been installed and are in full working condition, (ii) the 3D glasses cleaning machine, if applicable, has been delivered, (iii) projectionist training has been completed, and (iv) the earlier of (a) receipt of the written customer acceptance certifying the completion of installation and run-in testing of the equipment and the completion of projectionist training or (b) public opening of the theater, provided collectibility is reasonably assured.

The initial revenue recognized for sales-type leases consists of the initial payments received and the present value of future initial payments and fixed minimum ongoing payments computed at the interest rate implicit in the lease. Contingent payments in excess of the fixed minimum payments are recognized when reported by theater operators, provided collectibility is reasonably assured.

For operating leases, initial payments and fixed minimum ongoing payments are recognized as revenue on a straight-line basis over the lease term. For operating leases, the lease term is considered to commence when all of the following conditions have been met: (i) the projector, sound system and screen system have been installed and are in full working condition, (ii) the 3D glasses cleaning machine, if applicable, has been delivered, (iii) projectionist training has been completed, and (iv) the earlier of (a) receipt of the written customer acceptance certifying the completion of installation and run-in testing of the equipment and the completion of projectionist training or (b) public opening of the theater. Contingent payments in excess of fixed minimum ongoing payments are recognized as revenue when reported by theater operators, provided collectibility is reasonably assured.

Revenue from joint revenue sharing arrangements with upfront payments that qualify for classification as sales-type leases is recognized in accordance with the sales-type lease criteria discussed above. Contingent revenues from joint revenue sharing arrangements is recognized as box-office results and concessions revenues are reported by the theater operator, provided collectibility is reasonably assured.

Equipment and components allocated to be used in future joint revenue sharing arrangements, as well as direct labor costs and an allocation of direct production costs, are included in assets under construction until such equipment is installed and in working condition, at which time the equipment is depreciated on a straight-line basis over the lesser of the term of the joint revenue sharing arrangement and the equipment’s anticipated useful life.

Finance Income

Finance income is recognized over the term of the lease or over the period of time specified in the sales arrangement, provided collectibility is reasonably assured. Finance income recognition ceases when the Company determines that the associated receivable is not collectible.

Finance income is suspended when the Company identifies a theater that is delinquent, non-responsive or not negotiating in good faith with the Company. Once the collectibility issues are resolved the Company will resume recognition of finance income.

Terminations, Consensual Buyouts and Concessions

The Company enters into theater system arrangements with customers that provide for customer payment obligations prior to the scheduled installation of the theater system. During the period of time between signing and the installation of the theater system, which may extend several years, certain customers may be unable to, or elect not to, proceed with the theater system installation for a number of reasons including business considerations, or the inability to obtain certain consents, approvals or financing. Once the determination is made that the customer will not proceed with installation, the arrangement may be terminated under the default provisions of the arrangement or by mutual agreement between the Company and the customer (a “consensual buyout”). Terminations by default are situations when a customer does not meet the payment obligations under an arrangement and the Company retains the amounts paid by the customer. Under a consensual buyout, the Company and the customer agree, in writing, to a settlement and to release each other of any further obligations under the arrangement or an arbitrated settlement is reached. Any initial payments retained or additional payments received by the Company are recognized as revenue when the settlement arrangements are executed and the cash is received, respectively. These termination and consensual buyout amounts are recognized in Other revenues.

In addition, the Company could agree with customers to convert their obligations for other theater system configurations that have not yet been installed to arrangements to acquire or lease the IMAX digital theater system. The Company considers these situations to be a termination of the previous arrangement and origination of a new arrangement for the IMAX digital theater system. For all arrangements entered into or modified prior to the date of adoption of the amended FASB ASC 605-25, the Company continues to defer an amount of any initial fees received from the customer such that the aggregate of the fees deferred and the net present value of the future fixed initial and ongoing payments to be received from the customer equals the selling price of the IMAX digital theater

system to be leased or acquired by the customer. Any residual portion of the initial fees received from the customer for the terminated theater system is recorded in Other revenues at the time when the obligation for the original theater system is terminated and the new theater system arrangement is signed. Under the amended FASB ASC 605-25, as described in note 2(m) in Item 8 of the Company’s 2012 Form 10-K, for all arrangements entered into or materially modified after the date of adoption, the total arrangement consideration to be received is allocated on a relative selling price basis to the digital upgrade and the termination of the previous theater system. The arrangement consideration allocated to the termination of the existing arrangement is recorded in Other revenues at the time when the obligation for the original theater system is terminated and the new theater system arrangement is signed.

The Company may offer certain incentives to customers to complete theater system transactions including payment concessions or free services and products such as film licenses or 3D glasses. Reductions in, and deferral of, payments are taken into account in determining the sales price either by a direct reduction in the sales price or a reduction of payments to be discounted in accordance with the Leases or Interests Topic of the FASB ASC. Free products and services are accounted for as separate units of accounting. Other consideration given by the Company to customers are accounted for in accordance with the Revenue Recognition Topic of the FASB ASC.

Maintenance and Extended Warranty Services

Maintenance and extended warranty services may be provided under a multiple element arrangement or as a separately priced contract. Revenues related to these services are deferred and recognized on a straight-line basis over the contract period and are recognized in Services revenues. Maintenance and extended warranty services includes maintenance of the customer’s equipment and replacement parts. Under certain maintenance arrangements, maintenance services may include additional training services to the customer’s technicians. All costs associated with this maintenance and extended warranty program are expensed as incurred. A loss on maintenance and extended warranty services is recognized if the expected cost of providing the services under the contracts exceeds the related deferred revenue.

Other

The Company recognizes revenue in Services revenue from its owned and operated theaters resulting from box-office ticket and concession sales as tickets are sold, films are shown and upon the sale of various concessions. The sales are cash or credit card transactions with theatergoers based on fixed prices per seat or per concession item.

In addition, the Company enters into commercial arrangements with third party theater owners resulting in the sharing of profits and losses which are recognized in Service revenues when reported by such theaters. The Company also provides management services to certain theaters and recognizes revenue over the term of such services.

Revenues on camera rentals are recognized in Rental revenue over the rental period.

Revenue from the sale of 3D glasses is recognized in Equipment and product sales revenue when the 3D glasses have been delivered to the customer.

Other service revenues are recognized in Service revenues when the performance of contracted services is complete.

Film Production and IMAX DMR Services

In certain film arrangements, the Company produces a film financed by third parties, whereby the third party retains the copyright and the Company obtains exclusive distribution rights. Under these arrangements, the Company is entitled to receive a fixed fee or to retain as a fee the excess of funding over cost of production (the “production fee”). The third parties receive a portion of the revenues received by the Company from distributing the film, which is charged to costs and expenses applicable to revenues-services. The production fees are deferred, and recognized as a reduction in the cost of the film, based on the ratio of the Company’s distribution revenues recognized in the current period to the ultimate distribution revenues expected from the film.

Revenue from film production services where the Company does not hold the associated distribution rights are recognized in Service revenues when performance of the contractual service is complete, provided there is persuasive evidence of an agreement, the fee is fixed or determinable and collectibility is reasonably assured.

Revenues from digitally re-mastering (IMAX DMR) films where third parties own or hold the copyrights and the rights to distribute the film are derived in the form of processing fees and recoupments calculated as a percentage of box-office receipts generated from the re-mastered films. Processing fees are recognized as Service revenues when the performance of the related re-mastering service is completed, provided there is persuasive evidence of an arrangement, the fee is fixed or determinable and collectibility is reasonably assured. Recoupments, calculated as a percentage of box-office receipts, are recognized as Services revenues when box-office receipts are reported by the third party that owns or holds the related film rights, provided collectibility is reasonably assured.

Losses on film production and IMAX DMR services are recognized as costs and expenses applicable to revenues-services in the period when it is determined that the Company’s estimate of total revenues to be realized by the Company will not exceed estimated total production costs to be expended on the film production and the cost of IMAX DMR services.

Film Distribution

Revenue from the licensing of films is recognized in Services revenues when persuasive evidence of a licensing arrangement exists, the film has been completed and delivered, the license period has begun, the fee is fixed or determinable and collectibility is reasonably assured. When license fees are based on a percentage of box-office receipts, revenue is recognized when box-office receipts are reported by exhibitors, provided collectibility is reasonably assured.

Film Post-Production Services

Revenues from post-production film services are recognized in Services revenue when performance of the contracted services is complete provided there is persuasive evidence of an arrangement, the fee is fixed or determinable and collectibility is reasonably assured.

Allowances for Accounts Receivable and Financing Receivables

Allowances for doubtful accounts receivable are based on the Company’s assessment of the collectibility of specific customer balances, which is based upon a review of the customer’s credit worthiness, past collection history and the underlying asset value of the equipment, where applicable. Interest on overdue accounts receivable is recognized as income as the amounts are collected.

The Company monitors the performance of the theaters to which it has leased or sold theater systems which are subject to ongoing payments. When facts and circumstances indicate that there is a potential impairment in the accounts receivable, net investment in lease or a financing receivable, the Company will evaluate the potential outcome of either renegotiations involving changes in the terms of the receivable or defaults on the existing lease or financed sale agreements. The Company will record a provision if it is considered probable that the Company will be unable to collect all amounts due under the contractual terms of the arrangement or a renegotiated lease amount will cause a reclassification of the sales-type lease to an operating lease.

When the net investment in lease or the financing receivable is impaired, the Company will recognize a provision for the difference between the carrying value in the investment and the present value of expected future cash flows discounted using the effective interest rate for the net investment in the lease or the financing receivable. If the Company expects to recover the theater system, the provision is equal to the excess of the carrying value of the investment over the fair value of the equipment.

When the minimum lease payments are renegotiated and the lease continues to be classified as a sales-type lease, the reduction in payments is applied to reduce unearned finance income.

These provisions are adjusted when there is a significant change in the amount or timing of the expected future cash flows or when actual cash flows differ from cash flow previously expected.

Once a net investment in lease or financing receivable is considered impaired, the Company does not recognize interest income until the collectibility issues are resolved. When finance income is not recognized, any payments received are applied against outstanding gross minimum lease amounts receivable or gross receivables from financed sales.

Inventories

Inventories are carried at the lower of cost, determined on an average cost basis, and net realizable value except for raw materials, which are carried out at the lower of cost and replacement cost. Finished goods and work-in-process include the cost of raw materials, direct labor, theater design costs, and an applicable share of manufacturing overhead costs.

The costs related to theater systems under sales and sales-type lease arrangements are relieved from inventory to costs and expenses applicable to revenues-equipment and product sales when revenue recognition criteria are met. The costs related to theater systems under operating lease arrangements and joint revenue sharing arrangements are transferred from inventory to assets under construction in property, plant and equipment when allocated to a signed joint revenue sharing arrangement or when the arrangement is first classified as an operating lease.

The Company records provisions for excess and obsolete inventory based upon current estimates of future events and conditions, including the anticipated installation dates for the current backlog of theater system contracts, technological developments, signings in negotiation, growth prospects within the customers’ ultimate marketplace and anticipated market acceptance of the Company’s current and pending theater systems.

Finished goods inventories can contain theater systems for which title has passed to the Company’s customer, under the contract, but the revenue recognition criteria as discussed above have not been met.

Asset Impairments

The Company performs a qualitative, and when necessary quantitative, impairment test on its goodwill on an annual basis, coincident with the year-end, as well as in quarters where events or changes in circumstances suggest that the carrying amount may not be recoverable.

Goodwill impairment is assessed at the reporting unit level by comparing the unit’s carrying value, including goodwill, to the fair value of the unit. Significant estimates and judgment are involved in the impairment test. The carrying values of each unit are subject to allocations of certain assets and liabilities that the Company has applied in a systematic and rational manner. The fair value of the Company’s units is assessed using a discounted cash flow model. The model is constructed using the Company’s budget and long-range plan as a base.

Long-lived asset impairment testing is performed at the lowest level of an asset group at which identifiable cash flows are largely independent. In performing its review for recoverability, the Company estimates the future cash flows expected to result from the use of the asset or asset group and its eventual disposition. If the sum of the expected future cash flows is less than the carrying amount of the asset or asset group, an impairment loss is recognized in the consolidated statement of operations. Measurement of the impairment loss is based on the excess of the carrying amount of the asset or asset group over the fair value calculated using discounted expected future cash flows.

The Company’s estimates of future cash flows involve anticipating future revenue streams, which contain many assumptions that are subject to variability, as well as estimates for future cash outlays, the amounts of which, and the timing of which are both uncertain. Actual results that differ from the Company’s budget and long-range plan could result in a significantly different result to an impairment test, which could impact earnings.

Foreign Currency Translation

Monetary assets and liabilities of the Company’s operations which are denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the end of the period. Non-monetary items are translated at historical exchange rates. Revenue and expense transactions are translated at exchange rates prevalent at the transaction date. In the first quarter of 2013, the Company determined that the functional currency of one of its wholly-owned subsidiaries had changed from the Company’s reporting currency to the currency of the nation in which it domiciled. The adjustment attributable to current-rate translation of non-monetary assets as of the date of the change was reported in other comprehensive income (“OCI”). The functional currency of its other wholly-owned subsidiaries continues to be the United States dollar. Such exchange gains and losses are included in the determination of earnings in the period in which they arise.

Foreign currency derivatives are recognized and measured in the balance sheet at fair value. Changes in the fair value (gains or losses) are recognized in the consolidated statement of operations except for derivatives designated and qualifying as foreign currency hedging instruments. For foreign currency hedging instruments, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in OCI and reclassified to the consolidated statement of operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the consolidated statement of operations.

Pension Plan and Postretirement Benefit Obligations Assumptions

The Company’s pension plan and postretirement benefit obligations and related costs are calculated using actuarial concepts, within the framework of the Compensation – Retirement Benefits Topic of the FASB ASC. A critical assumption to this accounting is the discount rate. The Company evaluates this critical assumption annually or when otherwise required to by accounting standards. Other assumptions include factors such as expected retirement date, mortality rate, rate of compensation increase, and estimates of inflation.

The discount rate enables the Company to state expected future cash payments for benefits as a present value on the measurement date. The guideline for setting this rate is a high-quality long-term corporate bond rate. A lower discount rate increases the present value of benefit obligations and increases pension expense. The Company’s discount rate was determined by considering the average of pension yield curves constructed from a large population of high-quality corporate bonds. The resulting discount rate reflects the matching of plan liability cash flows to the yield curves.

The discount rate used is a key assumption in the determination of the pension benefit obligation and expense. A 1.0% change in the discount rate used could result in a $2.3 million — $2.7 million increase or decrease in the pension benefit obligation with a corresponding benefit or charge recognized in other comprehensive income in the year. A one year delay in Mr. Gelfond’s retirement date would increase the discount rate by 0.3% and would result in a $0.4 million reduction in the pension benefit obligation.

Deferred Tax Asset Valuation

As at September 30, 2013, the Company had net deferred income tax assets of $31.1 million. The Company’s management assesses realization of its deferred tax assets based on all available evidence in order to conclude whether it is more likely than not that the deferred tax assets will be realized. Available evidence considered by the Company includes, but is not limited to, the Company’s historical operating results, projected future operating results, reversing temporary differences, contracted sales backlog at September 30, 2013, changing business circumstances, and the ability to realize certain deferred tax assets through loss and tax credit carry-back and carry-forward strategies.

When there is a change in circumstances that causes a change in judgment about the realizability of the deferred tax assets, the Company would adjust the applicable valuation allowance in the period when such change occurs.

Tax Exposures

The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional tax expense based upon the outcomes of such matters. In addition, when applicable, the Company adjusts tax expense to reflect the Company’s ongoing assessments of such matters which require judgment and can materially increase or decrease its effective rate as well as impact operating results. The Company provides for such exposures in accordance with Income Taxes Topic of the FASB ASC.

Stock-Based Compensation

The Company utilizes a lattice-binomial option-pricing model (the “Binomial Model”) to determine the fair value of stock-based payment awards. The fair value determined by the Binomial Model is affected by the Company’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the Company’s expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The Binomial Model also considers the expected exercise multiple which is the multiple of exercise price to grant price at which exercises are expected to occur on average. Option-pricing models were developed for use in estimating the value of traded options that have no vesting or hedging restrictions and are fully transferable. Because the Company’s employee stock options and stock appreciation rights (“SARs”) have certain characteristics that are significantly different from traded options, and because changes in the subjective assumptions can materially affect the estimated value, in management’s opinion, the Binomial Model best provides an accurate measure of the fair value of the Company’s employee stock options and SARs. Although the fair value of employee stock options and SARs are determined in accordance with the Equity topic of the FASB ASC using an option-pricing model, that value may not be indicative of the fair value observed in a willing buyer/willing seller market transaction.

Impact of Recently Issued Accounting Pronouncements

See note 2 to the accompanying interim condensed consolidated financial statements in Item 1 for information regarding recent changes in accounting policies and the impact of recently issued accounting pronouncements impacting the Company.

Non-GAAP Financial Measures

In this report, the Company presents adjusted net income and adjusted net income per diluted share as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on its net income. The Company presents gross margin from its joint revenue sharing arrangements segment excluding initial launch costs because it believes that it is an important supplemental measure used by management to evaluate ongoing joint revenue sharing arrangement theater performance. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income and adjusted net income per diluted share should be considered in addition to, and not as a substitute for, net income and other measures of financial performance reported in accordance with U.S. GAAP.

RESULTS OF OPERATIONS

Management, including the Company’s Chief Operating Decision Maker (as defined in the Segment Reporting Topic of the FASB ASC) who is the Company’s CEO, assesses segment performance based on segment revenues, gross margins and film performance. Selling, general and administrative expenses, research and development costs, amortization of intangibles, receivables provisions (recoveries), write-downs net of recoveries, interest income, interest expense and tax (provision) recovery are not allocated to the segments. As identified in note 16 to the accompanying condensed consolidated financial statements in Item 1, the Company has the following seven reportable segments identified by category of product sold or service provided:

•

IMAX Theater Systems

•

The IMAX systems segment, which is comprised of the design, manufacture, sale or lease of IMAX theater projection system equipment.

•

The theater system maintenance segment, which consists of the maintenance of IMAX theater projection system equipment in the IMAX theater network.

•

The joint revenue sharing arrangements segment, which is comprised of the provision of IMAX theater projection system equipment to exhibitors in exchange for a certain percentage of box-office receipts, and in some cases, concession revenue and/or a small upfront or initial payment.

•

The other segment, which includes certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

•

Film

•

The film production and IMAX DMR segment, which is comprised of the production of films and performance of film re-mastering services.

•

The film distribution segment, which includes the distribution of films for which the Company has distribution rights.

•

The film post-production segment, which includes the provision of film post-production and film print services.

The Company’s Management’s Discussion and Analysis (“MD&A”) of Financial Condition and Results of Operations has been organized by the Company into two primary reporting groups – IMAX Theater Systems and Film. Each of the Company’s reportable segments, as identified above, have been classified into one of these broader reporting groups for purposes of MD&A discussion. The Company believes that this approach is consistent with management’s view of the business and is not expected to have an impact on the readers’ ability to understand the Company’s business. Management feels that a discussion and analysis based on its reporting groups is significantly more relevant as the Company’s consolidated statements of operations captions combine results from several segments.

Three Months Ended September 30, 2013 Versus Three Months Ended September 30, 2012

The Company reported net income of $1.6 million or $0.02 per basic and diluted share for the third quarter of 2013, as compared to net income of $14.9 million or $0.23 per basic share and $0.22 per diluted share for the third quarter of 2012. The quarter ended September 30, 2012 included the exceptional performance of The Dark Knight Rises: The IMAX Experience. Net income for the third quarter of 2013 includes a $2.8 million charge, or $0.04 per diluted share, for stock-based compensation (2012 - $2.8 million or $0.04 per diluted share). Adjusted net income, which consists of net income excluding stock-based compensation expense and the related tax impact, was $4.4 million, or $0.06 per diluted share, in the third quarter of 2013, as compared to adjusted net income of $17.8 million, or $0.26 per diluted share, for the third quarter of 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:


	Three Months Ended September 30, 2013					Three Months Ended September 30, 2012
	Net Income			Diluted EPS		Net Income		Diluted EPS
Reported net income	$	1,609		$	0.02	$	14,911	$	0.22
Adjustments:
Stock-based compensation		2,838			0.04		2,756		0.04
Tax (expense) benefit of items listed above		(85	)		—		114		—

Adjusted net income	$	4,362		$	0.06	$	17,781	$	0.26


Weighted average diluted shares outstanding					69,116				68,301

The following table sets forth the breakdown of revenue and gross margin by category:


	Revenue				Gross Margin
*(In thousands of US dollars)*	Three Months Ended September 30,				Three Months Ended September 30,
	2013		2012		2013			2012
IMAX Theater Systems
IMAX Systems
Sales and sales-type leases⁽¹⁾	$	6,419	$	21,937	$	3,928		$	12,575
Ongoing rent, fees, and finance income⁽²⁾		3,483		3,421		3,277			3,381
Other		2,230		4,997		(302	)		564

		12,132		30,355		6,903			16,520


Theater System Maintenance		8,103		7,042		3,218			2,828


Joint Revenue Sharing Arrangements		11,960		13,186		7,153			9,286


Film
Production and IMAX DMR		14,547		25,223		8,596			15,426
Film distribution and post-production		5,000		4,905		1,388			690

		19,547		30,128		9,984			16,116


	$	51,742	$	80,711	$	27,258		$	44,750

(1)	Includes initial payments and the present value of fixed minimum payments from equipment, sales and sales-type lease transactions.

(2)	Includes rental income from operating leases, contingent rents from operating and sales-type leases, contingent fees from sales arrangements and finance income.

Revenues and Gross Margin

The Company’s revenues for the third quarter of 2013 decreased by 35.9% to $51.7 million from $80.7 million in the same period last year, due in large part to decreases in revenue from the IMAX systems and film segments. The third quarter of 2012 included the exceptional box-office performance of The Dark Knight Rises: The IMAX Experience. The gross margin across all segments in the third quarter of 2013 was $27.3 million, or 52.7% of total revenue, compared to $44.8 million, or 55.4% of total revenue in the third quarter of 2012.

IMAX Systems

IMAX systems revenue decreased 60.0% to $12.1 million in the third quarter of 2013, as compared to $30.4 million in the third quarter of 2012, resulting primarily from the installation of fewer systems under sales or sales-type lease arrangements versus the prior-year period.

Revenue from sales and sales-type leases decreased 70.7% to $6.4 million in the third quarter of 2013 from $21.9 million in the third quarter of 2012. The Company recognized revenue on 5 full, new theater systems which qualified as either sales or sales-type leases in the third quarter of 2013, with a total value of $6.1 million, as compared to 14 full, new theater systems in the third quarter of 2012, with a total value of $17.8 million. The Company anticipates that its installations will vary from quarter to quarter given that a large portion of its theater systems in backlog are slated to be installed in newly built theaters or multiplexes. The installation of theater systems in newly built theaters or multiplexes depends primarily on the timing of the construction of those projects, which is not under the Company’s control. The Company did not recognize any revenue from xenon-based digital upgrades in the third quarter of 2013 as compared to 3 xenon-based digital upgrades in the third quarter of 2012, with a value of $1.1 million. Digital upgrades typically have lower sales prices and gross margin than full theater system installations. The Company has decided to offer digital upgrades at lower selling prices for strategic reasons since the Company believes that digital systems increase flexibility and profitability for the Company’s existing exhibition customers. There were no used system recognitions in the three months ended September 30, 2013 and 2012.

Average revenue per full, new sales and sales-type lease system was $1.2 million for the three months ended September 30, 2013, as compared to $1.3 million for the three months ended September 30, 2012. Average revenue per upgrade was $0.4 million for the three months ended September 30, 2012.

The breakdown in mix of sales and sales-type lease and joint revenue sharing arrangement (see discussion below) installations by theater system configuration for the third quarter of 2013 and 2012 is outlined in the table below:


	Three Months Ended September 30,
	2013			2012
New IMAX xenon-based digital theater systems - installed and recognized
Sales and sales-type lease arrangements		5			14
Short-term operating lease arrangement		1	⁽¹⁾		—
Joint revenue sharing arrangements		13			14

Total new theater systems		19			28


IMAX xenon-based digital theater system upgrades - installed and recognized
Sales and sales-type lease arrangements		—			3
Short-term operating lease arrangements		6	⁽¹⁾		—
Joint revenue sharing arrangements		2	⁽¹⁾		2

Total upgraded theater systems		8			5


IMAX xenon-based digital theater system upgrades - installed and deferred		1	⁽¹⁾		—

Total theater systems installed		28			33

(1)	Reflects xenon-based digital system configurations, which will be upgraded to a laser-based digital system configuration at a future date.

IMAX theater systems gross margin from full, new sales and sale-type leases was 63.8% in the third quarter of 2013 versus 62.4% in the third quarter of 2012. There was no gross margin experienced from digital upgrades in the third quarter of 2013, as compared to $0.7 million in the third quarter of 2012. There were no used systems installed during the third quarter of 2013 and 2012. In addition, in the third quarter of 2012, the Company incurred a charge of $0.4 million for equipment to enable certain theaters to elect to exhibit films such as The Dark Knight Rises in either digital or analog format. Furthermore, in the third quarter of 2012, the Company recorded a write-down of certain film-based projector inventories of $0.3 million.

During the third quarter of 2012, one of the Company’s customers acquired 3 IMAX theaters from another existing customer that had been operating under a joint revenue sharing arrangement. These theaters were purchased from IMAX under a sales arrangement. As a result of this sale transaction, the Company recorded revenue and margin of $3.0 million and $2.1 million, respectively. The above-referenced theaters were included in the Company’s third quarter of 2012 signings total. In addition, during the 2012 period the Company recognized the digital upgrade of two theaters under a joint revenue sharing arrangement, which were previously operated under sales/sales-type lease arrangements. No such transactions took place in the third quarter of 2013.

Ongoing rent revenue and finance income was $3.5 million in the third quarter of 2013, which was consistent with the prior year comparative period. Gross margin for ongoing rent and finance income decreased to $3.3 million in comparison to $3.4 million in the third quarter of 2013 and 2012, respectively. Contingent fees included in this caption amounted to $0.9 million and $0.6 million in the three months ended September 30, 2013 and 2012, respectively.

Other revenue decreased to $2.2 million in the third quarter of 2013 compared to $5.0 million in the same period in 2012, largely due to a decrease in revenues from theater operations (which reflects the impact of the strong film performance of The Dark Knight Rises: The IMAX Experience in the prior year comparative period.) Other revenue primarily includes revenue generated from the Company’s theater operations, camera rental business and after-market sales of projection system parts and 3D glasses.

The gross margin from other revenue was a loss of $0.3 million in the third quarter of 2013 as compared to a profit of $0.6 million in the third quarter of 2012.

Theater System Maintenance

Theater system maintenance revenue increased 15.1% to $8.1 million during the third quarter of 2013 as compared to $7.0 million in the third quarter of 2012. Theater system maintenance gross margin increased $0.4 million to $3.2 million in the third quarter of 2013 as compared to $2.8 million in the prior year comparative period. Maintenance revenue continues to grow as the number of theaters in the IMAX theater network grows. Maintenance margins can vary depending on the mix of theater system configurations in the theater network and the date(s) of installation and/or service.

Joint Revenue Sharing Arrangements

Revenue from joint revenue sharing arrangements decreased 9.3% to $12.0 million in the third quarter of 2013 compared to $13.2 million in the third quarter of 2012. The Company ended the third quarter of 2013 with 351 theaters operating under joint revenue sharing arrangements, as compared to 287 theaters at the end of the third quarter of 2012. The decrease in revenues from joint revenue sharing arrangements was primarily due to the weaker film performance experienced as compared to the prior year comparative period, which included the exceptional performance of The Dark Knight Rises: The IMAX Experience. During the quarter, the Company installed 13 full, new theaters under joint revenue sharing arrangements, as compared to 14 theaters in the prior year comparative period.

The gross margin from joint revenue sharing arrangements in the third quarter of 2013 decreased 23.0% to $7.2 million, as compared to $9.3 million in the third quarter of 2012. Included in the calculation of third quarter gross margin were certain advertising, marketing and commission costs primarily associated with new theater launches of $0.9 million, as compared to $1.1 million incurred in the prior year comparative period. Adjusted gross margin from joint revenue sharing arrangements, which excludes these expenses from both periods, was $8.0 million in the third quarter of 2013, as compared to $10.4 million in the third quarter of 2012. A reconciliation of gross margin from the joint revenue sharing arrangement segment, the most directly comparable U.S. GAAP measure, to adjusted gross margin is presented in the table below:


	Three Months Ended September 30,
	2013		2012
Gross margin from joint revenue sharing arrangements	$	7,153	$	9,286
Add:
Advertising, marketing and commission costs		890		1,087

Adjusted gross margin from joint revenue sharing arrangements	$	8,043	$	10,373

Film

Revenues from the Company’s film segments decreased 35.1% to $19.5 million in the third quarter of 2013 from $30.1 million in the third quarter of 2012, primarily due to lower film production and IMAX DMR revenues. Gross box-office generated by IMAX DMR films decreased 23.5% to $132.5 million for the third quarter of 2013 from $173.2 million for the third quarter of 2012. Film production and IMAX DMR revenues decreased 42.3% to $14.5 million in the third quarter of 2013 from $25.2 million in the third quarter of 2012. The decrease in film production and IMAX DMR revenues was primarily due to the weaker film slate in the third quarter of 2013 as compared to the prior year comparative period. The third quarter of 2012 included the exceptional performance of The Dark Knight Rises: The IMAX Experience, which contributed over $100.0 million in IMAX gross box-office, as well as additional DMR revenue from funding the associated film prints. Gross box-office per screen for the three months ended September 30, 2013 averaged $207,500 in comparison to $312,000 in the comparable period last year. In the third quarter of 2013, gross box-office was generated primarily by the exhibition of 17 films (listed below), as compared to 8 films primarily exhibited during the third quarter of 2012:


Three Months Ended September 30, 2013 — Films Exhibited		Three Months Ended September 30, 2012 — Films Exhibited
Jurassic Park: An IMAX 3D Experience Star Trek Into Darkness: An IMAX 3D Experience Fast & Furious 6: The IMAX Experience After Earth: The IMAX Experience Man of Steel: An IMAX 3D Experience World War Z: An IMAX 3D Experience Despicable Me 2: An IMAX 3D Experience White House Down: The IMAX Experience Man of Tai Chi: The IMAX Experience Lone Ranger: The IMAX Experience Pacific Rim: An IMAX 3D Experience Elysium: An IMAX 3D Experience The Mortal Instruments: City of Bones: An IMAX 3D Experience Riddick: An IMAX 3D Experience The Wizard of Oz: An IMAX 3D Experience Young Detective Dee: Rise of the Sea Dragon: An IMAX 3D Experience Metallica Through the Never: An IMAX 3D Experience		The Amazing Spiderman: An IMAX 3D Experience
		The Dark Knight Rises: The IMAX Experience
		Total Recall: The IMAX Experience
		The Bourne Legacy: The IMAX Experience
		Flying Swords of Dragon Gate: An IMAX 3D Experience
		Indiana Jones and the Raiders of the Lost Ark: The IMAX Experience
		Resident Evil: Retribution: An IMAX 3D Experience
		Tai Chi 0: An IMAX 3D Experience

Other revenues attributable to the film segment increased to $5.0 million in the third quarter of 2013 from $4.9 million in the third quarter of 2012.

The Company’s gross margin from its film segments in the third quarter of 2013 decreased to $10.0 million from $16.1 million in the third quarter of 2012. Film production and IMAX DMR gross margin decreased to $8.6 million in the third quarter of 2013 from $15.4 million in the third quarter of 2012, primarily due to lower film performance. Other gross margin attributable to the film segment for the third quarter of 2013 was $1.4 million as compared to $0.7 million in the prior year comparative period.

Selling, General and Administrative Expenses

Selling, general and administrative expenses of $19.8 million in the third quarter of 2013 as compared to the $19.4 million experienced in the third quarter of 2012. The following reflects the activity changes in selling, general and administrative expenses as compared to the prior year period:

•

a $1.0 million increase in staff costs, including salaries and benefits; offset by

•

a $0.5 million decrease due to a change in foreign exchange rates. During the third quarter ended September 30, 2013, the Company recorded a foreign exchange gain of $0.8 million for net foreign exchange gains/losses related to the translation of foreign currency denominated monetary assets and liabilities and unhedged foreign currency forward contracts as compared to a gain of $0.3 million recorded in the prior year comparative period; and

•

a $0.1 million net decrease in other general corporate expenditures.

Research and Development

Research and development expenses were $4.0 million in the third quarter of 2013 compared to $2.5 million in the third quarter of 2012 and are primarily attributable to the development of the Company’s new laser-based digital projection system. The Company is developing its next-generation laser projector, which is expected to provide greater brightness and clarity, a wider color gamut and deeper blacks, while consuming less power and lasting longer than existing digital technology, to ensure that the Company continues to provide the highest quality, premier movie going experience available to consumers.

IMAX cameras, enhancing the Company’s 2D and 3D image quality, expanding the applicability of the Company’s digital technology, and further enhancing the IMAX theater and sound system design through the addition of more channels, improvements to the Company’s proprietary tuning system and mastering processes.

Receivable Provisions, Net of Recoveries

The Company recorded receivable provisions, net of recoveries of $0.2 million for accounts receivable and financing receivables in the third quarter of 2013, which was consistent with the prior year comparative period.

The Company’s accounts receivables and financing receivables are subject to credit risk. These receivables are concentrated with the leading theater exhibitors and studios in the film entertainment industry. To minimize the Company’s credit risk, the Company retains title to underlying theater systems that are leased, performs initial and ongoing credit evaluations of its customers and makes ongoing provisions for its estimate of potentially uncollectible amounts. Accordingly, the Company believes it has adequately protected itself against exposures relating to receivables and contractual commitments.

Interest Income and Expense

Interest income was less than $0.1 million in the third quarter of 2013, which was consistent with the third quarter of 2012.

Interest expense was $0.3 million and $0.4 million in the third quarter of 2013 and 2012, respectively. Included in interest expense is the amortization of deferred finance costs of $0.1 million and less than $0.1 million in the third quarter of 2013 and 2012, respectively. The Company’s policy is to defer and amortize, over the life of the debt instrument, all the costs relating to debt financing which are paid directly to the debt provider.

Income Taxes

The Company’s effective tax rate differs from the statutory tax rate and will vary from year to year primarily as a result of numerous permanent differences, investments and other tax credits, the provision for income taxes at different rates in foreign and other provincial jurisdictions, enacted statutory tax rate increases or reductions in the year, changes due to foreign exchange, changes in the Company’s valuation allowance based on the Company’s recoverability assessments of deferred tax assets, and favorable or unfavorable resolution of various tax examinations.

There was no change in the Company’s estimates of the recoverability of its deferred tax assets based on an analysis of both positive and negative evidence, including projected future earnings. As at September 30, 2013, the Company had a gross deferred income tax asset of $37.2 million, against which the Company is carrying a $6.1 million valuation allowance. For the three months ended September 30, 2013, the Company recorded an income tax provision of $0.6 million, of which a provision of $0.1 million was related to an increase in its provisions for uncertain tax positions.

The Company anticipates utilizing the majority of its currently-available tax attributes over the next two years.

Equity-Accounted Investments

The Company accounts for investments in new business ventures using the guidance of the FASB ASC 323 “Investments – Equity Method and Joint Ventures” (“ASC 323”). At September 30, 2013, the equity method of accounting is being utilized for an investment with a carrying value of $2.0 million (December 31, 2012 - $3.0 million). For the three months ended September 30, 2013, gross revenues, cost of revenue and net loss for the investment were $1.2 million, $3.1 million and $3.3 million, respectively (2012 — $2.7 million, $2.9 million and $3.0 million, respectively). The Company has recorded its proportionate share of the net loss which amounted to $0.3 million for the third quarter of 2013 and which was consistent with the prior year comparative period.

Nine Months Ended September 30, 2013 Versus Nine Months Ended September 30, 2012

The Company reported net income of $16.3 million or $0.24 per basic and diluted share for the nine months ended September 30, 2013, as compared to net income of $28.5 million or $0.43 per basic and $0.42 per diluted share for the nine months ended September 30, 2012. Net income for the nine months ended September 30, 2013 includes an $8.8 million charge, or $0.12 per diluted share, for stock-based compensation (2012 – $10.3 million or $0.15 per diluted share). Adjusted net income, which consists of net income excluding stock-based compensation expense and the related tax expense, was $24.9 million, or $0.36 per diluted share, in the nine months ended September 30, 2013, as compared to adjusted net income of $38.6 million, or $0.57 per diluted share, for the nine months ended September 30, 2012. A reconciliation of net income, the most directly comparable U.S. GAAP measure, to adjusted net income and adjusted net income per diluted share is presented in the table below:


	Nine Months Ended September 30, 2013					Nine Months Ended September 30, 2012
	Net Income			Diluted EPS		Net Income			Diluted EPS
Net income	$	16,286		$	0.24	$	28,454		$	0.42
Add:
Stock-based compensation		8,772			0.12		10,252			0.15
Tax expense on items listed above		(159	)		—		(86	)		—

Adjusted net income	$	24,899		$	0.36	$	38,620		$	0.57


Weighted average diluted shares outstanding					68,853					68,187

The following table sets forth the breakdown of revenue and gross margin by category:


	Revenue				Gross Margin
	Nine Months Ended September 30,				Nine Months Ended September 30,
	2013		2012		2013			2012
IMAX Systems
Sales and sales-type leases⁽¹⁾	$	33,321	$	49,751	$	16,390		$	25,259
Ongoing rent, fees, and finance income⁽²⁾		10,111		9,312		9,758			9,216
Other		8,362		10,394		(29	)		287

		51,794		69,457		26,119			34,762


Theater System Maintenance		23,844		20,878		9,432			8,122


Joint Revenue Sharing Arrangements		39,672		40,477		26,796			28,340


Film
Production and IMAX DMR		54,854		58,805		30,372			35,714
Film distribution and post-production		13,740		16,900		4,154			3,506

		68,594		75,705		34,526			39,220


	$	183,904	$	206,517	$	96,873		$	110,444

(1)	Includes initial payments and the present value of fixed minimum payments from equipment, sales and sales-type lease transactions.

(2)	Includes rental income from operating leases, contingent rents from operating and sales-type leases, contingent fees from sales arrangements and finance income.

Revenues and Gross Margin

The Company’s revenues for the nine months ended September 30, 2013 decreased by 10.9% to $183.9 million from $206.5 million in the same period last year, due in large part to a decrease in revenue from the Company’s IMAX systems and film segments. The gross margin across all segments in the nine months ended September 30, 2013 was $96.9 million, or 52.7% of total revenue, compared to $110.4 million, or 53.5% of total revenue, in the nine months ended September 30, 2012.

IMAX Systems

IMAX systems revenue decreased 25.4% to $51.8 million in the nine months ended September 30, 2013, as compared to $69.5 million in the nine months ended September 30, 2012, resulting primarily from the installation of fewer systems under sales and sales-type lease arrangements versus the prior-year period.

Revenue from sales and sales-type leases decreased 33.0% to $33.3 million in the nine months ended September 30, 2013 from $49.8 million in the nine months ended September 30, 2012. The Company recognized revenue on 22 full, new theater systems which qualified as either sales or sales-type leases in the nine months ended September 30, 2013, with a total value of $25.8 million, versus 33 full, new theater systems in the nine months ended September 30, 2012, with a total value of $42.4 million. Additionally, the Company recognized revenue on the installation of 3 xenon-based digital upgrades in the nine months ended September 30, 2013, with a total value of $2.1 million, as compared to 11 xenon-based digital upgrades and one 3D GT upgrade (from a 2D GT system) in the nine months ended September 30, 2012, with a total value of $4.2 million. Digital upgrades typically have lower sales prices and gross margin than full theater system installations. The Company has decided to offer digital upgrades at lower selling prices for strategic reasons since the Company believes that digital systems increase flexibility and profitability for the Company’s existing exhibition customers. There were no used systems installed in the nine months ended September 30, 2013 and 2012.

Average revenue per full, new sales and sales-type lease systems was $1.2 million for the nine months ended September 30, 2013, compared to $1.3 million for the nine months ended September 30, 2012. Average revenue per digital upgrade was $0.7 million for the nine months ended September 30, 2013, as compared to $0.4 million during the nine months ended September 30, 2012.

The breakdown in mix of sales and sales-type lease and joint revenue sharing arrangements (see discussion below) installations by theater system configuration for the nine months ended September 30, 2013 and 2012 is outlined in the table below:


	Nine Months Ended September 30,
	2013			2012
New IMAX xenon-based digital theater systems - installed and recognized
Sales and sales-type lease arrangements		22			33
Short-term operating lease arrangement		1	⁽¹⁾		—
Joint revenue sharing arrangements		35			31

Total new theater systems		58			64


IMAX xenon-based digital theater system upgrades - installed and recognized
Sales and sales-type lease arrangements		3			12	⁽²⁾
Short-term operating lease arrangement		11	⁽¹⁾		—
Joint revenue sharing arrangements		2	⁽¹⁾		2

Total upgraded theater systems		16			14


IMAX xenon-based digital theater system upgrades - installed and deferred		1	⁽¹⁾		1


Total theater systems installed		75			79

(1)	Reflects xenon-based digital system configurations, which will be upgraded to a laser-based digital system configuration at a future date.

(2)	Includes one upgrade under a sale arrangement from a 2D GT projection system to a 3D projection system.

Settlement revenue was $0.4 million and $nil for the nine months ended September 30, 2013 and 2012, respectively.

IMAX theater systems margin from full, new sales and sale-type leases, excluding the impact of settlements and asset impairment charges, was 61.3% in the nine months ended September 30, 2013, as compared to 61.6% in the nine months ended September 30, 2012. Gross margin from digital upgrades was $0.9 million in the nine months ended September 30, 2013, as compared to $0.7 million in the nine months ended September 30, 2012. In addition, in the nine months ended September 30, 2012, the Company incurred a charge of $1.6 million for equipment to enable certain theaters to elect to exhibit films such as The Dark Knight Rises in either digital or analog format. Furthermore, in the nine months ended September 30, 2012, the Company recorded a write-down of certain film-based projector inventories of $0.3 million.

In the first nine months of 2013, the Company recognized revenue for 13 theater systems (10 sales and 3 operating leases) under a digital upgrade arrangement which were previously installed, but revenue recognition was deferred. The arrangement contained provisions providing the customer with standard digital upgrades, which were installed, and a number of as-of-yet undeveloped upgrades. The Company’s policy is to defer revenue recognition until the upgrade right expires, if applicable, or a digital upgrade is delivered. In the nine months ended September 30, 2013 the upgrade right in the agreement expired such that contract consideration became fixed. Therefore, the Company recognized revenue and gross margin of $3.1 million and a loss of $0.3 million, respectively, from these 10 theater systems which qualify as sales. Revenue earned from the 3 theater systems, which qualify as operating leases, are included in the Company’s ongoing rent revenue and finance income discussion below.

In the nine months ended 2013, one of the Company’s customers acquired an IMAX theater from another existing customer that had been operating under a joint revenue sharing arrangement. This theater was purchased from the Company under a sale arrangement. As a result of this sale transaction, the Company recorded revenue and margin of $0.9 million and $0.6 million, respectively. The above-referenced theater was included in the Company’s 2013 signings total. During the nine months ended September 30, 2012, one of the Company’s customers acquired 3 IMAX theaters from another existing customer that had been operating under a joint revenue sharing arrangement. These theaters were purchased from IMAX under a sales arrangement. As a result of this sale transaction, the Company recorded revenue and margin of $3.0 million and $2.1 million, respectively. The above-referenced theaters were included in the Company’s year-to-date signings total. In addition, during the 2012 comparative period the Company recognized the xenon-based digital upgrade of two theaters under a joint revenue sharing arrangement, which were previously operated under sales/sales-type lease arrangements.

Ongoing rent revenue and finance income increased to $10.1 million in the nine months ended September 30, 2013 compared to $9.3 million in the nine months ended September 30, 2012. Gross margin for ongoing rent and finance income increased to $9.8 million in the nine months ended September 30, 2013 from $9.2 million in the nine months ended September 30, 2012. Contingent fees included in this caption amounted to $2.5 million and $1.7 million in the nine months ended September 30, 2013 and 2012, respectively.

Other revenue decreased to $8.4 million in the nine months ended September 30, 2013, compared to $10.4 million in the same period in 2012, largely due to a decrease in revenue from the Company’s theater operations. Other revenue primarily includes revenue generated from the Company’s theater operations, camera rental business and after-market sales of projection system parts and 3D glasses.

The gross margin from other revenue was a loss of less than $0.1 million in the nine months ended September 30, 2013 as compared to a profit of $0.3 million in the nine months ended September 30, 2012.

Theater System Maintenance

Theater system maintenance revenue increased 14.2% to $23.8 million during the nine months ended September 30, 2013, as compared to $20.9 million during the nine months ended September 30, 2012. Theater system maintenance gross margin was $9.4 million in the nine months ended September 30, 2013 which is higher than the $8.1 million experienced in the nine months ended September 30, 2012. In the nine months ended September 30, 2012, the Company recorded a write-down of $0.2 million for certain service parts inventories. Maintenance margins can vary depending on the mix of theater system configurations in the theater network and the date(s) of installation and/or service.

Joint Revenue Sharing Arrangements

Revenue from joint revenue sharing arrangements decreased to $39.7 million in the nine months ended September 30, 2013, as compared to $40.5 million in the nine months ended September 30, 2012. The Company ended the nine month period with 351 theaters operating under joint revenue sharing arrangements, as compared to 287 theaters at the end of the nine months ended September 30, 2012. The decrease in revenues from joint revenue sharing arrangements was primarily due to the weaker film performance experienced partially offset by the greater number of operational theaters as compared to the prior year comparative period. During the nine months ended September 30, 2013, the Company installed 35 full, new theaters under joint revenue sharing arrangements, as compared to 31 new theaters during the prior year comparative period.

The gross margin from joint revenue sharing arrangements in the nine months ended September 30, 2013 decreased to $26.8 million from $28.3 million in the nine months ended September 30, 2012. Included in the calculation of gross margin in the first nine months of 2013 were certain advertising, marketing and commission costs primarily associated with new theater launches of $2.0 million, as compared to $2.1 million for such expenses in the prior year comparative period. Adjusted gross margin from joint revenue sharing arrangements, which excludes these expenses from both periods, was $28.8 million in the nine months ended September 30, 2013, compared to $30.5 million in the year ago period. A reconciliation of gross margin from the joint revenue sharing arrangement segment, the most directly comparable U.S. GAAP measure, to adjusted gross margin is presented in the table below:


	Nine Months Ended September 30,
	2013		2012
Gross margin from joint revenue sharing arrangements	$	26,796	$	28,340
Add:
Advertising, marketing and commission costs		2,033		2,119

Adjusted gross margin from joint revenue sharing arrangements	$	28,829	$	30,459

Film

Revenue from the Company’s film segments decreased 9.4% to $68.6 million in the nine months ended September 30, 2013 from $75.7 million in the nine months ended September 30, 2012, largely due to lower film production and IMAX DMR revenues. Gross box-office generated by IMAX DMR films increased to $481.9 million for the nine months ended September 30, 2013 from $468.4 million for the nine months ended September 30, 2012, an 2.9% increase year-over-year. Film production and IMAX DMR revenues decreased 6.7% to $54.9 million in the nine months ended September 30, 2013 from $58.8 million in the nine months ended September 30, 2012. The decrease in film production and IMAX DMR revenues was largely due to additional DMR revenue from funding film prints on The Dark Knight Rises: The IMAX Experience in the third quarter of 2012. Gross box-office per screen for the nine months ended September 30, 2013 averaged $777,200, in comparison to $892,800 in the comparable period last year. In 2013, gross box-office was generated primarily by the exhibition of 33 films to IMAX theaters (listed below), as compared to 26 films primarily exhibited during the nine months ended September 30, 2012, in each case as listed below:


Nine Months Ended September 30, 2013 — Films Exhibited		Nine Months Ended September 30, 2012 — Films Exhibited
Skyfall: The IMAX Experience Life of Pi: An IMAX 3D Experience CZ12: An IMAX 3D Experience The Hobbit: An Unexpected Journey: An IMAX 3D Experience Les Misérables: The IMAX Experience The Grandmaster: The IMAX Experience Hansel & Gretel: Witch Hunters: An IMAX 3D Experience Journey to the West: Conquering the Demons: An IMAX 3D Experience Top Gun: An IMAX 3D Experience A Good Day to Die Hard: The IMAX Experience Jack the Giant Slayer: An IMAX 3D Experience Oz: The Great and Powerful: An IMAX 3D Experience G.I. Joe: Retaliation: An IMAX 3D Experience Dragon Ball Z: Battle of the Gods: An IMAX 3D Experience		Happy Feet Two: An IMAX 3D Experience Mission: Impossible – Ghost Protocol: The IMAX Experience The Adventures of Tintin: The Secret of the Unicorn: An IMAX 3D Experience Flying Swords of Dragon Gate: An IMAX 3D Experience Underworld: Awakening: An IMAX 3D Experience Journey 2: The Mysterious Island: An IMAX 3D Experience The Lorax: An IMAX 3D Experience John Carter: An IMAX 3D Experience The Hunger Games: An IMAX 3D Experience Wrath of the Titans: An IMAX 3D Experience Titanic: An IMAX 3D Experience Houba! On the Trail of the Marsupilami: The IMAX Experience Battleship: The IMAX Experience The Avengers: An IMAX 3D Experience


Jurassic Park: An IMAX 3D Experience Oblivion: The IMAX Experience Iron Man 3: An IMAX 3D Experience Star Trek Into Darkness: An IMAX 3D Experience Fast & Furious 6: The IMAX Experience After Earth: The IMAX Experience Man of Steel: An IMAX 3D Experience World War Z: An IMAX 3D Experience Despicable Me 2: An IMAX 3D Experience White House Down: The IMAX Experience Man of Tai Chi: The IMAX Experience Lone Ranger: The IMAX Experience Pacific Rim: An IMAX 3D Experience Elysium: An IMAX 3D Experience The Mortal Instruments: City of Bones: An IMAX 3D Experience Riddick: An IMAX 3D Experience The Wizard of Oz: An IMAX 3D Experience Young Detective Dee: Rise of the Sea Dragon: An IMAX 3D Experience Metallica Through the Never: An IMAX 3D Experience		Dark Shadows: The IMAX Experience Men in Black III: An IMAX 3D Experience Prometheus: An IMAX 3D Experience Madagascar 3: Europe’s Most Wanted: An IMAX 3D Experience Rock of Ages: The IMAX Experience The Amazing Spiderman: An IMAX 3D Experience The Dark Knight Rises: The IMAX Experience Total Recall: The IMAX Experience The Bourne Legacy: The IMAX Experience Indiana Jones and the Raiders of the Lost Ark: The IMAX Experience Resident Evil: Retribution: An IMAX 3D Experience Tai Chi 0: An IMAX 3D Experience

Other revenues attributable to the film segment decreased 18.7% to $13.7 million in the nine months ended September 30, 2013 from $16.9 million in the nine months ended September 30, 2012. This decrease was largely due to the result of no IMAX original films being released in the current period, whereas To the Arctic 3D was released in the nine months ended September 30, 2012.

The Company’s gross margin from its film segments decreased 12.0% in the nine months ended September 30, 2013 to $34.5 million from $39.2 million in the nine months ended September 30, 2012. Film production and IMAX DMR gross margins decreased to $30.4 million from $35.7 million in the nine months ended September 30, 2012, primarily due to overall lower film performance. Other gross margin attributable to the film segment was $4.2 million in the nine months ended September 30, 2013 as compared to $3.5 million in the nine months ended September 30, 2012.

Selling, General and Administrative Expenses

Selling, general and administrative expenses of $59.4 million in the nine months ended September 30, 2013 as compared to $59.0 million in the prior year comparative period. The following reflects the activity changes in selling, general and administrative expenses as compared to the prior year period:

•

a $2.1 million increase in salaries and benefits and other staff costs, net of lower travel and entertainment costs of $0.9 million;

•

a $1.3 million increase due to a change in foreign exchange rates. During the nine months ended September 30, 2013, the Company recorded a foreign exchange loss of less than $0.1 million for net foreign exchange gains/losses related to the translation of foreign currency denominated monetary assets and liabilities and unhedged foreign currency forward contracts as compared to a gain of $1.2 million recorded in the prior year comparative period; and

•

a $0.7 million net increase in other general corporate expenditures.

These increases were offset by:

•

a $2.2 million decrease resulting from a gain on the curtailment of Canadian postretirement benefits; and

•

a $1.5 million decrease in the Company’s stock-based compensation expense.

Research and Development

Research and development expenses increased to $11.3 million in the nine months ended September 30, 2013 compared to $7.6 million in the nine months ended September 30, 2012 and are primarily attributable to the development of the Company’s new

laser-based digital projection system. The Company is developing its next-generation laser projector, which is expected to provide greater brightness and clarity, a wider color gamut and deeper blacks, while consuming less power and lasting longer than existing digital technology, to ensure that the Company continues to provide the highest quality, premier movie going experience available to consumers.

A high level of research and development is expected to continue throughout 2013 as the Company continues its efforts to develop its next-generation laser-based projection system. In addition, the Company plans to continue to fund research and development activity in other areas considered important to the Company’s continued commercial success, including further improving the reliability of its projectors, developing IMAX theater systems’ capabilities in both home and live entertainment, developing more IMAX cameras, enhancing the Company’s 2D and 3D image quality, expanding the applicability of the Company’s digital technology, and further enhancing the IMAX theater and sound system design through the addition of more channels, improvements to the Company’s proprietary tuning system and mastering processes.

Receivable Provisions, Net of Recoveries

Receivable provisions net of recoveries for accounts receivable and financing receivables amounted to a net provision of $0.3 million in the nine months ended September 30, 2013 as compared to $0.8 million for the nine months ended September 30, 2012.

The Company’s accounts receivables and financing receivables are subject to credit risk. These receivables are concentrated with the leading theater exhibitors and studios in the film entertainment industry. To minimize the Company’s credit risk, the Company retains title to underlying theater systems leased, performs initial and ongoing credit evaluations of its customers and makes ongoing provisions for its estimate of potentially uncollectible amounts. Accordingly, the Company believes it has adequately protected itself against exposures relating to receivables and contractual commitments.

Interest Income and Expense

Interest income was less than $0.1 million in the nine months ended September 30, 2013, as compared to $0.1 million in the nine months ended September 30, 2012.

Interest expense was $1.0 million in the nine months ended September 30, 2013, which decreased from the $1.4 million experienced in the nine months ended September 30, 2012. Included in interest expense is the amortization of deferred finance costs in the amount of $0.3 million in the nine months ended September 30, 2013 as compared to $0.1 million in the prior year comparative period. The Company’s policy is to defer and amortize all the costs relating to debt financing which are paid directly to the debt provider, over the life of the debt instrument.

Income Taxes

There was no change in the Company’s estimates of the recoverability of its deferred tax assets based on an analysis of both positive and negative evidence including projected future earnings. The Company recorded an income tax provision of $6.6 million for the nine months ended September 30, 2013, of which a provision of $0.3 million is related to an increase in its provisions for uncertain tax positions. For the nine months ended September 30, 2012, the Company recorded an income tax provision of $11.5 million, of which a provision of $0.2 million was related to an increase in its provisions for uncertain tax positions.

Due to a change in enacted tax rates, the Company recorded an increase to deferred tax assets and a decrease to the deferred tax provision of $0.7 million in the nine months ended September 30, 2012.

Equity-Accounted Investments

The Company accounts for investments in new business ventures using the guidance of the FASB ASC 323. At September 30, 2013, the equity method of accounting is being utilized for an investment with a carrying value of $2.0 million (December 31, 2012 - $3.0 million). For the nine months ended September 30, 2013, gross revenues, cost of revenue and net loss for the investment were $5.4 million, $10.0 million and $9.8 million, respectively (2012 — $6.5 million, $8.9 million and $9.9 million, respectively). The Company recorded its proportionate share of the net loss which amounted to $1.0 million for the nine months ended September 30, 2013 and 2012, respectively.

LIQUIDITY AND CAPITAL RESOURCES

The Company’s indebtedness under the Credit Facility includes the following:


	September 30, 2013		December 31, 2012
Revolving Loan	$	5,000	$	11,000

The Credit Facility provides that the Company will be required to maintain a Fixed Charge Coverage Ratio (as defined in the Credit Agreement) of not less than 1.1:1. The Company will also be required to maintain minimum EBITDA (as defined in the Credit Agreement) of $70.0 million between closing and September 30, 2013, which requirement increases to $80.0 million on December 31, 2013, $90.0 million on December 31, 2014, and $100.0 million on December 31, 2015. The Company must also maintain a Maximum Total Leverage Ratio (as defined in the Credit Agreement) of 2.5:1 between closing and September 30, 2013, which requirement decreases to (i) 2.25:1 on December 31, 2013; (ii) 2.0:1 on December 31, 2014; and (iii) 1.75:1 on December 31, 2015. The ratio of total debt to EBITDA was 0.06:1 as at September 30, 2013, where Total Debt (as defined in the Credit Agreement) is the sum of all obligations evidenced by notes, bonds, debentures or similar instruments and was $5.0 million. EBITDA is calculated as follows:


EBITDA per Credit Facility:	For the 3 months ended September 30, 2013		For the 12 months ended September 30, 2013⁽¹⁾
*(In thousands of U.S. Dollars)*
Net income	$	1,609	$	29,169
Add:
Loss from equity accounted investments		344		1,322
Provision for income taxes		619		10,159
Interest expense, net of interest income		301		271
Depreciation and amortization, including film asset amortization		8,699		36,716
Write-downs net of recoveries including asset impairments and receivable provisions		224		370
Stock and other non-cash compensation		3,031		12,469
Gain on curtailment of postretirement benefits		—		(2,185	)

	$	14,827	$	88,291

(1)	Ratio of total debt calculated using twelve months ended EBITDA

Letters of Credit and Other Commitments

As at September 30, 2013, the Company did not have any letters of credit and advance payment guarantees outstanding (December 31, 2012 — $nil), under the Credit Facility.

The Company also has a $10.0 million facility for advance payment guarantees and letters of credit through the Bank of Montreal for use solely in conjunction with guarantees fully insured by EDC (the “Bank of Montreal Facility”). The Bank of Montreal Facility is unsecured and includes typical affirmative and negative covenants, including delivery of annual consolidated financial statements within 120 days of the end of the fiscal year. The Bank of Montreal Facility is subject to periodic annual reviews. As at September 30, 2013, the Company had letters of credit and advance payment guarantees outstanding of $0.3 million under the Bank of Montreal Facility as compared to $0.9 million as at December 31, 2012.

Cash and Cash Equivalents

As at September 30, 2013, the Company’s principal sources of liquidity included cash and cash equivalents of $26.0 million, the Credit Facility, anticipated collection from trade accounts receivable of $44.3 million including receivables from theaters under joint revenue sharing arrangements and DMR agreements with studios, anticipated collection from financing receivables due in the next 12 months of $18.0 million and payments expected in the next 12 months on existing backlog deals. As at September 30, 2013, the Company had drawn down $5.0 million on the Credit Facility (with remaining availability of $195.0 million). There were $nil letters of credit and advance payment guarantees outstanding under the Credit Facility and $0.3 million under the Bank of Montreal Facility.

During the nine months ended September 30, 2013, the Company’s operations provided cash of $33.0 million. The Company used cash of $24.3 million to fund capital expenditures, principally to build equipment for use in joint revenue sharing arrangements, to purchase other intangible assets, including costs to develop the Company’s new enterprise resource planning (“ERP”) system, and to purchase property, plant, and equipment. Based on management’s current operating plan for 2013, the Company expects to continue to use cash to deploy additional theater systems under joint revenue sharing arrangements and to fund DMR agreements with studios. Cash flows from joint revenue sharing arrangements are derived from the theater box-office and concession revenues and the Company invested directly in the roll out of 37 theater systems under joint revenue sharing arrangements during the nine months ended September 30, 2013.

The Company believes that cash flow from operations together with existing cash and borrowing available under the Credit Facility will be sufficient to fund the Company’s business operations, including its strategic initiatives relating to existing joint revenue sharing arrangements for the next 12 months.

The Company’s operating cash flow will be adversely affected if management’s projections of future signings for theater systems and film performance, theater installations and film productions are not realized. In addition, as a result of the implementation of the Company’s new ERP system, certain invoicing and collections were delayed during the first quarter of the year. The Company has made significant progress in resolving these delays and anticipates that the impact will be substantially resolved during the remainder of 2013. The Company believes these amounts, the majority of which have now been billed, are collectible. The Company forecasts its short-term liquidity requirements on a quarterly and annual basis. Since the Company’s future cash flows are based on estimates and there may be factors that are outside of the Company’s control (see “Risk Factors” in Item 1A in the Company’s 2012 Form 10-K), there is no guarantee that the Company will continue to be able to fund its operations through cash flows from operations. Under the terms of the Company’s typical sale and sales-type lease agreement, the Company receives substantial cash payments before the Company completes the performance of its obligations. Similarly, the Company receives cash payments for some of its film productions in advance of related cash expenditures.

Operating Activities

The Company’s net cash provided by operating activities is affected by a number of factors, including the proceeds associated with new signings of theater system lease and sale agreements in the year, costs associated with contributing systems under joint revenue sharing arrangements, the box-office performance of films distributed by the Company and/or released to IMAX theaters, increases or decreases in the Company’s operating expenses, including research and development, and the level of cash collections received from its customers.

Cash provided by operating activities amounted to $33.0 million for the nine months ended September 30, 2013. Changes in other non-cash operating assets as compared to December 31, 2012 include: an increase of $5.7 million in financing receivables; an increase of $2.3 million in accounts receivable; an increase of $5.5 million in inventories; an increase of $0.7 million in prepaid expenses; and a decrease of $0.5 million in other assets which includes a $0.1 million decrease in insurance recoveries receivable and a $0.9 million decrease in other assets. These decreases were offset by a $0.5 million increase in commission and agency fees. Changes in other operating liabilities as compared to December 31, 2012 include: a decrease in deferred revenue of $0.2 million related to backlog payments received in the current period, offset by amounts relieved from deferred revenue related to theater system installations; an increase in accounts payable of $2.8 million; and an increase of $1.2 million in accrued liabilities which is net of $2.0 million for variable stock-based compensation payments in the period.

Investing Activities

Net cash used in investing activities amounted to $26.8 million in the nine months ended September 30, 2013, which includes an investment in joint revenue sharing equipment of $16.3 million, purchases of $6.2 million in property, plant and equipment, an investment in new business ventures of $2.5 million and an increase in other intangible assets of $1.8 million.

Financing Activities

Net cash used in financing activities in the nine months ended September 30, 2013 amounted to $1.5 million as compared to $19.3 million for nine months ended September 30, 2012, which includes net bank indebtedness repayments of $6.0 million, fees paid of $2.1 million relating to the Credit Facility amendment and $0.2 million in share issuance expenses. These payments were offset by proceeds from the issuance of common shares resulting from stock option exercises of $6.8 million.

Capital Expenditures

Capital expenditures, including the Company’s investment in joint revenue sharing equipment, purchase of property, plant and equipment, net of sales proceeds, other intangible assets and investments in film assets were $41.1 million for the nine months ended September 30, 2013 as compared to $36.3 million for the nine months ended September 30, 2012.

CONTRACTUAL OBLIGATIONS

Payments to be made by the Company under contractual obligations are as follows:


	Payments Due by Period
*(In thousands of U.S. Dollars)*	Total Obligations		2013		2014		2015		2016		2017		Thereafter
Pension obligations⁽¹⁾	$	21,058	$	—	$	21,058	$	—	$	—	$	—	$	—
Credit Facility⁽²⁾		5,000		—		—		—		—		—		5,000
Operating lease obligations⁽³⁾		10,572		1,718		5,699		1,242		533		533		847
Purchase obligations⁽⁴⁾		9,769		9,628		141		—		—		—		—
Postretirement benefits obligations⁽⁵⁾		2,515		59		76		102		122		140		2,016
Capital lease obligations⁽⁶⁾		4		4		—		—		—		—		—

	$	48,918	$	11,409	$	26,974	$	1,344	$	655	$	673	$	7,863

(1)	The SERP assumptions are that Mr. Gelfond will receive a lump sum payment six months after retirement at the end of the current term of his employment agreement (December 31, 2013), although Mr. Gelfond has not informed the Company that he intends to retire at that time.

(2)	Interest on the Credit Facility is payable quarterly in arrears based on the applicable variable rate and is not included above.

(3)	The Company’s total minimum annual rental payments to be made under operating leases, mostly consisting of rent at the Company’s properties in New York and Santa Monica, and at the various owned and operated theaters.

(4)	The Company’s total payments to be made under binding commitments with suppliers and outstanding payments to be made for supplies ordered but yet to be invoiced.

(5)

In February 2013, the Company amended the Canadian postretirement plan to reduce future benefits provided under the plan. As a result of this change, the Company’s postretirement liability was reduced by $2.6 million, resulting in a pre-tax curtailment gain in the first quarter of 2013 of $2.2 million.

(6)	The Company’s total minimum annual payments to be made under capital leases, mostly consisting of payments for IT hardware and various other fixed assets.

Pension and Postretirement Obligations

The Company has an unfunded defined benefit pension plan (the “SERP”) covering Messrs. Gelfond and Wechsler. As at September 30, 2013, the Company had an unfunded and accrued projected benefit obligation of approximately $20.5 million (December 31, 2012 — $20.4 million) in respect of the SERP.

On August 1, 2010, the Company made a lump sum payment to Mr. Wechsler in accordance with the terms of the plan, representing a settlement of Mr. Wechsler’s entitlement under the SERP. Under the terms of the SERP, if Mr. Gelfond’s employment is terminated other than for cause (as defined in his employment agreement), he is entitled to receive SERP benefits in the form of a lump sum payment. SERP benefit payments to Mr. Gelfond are subject to a deferral for six months after the termination of his employment, at which time Mr. Gelfond will be entitled to receive interest on the deferred amount credited at the applicable federal rate for short-term obligations. The term of Mr. Gelfond’s current employment agreement has been extended through December 31, 2013, although Mr. Gelfond has not informed the Company that he intends to retire at that time. Under the terms of the extension, Mr. Gelfond also agreed that any compensation earned during 2011, 2012 and 2013 would not be included in calculating his entitlement under the SERP.

The Company has a postretirement plan to provide health and welfare benefits to Canadian employees meeting certain eligibility requirements. As at September 30, 2013, the Company had an unfunded benefit obligation of $2.0 million (December 31, 2012 — $4.6 million). In February 2013, the Company amended the Canadian postretirement plan to reduce future benefits provided under the plan. As a result of this change, the Company’s postretirement liability was reduced by $2.6 million, resulting in a pre-tax curtailment gain in the first quarter of 2013 of $2.2 million. See note 4 to the audited consolidated financial statements in Item 8 of the Company’s 2012 Form 10-K for additional details.

In July 2000, the Company agreed to maintain health benefits for Messrs. Gelfond and Wechsler upon retirement. As at September 30, 2013, the Company had an unfunded benefit obligation of $0.5 million (December 31, 2012 — $0.5 million).

OFF-BALANCE SHEET ARRANGEMENTS

There are currently no off-balance sheet arrangements that have or are reasonably likely to have a current or future material effect on the Company’s financial condition.

Item 3. Quantitative and Qualitative Factors about Market Risk

The Company is exposed to market risk from foreign currency exchange rates and interest rates, which could affect operating results, financial position and cash flows. Market risk is the potential change in an instrument’s value caused by, for example, fluctuations in interest and currency exchange rates. The Company’s primary market risk exposure is the risk of unfavorable movements in exchange rates between the U.S. dollar, the Canadian dollar and the Chinese Yuan Renminbi. The Company does not use financial instruments for trading or other speculative purposes.

Foreign Exchange Rate Risk

A majority of the Company’s revenue is denominated in U.S. dollars while a significant portion of its costs and expenses is denominated in Canadian dollars. A portion of the Company’s net U.S. dollar cash flows is converted to Canadian dollars to fund Canadian dollar expenses through the spot market. The Company has incoming cash flows from its revenue generating theaters and ongoing operating expenses in China through its wholly-owned subsidiary IMAX Shanghai Multimedia Technology Co. Ltd. In Japan, the Company has ongoing Yen-denominated operating expenses related to its Japanese operations. Net Renminbi and Japanese Yen cash flows are converted to U.S. dollars through the spot market. The Company also has cash receipts under leases denominated in Japanese Yen, Euros and Canadian dollars.

The Company manages its exposure to foreign exchange rate risks through the Company’s regular operating and financing activities and, when appropriate, through the use of derivative financial instruments. These derivative financial instruments are utilized to hedge economic exposures as well as reduce earnings and cash flow volatility resulting from shifts in market rates.

For the three and nine months ended September 30, 2013, the Company recorded a foreign exchange gain of $0.8 million and a loss of less than $0.1 million, respectively, as compared to a foreign exchange gain of $0.3 million and gain of $1.2 million for the three and nine months ended September 30, 2012, respectively, associated with the translation of foreign currency denominated monetary assets and liabilities and unhedged foreign exchange contracts.

The Company entered into a series of foreign currency forward contracts to manage the Company’s risks associated with the volatility of foreign currencies. The forward contracts have settlement dates throughout 2014. In addition, at September 30, 2013, the Company held foreign currency forward contracts to manage foreign currency risk on future anticipated Canadian dollar expenditures that were not considered foreign currency hedges by the Company. Foreign currency derivatives are recognized and measured in the balance sheet at fair value. Changes in the fair value (gains or losses) are recognized in the condensed consolidated statement of operations except for derivatives designated and qualifying as foreign currency hedging instruments. For foreign currency hedging instruments, the effective portion of the gain or loss in a hedge of a forecasted transaction is reported in other comprehensive income and reclassified to the condensed consolidated statement of operations when the forecasted transaction occurs. Any ineffective portion is recognized immediately in the condensed consolidated statement of operations. The notional value of foreign currency hedging instruments was $24.6 million as at September 30, 2013 (December 31, 2012 — $8.1 million). A gain of $0.5 million and loss of $0.3 million was recorded to Other Comprehensive Income with respect to the depreciation/appreciation in the value of these contracts in the three and nine months ended September 30, 2013, respectively (2012 — gain of $0.6 million and gain of $0.8 million, respectively). A loss of $0.2 million and loss of $0.1 million for the three and nine months ended September 30, 2013, respectively (2012 — gain of $0.2 million and gain of less than $0.1 million, respectively) was reclassified from Accumulated Other Comprehensive Income to selling, general and administrative expenses. Appreciation or depreciation on forward contracts not meeting the requirements for hedge accounting in the Derivatives and Hedging Topic of the FASB Accounting Standards Codification are recorded to selling, general and administrative expenses. The notional value of forward contracts that do not qualify for hedge accounting at September 30, 2013 was $nil (December 31, 2012 — $nil).

For all derivative instruments, the Company is subject to counterparty credit risk to the extent that the counterparty may not meet its obligations to the Company. To manage this risk, the Company enters into derivative transactions only with major financial institutions.

At September 30, 2013, the Company’s financing receivables and working capital items denominated in Canadian dollars, Renminbi, Yen and Euros was $18.9 million. Assuming a 10% appreciation or depreciation in foreign currency exchange rates from the quoted foreign currency exchange rates at September 30, 2013, the potential change in the fair value of foreign currency-denominated financing receivables and working capital items would have been $1.9 million. A significant portion of the Company’s selling, general, and administrative expenses is denominated in Canadian dollars. Assuming a 1% change appreciation or depreciation in foreign currency exchange rates at September 30, 2013, the potential change in the amount of selling, general, and administrative expenses would be $0.1 million for every $10.0 million in Canadian denominated expenditures.

Interest Rate Risk Management

The Company’s earnings are also affected by changes in interest rates due to the impact those changes have on its interest income from cash, and its interest expense from variable-rate borrowings under the Credit Facility.

As at September 30, 2013, the Company borrowings under the Credit Facility were $5.0 million (December 31, 2012 — $11.0 million).

The Company’s largest exposure with respect to variable rate debt comes from changes in LIBOR. The Company had variable rate debt instruments representing approximately 3.1% and 6.5% of its total liabilities as at September 30, 2013 and December 31, 2012, respectively. If interest rates available to the Company increased by 10%, the Company’s interest expense would increase by approximately less than $0.1 million and interest income from cash would increase by approximately less than $0.1 million for the quarter ended September 30, 2013. These amounts are determined by considering the impact of the hypothetical interest rates on the Company’s variable-rate debt and cash balances at September 30, 2013.

Item 4. Controls and Procedures

EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES

The Company maintains disclosure controls and procedures designed to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the specified time periods and that such information is accumulated and communicated to management, including the CEO and the Chief Financial Officer (“CFO”), to allow timely discussions regarding required disclosure. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

The Company’s management, with the participation of its CEO and its CFO, has evaluated the effectiveness of the Company’s “disclosure controls and procedures” (as defined in the Securities Exchange Act of 1934 Rules 13a-15(e) or 15d-15(e)) as at September 30, 2013 and has concluded that, as at the end of the period covered by this report, the Company’s disclosure controls and procedures were adequate and effective. The Company will continue to periodically evaluate its disclosure controls and procedures and will make modifications from time to time as deemed necessary to ensure that information is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s (the “SECs”) rules and forms.

CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

During the first quarter of 2013, the Company implemented a new enterprise resource planning (“ERP”) system. The implementation of the new ERP system resulted in material changes to the nature and type of the Company’s internal controls over financial reporting during the nine months ended September 30, 2013. The Company reviewed the implementation effort as well as the impact on its internal controls over financial reporting and where appropriate, is making changes to these controls over financial reporting to address these system changes. The Company expects the transition period to be completed in the fourth quarter of 2013 as controls evolve under the new system. The Company believes that the internal control changes resulting from the new ERP implementation will improve the overall control environment. There were no other changes in the Company’s internal controls over financial reporting during the quarter ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

See note 10 to the accompanying condensed consolidated financial statements in Item 1 for information regarding legal proceedings involving the Company.

Item 1A. Risk Factors

The have been no material changes to the factors disclosed in Item 1A. Risk Factors in the Company’s Annual Report on Form 10-K. The risks described in the Company’s 2012 Form 10-K are not the only risks facing the Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Item 6. Exhibits


Exhibit No.		Description

3.1		Restated Articles of Incorporation of IMAX Corporation, dated July 30, 2013.

31.1		Certification Pursuant to Section 302 of the Sarbanes — Oxley Act of 2002, dated October 24, 2013, by Richard L. Gelfond.

31.2		Certification Pursuant to Section 302 of the Sarbanes — Oxley Act of 2002, dated October 24, 2013, by Joseph Sparacio.

32.1		Certification Pursuant to Section 906 of the Sarbanes — Oxley Act of 2002, dated October 24, 2013, by Richard L. Gelfond.

32.2		Certification Pursuant to Section 906 of the Sarbanes — Oxley Act of 2002, dated October 24, 2013, by Joseph Sparacio.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	IMAX CORPORATION

Date: October 24, 2013		By:	/s/ JOSEPH SPARACIO
			Joseph Sparacio
			Executive Vice-President & Chief Financial Officer
			(Principal Financial Officer)

Date: October 24, 2013		By:	/s/ JEFFREY VANCE
			Jeffrey Vance
			Senior Vice-President, Finance & Controller
			(Principal Accounting Officer)

EX-3.1

IMAX CORPORATION

EXHIBIT 3.1

Restated Articles of Incorporation


		Industry Canada		Industrie Canada


Restated Certificate of		Certificat de constitution à
Incorporation		jour

Canada Business Corporations Act		Loi canadienne sur les sociétés par actions

IMAX CORPORATION

Corporate name / Dénomination sociale

399473-2

Corporation number / Numéro de société


I HEREBY CERTIFY that the articles of incorporation of the above-named corporation were restated under section 180 of the Canada Business Corporations Act as set out in the attached restated articles of incorporation.		JE CERTIFIE que les statuts constitutifs de la société susmentionnée ont été mis à jour en vertu de l’article 180 de la Loi canadienne sur les sociétés par actions, tel qu’il est indiqué dans les statuts mis à jour ci-joints.

LOGO

Marcie Girouard

Director / Directeur

2013-07-30

Date of Restatement (YYYY-MM-DD)

Date de constitution à jour (AAAA-MM-JJ)

LOGO

(GRAPHIC) Industry Canada Canada Business Corporations Act
Industrie Canada Lol canadienne sur les sociétés par actions
FORM 7 RESTATED ARTICLES OF INCORPORATION (SECTION 180)
FORMULAIRE 7 STATUTS CONSTITUTIFS MIS À J OUR (ARTICLE 180)
1 - Name of the Corporation – Dénomination sociale de la société IMAX CORPORATION
Corporation No. - No de la société 399473-2
2 - The province of territory in Canada where the registered office is situated Ontario
La province ou le territoire au Canada ou est situé le siège social
3 - The classes and any maximum number of shares that the corporation is authorized to issue
Catégories at tout nombre maximal d’actions que la société est autorisés à àmettra
The Corporation is authorized to issue an unlimited number of Common Shares and an unlimited number of Special Shares, issuable in series. Schedule I sets forth the rights, privileges, restrictions and conditions of such shares.
4 - Restrictions, if any, on share transfers None.
Restrictions sur le transfert des actions, s’ll y a lieu
5 - Number (or minimum and maximum number) of directors Minimum: 1, Maximum : 15
Nombre (ou nombre minimal et maximal) d’administrateurs
6 - Restrictions, if any, on business the corporation may carry on None.
Limites imposées à l’activité commerciale de la société, s’ll y a lieu
7 - Other provisions, if any See Schedule II attached hereto.
Autres dispositions, s’ll y a lieu
These restated articles of incorporation correctly set out, without substantive change, the corresponding provisions of the articles of incorporation as amended and supersede the original articles of incorporation.
Cette miss à jour des statuts constitutifs démontre exactement, sans changement substantial, les dispositions correspondantes des statuts constitutifs modifiés qui remplacant les statuts constitutifs originaux.
Signature Printed Name - Nom an lettres mouides G. Mary Ruby
(GRAPHIC)
8 - Capacity of – En quaitté da Chief Administrative Officer and Corporate Secretary
9 - Tel. No. No de tèl.
FOR DEPARTMENTAL USE ONLY – A L’USAGE DU MINISTERE SEULEMENT
IC 3187(2003/08) E-MAIL (GRAPHIC)
2013-07-30
15:40

SCHEDULE I

1.	Common Shares

The rights, privileges, restrictions and conditions attaching to the Common Shares are as follows:

(a)

Payment of Dividends: The holders of the Common Shares shall be entitled to receive dividends if, as and when declared by the Board of Directors of the Corporation out of the assets of the Corporation properly applicable to the payment of dividends in such amounts and payable in such manner as the Board of Directors may from time to time determine. Subject to the rights of the holders of any other class of shares of the Corporation entitled to receive dividends in priority to or ratably with the holders of the Common Shares, the Board of Directors may in their sole discretion declare dividends on the Common Shares to the exclusion of any other class of shares of the Corporation.

(b)

Participation upon Liquidation, Dissolution or Winding-Up: In the event of the liquidation, dissolution or winding-up of the Corporation, or other distribution of assets of the Corporation among its shareholders for the purpose of winding-up its affairs, the holders of the Common Shares shall, subject to the rights of the holders of any other class of shares of the Corporation entitled to receive the assets of the Corporation upon such a distribution in priority to or ratably with the holders of the Common Shares, be entitled to participate ratably in any distribution of the assets of the Corporation.

(c)

Voting Rights: The holders of the Common Shares shall be entitled to receive notice of an to attend all annual and special meetings of the shareholders of the Corporation and to one vote in respect of each Common Share held at all such meetings.

2.	Special Shares

The rights, privileges, restrictions and conditions attaching to the Special Shares are as follows;

(a)

Series: The Special Shares may at any time or from time to time be issued in one or more series. The Board of Directors of the Corporation may from time to time before the issue thereof fix the number of shares in, and determine the designation, rights, privileges, restrictions and conditions attaching to the shares of, each series of Special Shares.

(b)

Priority: The Special Shares shall be entitled to priority over the Common Shares and all other shares ranking junior to the Special Shares with respect to the payment of dividends and the distribution of assets of the Corporation in the event of any liquidation, dissolution or winding-up of the Corporation or other distribution of assets of the Corporation among its shareholders for the purpose of winding-up its affairs.

(c)

Voting Rights: Except as otherwise provided by law, the holders of the Special Shares shall not, as such, be entitled to receive notice of or to attend any

MT DOCS 12832174v1

meeting of the shareholders of the Corporation and shall not be entitled to vote at any such meeting. Without limiting the generality of the foregoing, the holders of the Special Shares shall not be entitled to vote separately as a class on any proposal to amend the Articles of the Corporation to:

(i)

increase or decrease any maximum number of authorized Special Shares, or increase any maximum number of authorized shares of a class having rights or privileges equal or superior to the Special Shares; or

(ii)

effect an exchange, reclassification or cancellation of all or part of the Special Shares; or

(iii)

create a new class of shares equal or superior to the Special Shares.

MT DOCS 12832174v1

- 2 -

SCHEDULE II

The number of directors of the Corporation at any time shall be such number within the minimum and maximum number of directors set forth in the articles of the Corporation as is determined from time to time by resolution of the directors in light of the Corporation’s contractual obligations in effect from time to time.

Subject to the Canada Business Corporations Act and the Corporation’s contractual obligations then in effect, the directors may fill any vacancies among the directors, whether arising due to an increase in the number of directors within the minimum and maximum number of directors set forth in the articles of the Corporation or otherwise.

3.	Directors elected at a meeting of shareholders will hold offices until the next annual meeting of shareholders or until their successors are elected or appointed.

Meetings of shareholders may be held in New York, New York; Los Angeles, California; Santa Monica, California; San Diego, California; Chicago, Illinois; Houston, Texas; San Antonio, Texas; Dallas, Texas; Philadelphia, Pennsylvania; Phoenix, Arizona; Detroit, Michigan; and Washington, DC; or in any place in Canada that the directors from time to time determine.

MT DOCS 12832174v1

EX-31.1

IMAX CORPORATION

Exhibit 31.1

Certification Pursuant to Section 302 of the Sarbanes - Oxley Act of 2002

I, Richard L. Gelfond, certify that:

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 of the registrant, IMAX Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:	October 24, 2013	By:	/s/ Richard L. Gelfond
		Name:	Richard L. Gelfond
		Title:	Chief Executive Officer

EX-31.2

IMAX CORPORATION

Exhibit 31.2

Certification Pursuant to Section 302 of the Sarbanes - Oxley Act of 2002

I, Joseph Sparacio, certify that:

I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 of the registrant, IMAX Corporation;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:	October 24, 2013	By:	/s/ Joseph Sparacio
		Name:	Joseph Sparacio
		Title:	Executive Vice President & Chief Financial Officer

EX-32.1

IMAX CORPORATION

Exhibit 32.1

CERTIFICATIONS

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (A) and (B) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), I, Richard L. Gelfond, Chief Executive Officer of IMAX Corporation, a Canadian corporation (the “Company”), hereby certify, to my knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2013 (the “Form 10-Q”) of the Company fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:	October 24, 2013	/s/ Richard L. Gelfond
		Richard L. Gelfond
		Chief Executive Officer

EX-32.2

IMAX CORPORATION

Exhibit 32.2

CERTIFICATIONS

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (A) and (B) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), I, Joseph Sparacio, Executive Vice President & Chief Financial Officer of IMAX Corporation, a Canadian corporation (the “Company”), hereby certify, to my knowledge, that:


Date:	October 24, 2013	/s/ Joseph Sparacio
		Joseph Sparacio
		Executive Vice President & Chief Financial Officer